The Design and Application of Bis-Urea Derived Supramolecular Gelators by FOSTER, JONATHAN,ANDREW
Durham E-Theses
The Design and Application of Bis-Urea Derived
Supramolecular Gelators
FOSTER, JONATHAN,ANDREW
How to cite:
FOSTER, JONATHAN,ANDREW (2012) The Design and Application of Bis-Urea Derived Supramolecular
Gelators, Durham theses, Durham University. Available at Durham E-Theses Online:
http://etheses.dur.ac.uk/3598/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Oﬃce, Durham University, University Oﬃce, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
2
  
 
 
The Design and Application of Bis-Urea 
Derived Supramolecular Gelators 
 
 
 
 
 
A thesis submitted for the fulfilment of the requirements for the degree of 
Doctor of Philosophy 
In the faculty of Science of Durham University 
by 
Jonathan Andrew Foster 
 
 
 
 
 
Department of Chemistry 
Durham University 
South Road 
Durham 
 
2012
 i 
 
Abstract The design and application of bis-urea derived 
supramolecular gelators 
 
A series of amino-acid derived bis-urea gelators were synthesised, some of which show 
strong gelation in a wide variety of solvents. The gels were probed at the molecular, 
microscopic and macroscopic levels to gain insights into the gelation behaviour observed. 
Mixtures of different gelators also result in gels, some of which show different fibre 
morphologies and X-ray powder patterns to the pure gelators. The series was extended to 
include fluorescent 1- and 2-pyrenylalanine derived gelators and the fluorescence behaviour 
of the gels in solution, the gel state, in mixed gels and with the addition of anions was 
investigated. Tetrabutylammonium-acetate was found to disrupt urea-hydrogen bonding 
leading to the break-down of the gels, a process which was followed by NMR spectroscopy, 
rheometry and fluorescence spectroscopy. Two gelators were used to template the formation 
of porous polymers which SEM and gas adsorption studies show reflect the different fibre 
morphologies observed in the gels. 
 
The use of supramolecular gels as a medium for controlling the crystallisation of 
pharmaceutical compounds was developed. Proof of principle for the growth of a wide range 
of pharmaceutical compounds from a variety of different gels was demonstrated. The 
supramolecular nature of the gels was exploited by using anions to break down the gels in 
order to recover the crystals.  Comparison of crystals grown from gels with those grown from 
solution highlighted a number of differences in crystal form, habit and stability. Gelators 
which mimic the chemical functionality of the drug compound being crystallised were 
synthesised. A study investigating the crystallisation of 5-methyl-2-[(2-nitrophenyl)amino]-3-
thiophenecarbonitrile (ROY) showed some differences in polymorphism when crystallised 
from a gel designed to mimic ROY compared to generic gels. A placement with the particle 
science group at GSK explored the potential of supramolecular gels for use in early stage 
screening of pharmaceutical compounds in an industrial setting.  
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Chapter 1: Design and application of urea-derived supramolecular 
gelators 
1.1 Introduction 
1.1.1 Common Characteristics 
Everyday products such as jelly, hair gel, contact lenses and lithium grease are readily 
identified as gels despite their very different molecular and structural compositions. Gels are 
materials which have solid-like flow properties despite being predominantly liquid in 
composition. The gel state arises when solvent is trapped through surface tension by a 
continuous, sample spanning structure. This structure may be lamellar (e.g. soaps and clays), 
a covalent polymeric network (e.g. silica gels), a polymeric network formed through physical 
aggregation (e.g. gelatin) or particulate in nature (e.g. precipitates consisting of highly 
anisotropic particles).
1
 
 
Figure 1 Optical micrographs showing time evolution of a fibrillar gel network upon slow cooling of N-lauroyl-
L-glutamic acid di-n-butylamide/propylene glycol: (a) one-dimensional growth of fibres, b) and c) branching of 
fibres d) aggregation of fibres, e) formation of sample spanning network.
2
   
 
Considerable progress has recently been made in the development and characterisation of 
supramolecular gels in which the macromolecular networks are assembled through non-
covalent interactions. The basic building block of a supramolecular gel is a low molecular 
weight compound (known as a low molecular weight gelator, LMWG) which typically makes 
up 1 % of the gel by weight whilst the remaining 99% is solvent. The LMWG undergo an 
arrested crystallisation stacking together preferentially in one direction to give highly 
anisotropic structures (Figure 1a). These structures either physically entangle or cross link 
 2 
 
through intermolecular interactions to form a sample spanning network which traps large 
volumes of solvent through surface tension. Because the gel network is held together by 
supramolecular interactions most LMWGs are thermally reversible and reform upon cooling 
from a hot solution. 
 
A wide variety of chemical species form supramolecular gels including surfactants,
3
 fatty 
acids,
4
  nucleobases,
5
 porphyrin derivatives,
6
 dendrimers,
7
 amino acids,
8
 peptides
9
 and
 
carbohydrates.
10
 These compounds contain a number of motif-forming functional groups 
which enable the anisotropic aggregation required for gel formation to take place. These 
include amides, ureas, oxalamides,
11
 (-XCONH- hydrogen bonding), carbohydrates (multiple 
–OH hydrogen bonding), steroids (hydrophobic surfaces), nucleobases (hydrogen bonding 
and π-π stacking) and long chain alkanes (van der Waals interactions).12 A variety of host-
guest interactions have also been exploited effectively to create supramolecular gels.
13
 In 
addition to a single gelling component, a variety of multi-component gelators have been 
developed. Such systems may consist of two or more organic components coming together to 
form a gel,
14-17
 incorporation of a metal ion to form a metallo-gel
12, 18, 19
 or the inclusion of 
nano-materials to form composite gels.
20-23
 
 
The nature of the solvent mediates the relative importance of different types of gelator-
gelator interactions. In organic solvents aggregation is typically driven by attractive forces 
between gelator units, such as hydrogen bonding, dipolar interactions, electron transfer and 
metal-co-ordinated interactions.
24
 Such systems are termed organogels.
24
 However, such 
interactions tend to lose their strength in water due to solvation, so it is often less directional 
hydrophobic effects which dictate hydrogel formation.
25
 Stronger attractive components such 
as salt bridges, metal co-ordination and co-operative hydrogen bonding can also play a role, 
particularly when shielded from solvent by hydrophobic groups.
26
 Some gelators are able to 
gel both aqueous and organic solvents and such systems are described as amphiphilic 
gelators.
27
  
 
Although a diverse range of compounds form gels, the delicate balance of interactions 
required to bring about gel formation means small changes in molecular structure can lead to 
large differences in gelation behaviour. This may be due to subtle differences in 
conformation, steric interactions or electronic effects resulting from the different substituents. 
 3 
 
Solvent-gelator interactions must also be taken into consideration in terms of the solubility of 
the gelator, templating effects on the nucleation of different forms and wetting of the gel 
matrix. These factors make a priori predictions about which compounds will form gels and 
under what conditions difficult and most new classes of gelator are still discovered 
serendipitously.
28
  
 
One successful attempt to predict the packing of a gel, formed by sonication of melamine and 
uric acid, was made by Anderson et al.
29
 They used ab initio crystal structure calculation to 
identify the lowest lattice energy combinations from 250,000 candidate structures, one of 
which was found to match the X-ray powder pattern of the dried gel. However, these gelators 
have unusually rigid structures for LMWGs which aided prediction and many gels are not 
formed under thermodynamic control. Gelators can be polymorphic and in a recent example 
four different crystal forms were crystallised from gels of the same silver(I) gelator in 
different solvents.
30
 In a number of cases crystallisation of the gelator has been observed to 
occur over time if the gel is not the thermodynamically stable phase.
17, 31-33
 
 
In comparison to the gelator-gelator interactions, relatively little is known about the role of 
solvent in gel formation. Smith and co-workers considered the effect of Kamlet-Taft 
parameters on a series of lysine derived bis-urea gelators with different length alkyl chains.
34
 
They found that the α parameter (hydrogen bond donor ability) of the solvent was most 
important in determining whether a gelator network can be established, the β parameter 
(hydrogen bond acceptor ability) modulates gelator-gelator interactions whilst the π* 
parameter (polarisability) tunes interactions between gel fibres and solvent molecules. 
Dissolution studies for a series of pyridine derived compounds showed that room temperature 
solubility was a poor indicator of gelation ability.
35
 However, gelators were found to exhibit 
higher dissolution enthalpies and entropies than non-gelators consistent with stronger 
intermolecular interactions and more order in the solid state. Similar findings were observed 
when the range of gelators was extended to include a series of peptide derived gelators.
36  
 
1.1.2 Characterising the gel state 
The bench-top test to determine whether a compound forms a gel is to invert a vial containing 
a low concentration of the potential gelator recrystallised from a hot solution; if the mixture 
doesn’t flow then it is considered to have gelled. This is essentially a crude rheometric 
 4 
 
measurement and more detailed, quantitative measurements can be made using a rheometer. 
Gels are viscoelastic materials displaying both solid-like behaviour, characterised by an 
elastic storage modulus G′, and liquid-like viscous behaviour, characterised by the elastic loss 
modulus G′′ (equation 1).  Both G′ and G′′ have units of Pascals. As gels are solid-like in 
their flow properties, G′ is typically an order of magnitude greater than G′′ under a weak 
applied stress (σ). In a gel G′ should also be constant over a wide range of frequencies when a 
low stress is applied.
12, 24, 37, 38
 
           (1) 
    
  
  
     (2) 
     
  
  
     (3) 
At higher stresses the gels shear and begin to flow, a point referred to as the yield stress. This 
correlates with a drop in G′ below that of G′′ indicating liquid like behaviour. This transition 
can also be observed by monitoring the phase difference (δ) between the applied stress (σ) 
and resulting strain (ε) which should be close to 0° in the solid-like gels (equations 2 and 3). 
The magnitude of G′ gives an indication about the relative strength of the gel, however small 
differences in sample preparation and the presence of defects such as air bubbles can lead to 
significant variation in the values obtained.
24
 
 
The minimum concentration of gelator required to form a gel is termed the critical gelator 
concentration (CGC) and may be measured by rheometry or more typically the inversion test. 
The temperature at which the gel-sol transition takes place, known as the Tgel, is typically 
measured using the ‘dropping ball’ test. A ball bearing is placed on the surface of a gel and 
the sample gradually heated in a water bath with the point at which the gel can no-longer 
support the ball bearing defining the Tgel. Alternative measurements can be made by 
rheology, differential scanning calorimetry (DSC) or spectroscopic techniques with the same 
gel giving disparate readings depending on what level of structural break down is being 
characterised.
39, 40
 The break-down of the gel matrix does not necessarily correlate with 
dissolution of the gelator and a number of methods have been employed to measure the 
solubility of the gelator molecules.
34, 35, 41
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Figure 2 Hydrogel formed by riboflavin and melamine imaged using a) optical microscopy, b) fluorescence 
microscopy, c) scanning electron microscopy (SEM), d) transmission electron microscopy (TEM), e) atomic 
force microscopy (AFM) f) 3D reconstruction of e) showing helical fibres.
42
 
 
Optical microscopy provides real time imaging of the gel matrix in its solvated state, 
allowing dynamic features such the growth of fibres from solution (Figure 1) to be captured.
2
 
However, it is the wide spread availability of scanning electron microscopy (SEM) in recent 
years that has allowed detailed images to be built up about the nanoscopic morphology of the 
c 
a b 
d 
e f 
 6 
 
gel matrix and interactions between gel fibres. One limitation of this and related techniques, 
such as transmission electron microscopy (TEM), is the requirement for high vacuum. 
Samples are therefore typically viewed as dried xerogels, opening up the possibility of 
changes in gel structure upon loss of solvent.
36
 Cryo-SEM allows for in situ de-solvation of 
the gels minimising the chance of transformations whilst environmental SEM allows imaging 
of solvated gels, albeit with lower resolution. More detailed imaging techniques such as 
atomic force microscopy and scanning tunnelling microscopy have also been applied to 
LMWGs. A good comparison of the different techniques is provided by Saha et al. who 
imaged a hydrogel formed by riboflavin and melamine using a range of techniques as shown 
in Figure 2.
42
 
 
Single crystal structure determination remains an invaluable tool for understanding how small 
molecule gelators pack together in the solid state. The relationship between the gel and 
crystalline state is typically established by comparing X-ray powder diffraction (XRPD) data 
for the xerogels with calculated patterns derived from crystal structure data, although the 
possibility of rearrangement upon drying remains.
30, 36
 X-ray powder patterns have been run 
directly on more crystaline gel samples with the broad pattern for the solvent background 
subtracted to emphasise the gelator peaks.
43
 Other diffraction techniques such as small angle 
X-ray or neutron scattering (SAXS and SANS respectively) provide further information 
about spacing between gelator molecules.
9, 41
 Other techniques such as IR, Raman and NMR 
spectroscopy have also been used to provide insights into intermolecular interactions.
42, 44
 
 
1.2 Urea derived Gelators 
1.2.1 Urea derived gelators 
One motif that has proved prolific at bringing about gelation in low molecular weight 
compounds is the urea moiety. Key to the success of urea derivatives in bringing about 
gelation is the formation of the α-urea tape motif. Urea groups stack together to form a chain 
of 6-membered hydrogen bonded rings based on two hydrogen bond donors and one carbonyl 
acceptor,       
     in graph set nomenclature (Figure 3a).45 The strength of this interaction 
between two urea molecules was calculated to be 44.80 kJmol
-1
.
46
 It is these hydrogen 
bonded chains which typically provide the strong directionality required to form high aspect 
ratio fibres which (upon physical entanglement) lead to the formation of gels (Figure 3b).  
 7 
 
    
Figure 3 a) Ureas are an example of a functional group which can favourably stack together through hydrogen 
bonds to give one-dimensional fibrils. b) These fibrils can aggregate to form larger fibres which interweave to 
create a sample spanning network.
25
  
 
The simplest urea based gelator, and possibly the lowest molecular weight gelator to date, is 
N,N′-dimethylurea (Mw 88) which forms gels in silicone oil.
46
 This compound forms part of a 
series of related N,N′-dialkylurea gelators with different alkyl chain lengths developed by 
Weiss and co-workers. The optimum length was found to be the dipropyl derivative with 
shorter and longer chain lengths requiring higher concentrations of compound to produce a 
stable gel. Mono-alkylated ureas with primary amido groups are typically more efficiently in 
hydrogen bonding than secondary amido groups, although the hydrophobic contributions of 
the alkyl chains are also important.  
 
In a recent paper, Kim et al. compared the gelation behaviour of (R)- and (S)-2-heptylurea 
with a racemic mixture.
47
 The individual enantiomers formed gels in a greater range of 
solvents at lower concentrations than a racemic mixture or n-hexylurea. SEM studies showed 
1D structures are formed by the resolved compounds whilst 2D ribbons are formed by the 
racemic and achiral gelators (Figure 4a and b). The crystal structure obtained for racemic 2-
heptylurea (Figure 4c) was found to be in      , a space group not available to the pure 
enantiomers potentially explaining the differences in morphology and gelation behaviour 
observed. 
  
O
N N
O
HH
R R
N N
O
HH
R R
N N
HH
R R
a) b) 
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Figure 4 SEM images showing morphologies obtained from 1:1 ethylacetate:hexane for a) rac-2-heptylurea and 
b) (s)-2-helptylurea. c) crystal structure obtained for racemic 2-heptylurea. 47  
 
 
                   
 
  
        
         
                              
 
Figure 5 Molecular modelling of compound 2 (R= CH3) showing a) intramolecular hydrogen bonding in 
monomer  b) anti-parallel and c) parallel hydrogen bonding in stacks.
48
 Model for the incorporation of R,R-4 
into an aggregate of d) R,R-3 e) S,S-3 showing the distinct environments of the azobenzene groups. 
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Much of the early work on urea derived gelators was undertaken by Van Esch and co-
workers. They developed a series of cyclic bis-ureas including compounds 2, 3 and 4. 
48-50
    
Molecular modelling showed compound 2 can potentially adopt either parallel or antiparallel 
bis-urea chains (Figure 5).
48
 On its own an antiparallel arrangement of the monomer is 
favoured due to an intramolecular hydrogen bond between the urea groups. Parallel and 
antiparallelstacks are equally favourable and experimental results indicate a number of 
different phases may be present, potentially within a single gel. A wide range of derivatives 
based on the same hexane bis-urea structure were synthesised. A study testing the gelation 
behaviour of derivative 3 in a range of alcohols found that the thermal stability of the gels 
formed increased with the polarity of the solvent.
49
 This is the opposite behaviour to that 
which is expected if hydrogen-bond formation is the primary driving force for aggregation 
which indicates that solvophobic interactions from the dodecyl chains is the dominant 
interaction in the polar solvents tested. 1,2-bis(ureido)cyclohexane derivatives such as 
compound 3 and the related azobenzene functionalised compound 4 have two stereogenic 
centres. The R,R-diasteriomer of compound 4 was found to form a mixed gels with the R,R- 
and S,S-diasteriomers of 3 (Figure 5d and e).
50
  
 
Chiral S-phenylethyl end groups were deliberately incorporated into a series of 
oligomethylene spaced bis-urea gelators developed by Steed and co-workers.
51, 52
 For bis-
ureas, the two urea tapes may run in the same (parallel) or opposite (antiparallel) direction.  
In this series, gelation was only observed for even spacer lengths (no. of carbon atoms  n = 2-
8) where antiparallel bis-urea tapes are formed whilst the parallel urea tapes observed in odd 
spaced compounds produced only precipitates (Figure 6). The same effect has been observed 
in a variety of other related systems.
53
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Figure 6 Alternation effect observed in a series of bis-urea gelators 5 (n= 2-8) with different lengths of alkane 
space where n= number of alkyl units in spacer (c). Even spacer lengths result in antiparallel bis-urea tapes (a) 
and give rise to gels whilst odd spacer lengths result in parallel bis-urea tapes (b) and are not associated with 
gelation.
51
 
 
A number of tripodal ureas have been developed based around a tris(2-aminoethyl)amine   
core.
54-56 As seen for gelator 6 the urea moiety in one arm undergoes intramolecular hydrogen 
bonding with the urea in the second arm (Figure 7). The second arm then intermolecularly 
hydrogen bonds to the third arm of an adjacent molecule and the process is mirrored by the 
second molecule producing antiparallel urea stacks akin to those seen in bis-urea gelators.
54
 
Compound 7 is unusual in showing a lamellar, rather than fibrous, morphology (Figure 7c 
and d). Aggregation into the second dimension is brought about by hydrophobic interactions 
between the alkyl chains. Aggregation into the third dimension depends upon the solvent 
from which the gel is crystallised leading to different xerogel morphologies. The wettability 
of xerogels of 7 was found to depend upon the solvent from which the gel is formed with 
a) b) 
c) 
N
H
N
H
O
N
H
N
H
O
n
 
5 
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contact angles of 80.3° from nBuOH and 146.0° from xylene.56  A tetra-urea gelator based on 
a [2.2]paracyclophane-bridged imidazole dimer has also been reported although little 
structural information is given.
57
  
 
 
 
Figure 7 X-ray crystallographic structures of 6 showing a) intramolecular hydrogen bonding between urea arms 
b) formation of antiparallel urea tapes.
54
  SEM image of xerogels of 7 showing unusual lamellar structures 
formed from (c) n-BuOH and (d) xylene 
56
 
 
The urea carbonyl oxygen atom is not a particularly effective hydrogen bond acceptor and its 
basicity depends on the electronic and steric properties of the substituents attached to the 
nitrogen atoms.
38
 The presence of electron withdrawing aromatic moieties, such as 
nitrophenyl groups, results in significant intramolecular CH···O hydrogen bonding making it 
unavailable for use as a hydrogen bonding acceptor. Interactions with hydrogen bond 
acceptors present in solvent molecules can result in the formation of inclusion compounds 
rather than hydrogen bonded polymers (Figure 8a).
58
 Recently a series of mono-urea 
compounds incorporating aromatic rings functionalised with nitro and acid groups have been 
produced. Many of the gelators, including compounds 8 and 9, form gels based on a mixture 
of urea-urea, nitro-urea and carboxylic acid dimerisation and solvent interactions (Figure 8b 
and c).
59
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Figure 8 Hydrogen bonding patterns observed in crystal structure including gelators b) 8 and c) 9. 
 
1.3 Anion tuning of urea derived gelators 
Anions have been exploited to disrupt the gelation ability of a variety of bis-urea gelators that 
form gels based on the α-urea motif.12, 38, 60-63 Rheological studies undertaken on gels of 
series 5 show how the addition of increasing equivalents of anion results in a decrease in the 
elastic storage modulus (G′) and yield stress (Figure 9).51 NMR spectroscopic studies, 
conducted in acetonitrile above the Tgel, showed competing 1:1 binding of the gelator 
molecules to the anions (K11 = 18,000 for 5 n= 6 with acetate) versus self association (K20 = 
6,000 for 5 n= 6). Binding was found to be strongest for acetate, followed by chloride then 
nitrate and was too weak to determine for tetrafluoroborate.  
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Figure 9 a) Scheme showing binding of 5 n= 6 to acetate. b) Graph showing the influence of different anions 
(0.1 equivalents added as TBA
+
 salts)  on the storage modulus (G′) as a function of oscillatory stress (σ) of the 
0.3 % by weight gel of compound 5 n= 2 in acetonitrile.  The anions added are BF4
−
 (△); Br− (◇); NO3
−
 (□); 
Cl
−
 (+) and MeCO2
−
 (♦) and pure gelator (○).  
 
Insights into this process are gained from tris-urea 10 which forms needle-shaped crystals, 
rather than gels, in the presence of sodium chloride. The single crystal structure revealed no 
anion was incorporated into the crystals.
55
 The association constant for chloride in DMSO 
was found to be  K11 = 1154  and the anion is thought to retard the 1-dimensional growth of 
gel fibres by reversibly binding to the urea tape. Interestingly the X-ray structure shows 10 
forms parallel urea tapes, unlike gelator 6,  and it is thought that the binding of the chloride 
anions may re-orientate the urea groups. Fluoride ions were found to disrupt the formation of 
gels of 11,
64
 a process which could be reversed by the addition of trifluoroacetic acid. As well 
as the disruption of hydrogen bonding, the basicity of fluoride means it may deprotonate the 
urea group as is observed for a variety of urea derived fluoride sensors.
65, 66
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The presence of various anions was found to induce gelation in proline functionalised 
calix[4]arene 12 by Ogden and co-workers.
67
 NMR spectroscopy indicated no binding 
interactions were taking place between the gelator and the anions. The effect of anion was 
found to correlate well with the Hofmeister series which classifies ions in order of their 
ability to order water. More hydrated salts (termed kosmotropic) have the effect of 
strengthening the hydrophobic effect and decreasing the solubility of nonpolar molecules 
whilst less hydrated salts (termed chaotropic) have the opposite effect. The presence of 
chaotropic anions, such as nitrate, bromide and chloride induced gel formation whilst 12 
remained in solution in the presence of kosmotropic anions such as sulphate. 
 
Pyrazole derived mono-urea based gelator 13 was found to form hydrogels under acidic 
conditions.
68
 The rheology, morphology and structure of the gels formed depends on the 
identity of the acid used to protonate the gelator. The magnitude of G′ and yield stress was 
highest when gels were formed using kosmotropic ions. TEM and SEM imaging revealed 
chaotropic anions such as BF4
-
 and PF4
-
 resulted in particulate gels whilst kosmotropic 
oxyanions such as SO4
2-
, HPO4
2-
, EtPO3
2-
 and MePO3
2-
 produced fibrous morphologies 
(Figure 9a). Single crystal structural characterisation revealed a number of different highly 
solvated structures with hydrogen bonding taking place between urea, pyrazole, anion and 
solvent molecules but no urea tapes (Figure 9c).  
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Figure 10 a) TEM image showing of 13 in water acidified with H2SO4 b) SEM image showing dried xerogel of 
13 acidified with HBF4 c) molecular structure of BF4 salt of 13.  
 
Pyridyl ureas are one class of compound which have been particularly well studied with 
NH···Npyridyl interactions typically taking place instead of the α-urea motif.
69
 These 
competing motifs were exploited by Steed and co-workers who found that the addition of 
Ag(I) and Cu(II) salts could be used to dramatically enhance gelation of a number of 
bis(pyridyl ureas).
18, 19, 70, 71
 The metal ions bond preferentially to the pyridyl nitrogen, 
“turning off” the NH···Npyridyl interactions enabling gel formation through the formation of 
co-ordination polymers. Mixtures of CuBr2 and 14 in methanol were found not to gel until 
suddenly shaken at which point a gel rapidly forms. The gel can then be broken down by the 
addition of TBA-acetate but restored by the addition of further equivalents of copper in the 
form of Cu(BF4)2. The mechanism is thought to be linked to the sequestration of the 
copper(II) ions by the acetate resulting in the formation of a stable complex 
[Cu2(OAc)4(H2O)2].
71
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Figure 11 a) Crystal structures obtained for 14 with Cu(NO3)2 showing metallo polymer [Cu(14)2](NO3)2.3H2O. 
3MeOH of a type potentially responsible for gelation.
19
 b) Photo showing mixture of 14 with CuBr2 (0.3 equiv.) 
in methanol (left to right) before shaking, after shaking, 5 minutes after injection of TBA-acetate, 30 minutes 
after injection of TBA acetate, and 5 minutes after injection of Cu(BF4)2 (1 equiv.). 
71
 
 
1.4  Applications 
Gels have a diverse array of unusual and useful properties which have been exploited in a 
variety of ways. Until recently, generic polymeric gels have typically been used in bulk 
applications for use as lubricants and as gelling agents in food and consumer products. 
However, recent progress in the design and understanding of supramolecular gelators has 
greatly extended the range of possibilities to include a wide range of high-tech applications.
72, 
73
  
1.4.1 Responsive materials 
Because the network formed by LMWGs is held together by supramolecular interactions, the 
gel state is inherently reversible and can be turned on and off in response to a variety of 
stimuli.
74
 The majority of LMWGs are thermoreversible, dissolving at high temperatures and 
re-setting upon cooling, although a more unusual subclass display the opposite behaviour.
75-77
 
Gels have been designed incorporating functionalities which make them responsive to 
external stimuli such as pH,
9, 78-80
 redox reactions,
81, 82
 light
83-85
 and ultrasound.
86-88
 The 
presence of specific chemical species such as cations,
12, 19, 71
 anions,
60, 78
 neutral species
74
, or 
guest molecules
13
 can also be used to trigger or disrupt gelation. The transformation of a 
solution to a gel can lead to an increase in viscosity by a factor of 10
10
 upon gelation.
37
 The 
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ability of gels to elicit such a dramatic change in their properties in response to external 
stimuli makes them remarkable candidates for use as ‘smart’ materials.  
 
LMWGs have been used to trap chemical species which are then released in response to a 
specific chemical stimulus. Incorporating a drug functionality into a gelator which forms a 
stable gel under physiological conditions but which breaks up in the presence of a particular 
physiological stimulus (change in pH,
79
 salt concentration
89
, enzyme
90
) allows for the 
targeted delivery of a drug to a diseased site. This would reduce the dosage of drug required 
and so reduce any adverse side effects. The gel matrix can be used to solubilise and transport 
otherwise hydrophobic drug compounds.
91
 A number of pharmaceutically active compounds 
can be readily modified to form gels with the drug released upon enzyme mediated 
hydrolysis.
92-94
 The opposite approach, whereby a specific enzyme in a bacteria
95
 or 
mammalian cell modifies a soluble small molecule triggering gelation
96
 also holds promise as 
a therapeutic approach.
97
  
 
 
Figure 12 Gels of 15 functioning as an AND gate- with the input of both an increase in pH AND the addition of 
EDTA (leading to a decrease in calcium ion concentration) in either order required to output dissolution of the 
gel.
 98
  
 
Molecules which respond in different ways to a number of stimuli can act as logic gates.
 99
 
Komatsu et al. developed a gelator which is responsive to temperature, pH, calcium ion 
concentration and irradiation with light; compound 15 in Figure 12. Using different 
combinations of stimuli they were able to apply AND, OR, NAND and NOR logic operations 
to control and fine tune the release of substrates from the gel.
98 
Photoresponsive hydrogels 
have also be used as nanolitre reaction vessels with the fusion of gels containing reactants 
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controlled using light.
100
 Rather than undergoing a sol-gel transition, a hydrogel developed by 
Zhou et al. shrank and expanded in response to changes in pH which they showed could be 
used to control the rate of drug release. 
101
 
 
1.4.2 Scaffold material 
Hydrogels resemble the extracellular matrix of the body and can provide a scaffold for tissue 
engineering and matrices for drug delivery.
102
 LMWGs offer some advantages in terms of 
biocompatibility over polymeric systems owing to their supramolecular nature. A number of 
amphiphilic polypeptide hydrogelators have been used for the in vitro culture of liver 
(progenitor)
103
 and collagen producing chondrocytes.
104
 Similar gelators have been shown to 
aid the repair of spinal cord injuries in mice
105
 and optical nerve damage in hamsters.
106
 The 
latter gelator was also found to bring about rapid hemostasis in a variety of tissue types, 
potentially revolutionising the way bleeding is controlled during surgery.
107
  
 
LMWGs can be enhanced with nanoscopic materials in order to take advantage of their 
unusual properties or to strengthen the gel. Examples include the incorporation of silver 
nanoparticles,
108
 quantum dots,
88
 carbon nanotubes (CNTs),
21
 buckminsterfullerene (C60),
22
 
graphene,
20, 109
  polymer nanobeads,
110
 and up-conversion rare earth nanophosphors 
(UCNPs)
111
 to form composite gels. A particularly impressive example is the mixing of clay 
nanosheets (CNCs) with a ganadinium functionalised dendrimer which formed self-healing 
hydrogels capable of forming free standing structures. 
23, 112
 The hydrogels can be cut and the 
segments stuck back together to form structures such as the bridge shown in Figure 13.  
 
Figure 13 a) A shape-persistant free-standing bridge prepared by fusing together freshly cut blocks of hydrogel 
(methylene blue was incorporated into alternating blocks). b)  Clay nanoparticles solubilised with an anionic 
surfactant are gelled by a dendritic gelator bearing guanidinium groups.
112
 
 
b) 
Solubilised clay 
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Multivalent 
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a) 
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Polymeric gels are widely used for the separation of compounds owing to their ability to 
restrict the flow of molecules. The use of LMWGs was used to extend the range of solvents 
available for electrophoresis to include organic solvents such as acetonitrile.
113
 The reversible 
nature of the gels allows for easy separation of analytes, reactants and products from the 
matrix and even direct analysis by mass spectrometry. The separation of proteins was 
achieved using supramolecular gel mimicking the popular SDS-PAGE method.
114
 A n-hexyl-
galactonamide gelator was found to develop a partial charge when a voltage is applied 
allowing for the separation of neutral compounds by electroosmosis.
115
 
 
Self assembly of a gel scaffold can be used to organise highly conjugated organic molecules 
for applications such as light harvesting and for use as molecular wires.
 116-118
  
Tetrathiafulvalene (TTF), which is known to conduct in the condensed state, was modified to 
include an amide hydrogen bonding functionality resulting in the formation of fibrous 
structures in hexane which gave rise to a gel. A mixed valence state was generated by 
exposure of the xerogel to iodine vapour producing conductive nanowires.
119
 An organic 
supramolecular light-harvesting antenna was created by encapsulating an energy-accepting 
molecular wire into an energy donating π-gel scaffold.6  
 
1.4.3 Templating  
The ‘soft’ matrix of gels can be ‘fixed’ in a variety of ways to give permanent, rigid 
structures. This can be achieved by the positioning of polymerisable functional groups such 
as on the outside of the gel fibres, such that they can be polymerised to give a permanent 
covalent structure. 
61, 63, 120-123
 An alternative approach is to deposit an inorganic material on 
the inner or outer surface of the gel template to produce an organic-inorganic composite.
124
 
LMWGs have been used to gel polymer precursors, such as methyl methacrylate, which are 
then polymerised to give composite materials.
125, 126
 These composite materials can have 
superior physical properties to the pure materials.
127
 The supramolecular nature of the gel 
matrix means it can be removed by washing or chemical treatment of the composite to leave 
an imprint of the gel structure in the polymer.
128-133
  
 
LMWGs have also been used to template the formation of nanoparticles. Das and co-workers 
exploited the intrinsic reducing ability of the tryptophan residue for in situ synthesis of 
gold
134
 and silver
135 
 nanoparticles within hydrogels of tryptophan based dipeptide 
 20 
 
amphiphiles. Steed found a pyridyl-urea gelator which formed gels in the presence of silver 
ions, gradually precipitating silver nanoparticles within the gel fibres.
136
 The organised 
structure of supramolecular gels has also been utilised to catalyse a variety of other 
reactions.
137
 
 
Figure 14 TEM images  showing a) gold
138
 b) silver
139
 and c) silver
140
 nanoparticles on gel fibres. 
 
1.5 A medium for crystal growth 
1.5.1 Gel Phase Crystal Growth  
Crystallisation is enormously important in a variety of natural and commercial processes.
141
 
Transient fluctuations in a supersaturated solution bring solute molecules together to form 
molecular clusters or nuclei.
142
 A critical nucleus size must be reached before the energy 
gained from the formation of a crystal lattice is able to offset the increase in surface energy 
and crystal growth becomes energetically favourable.
143
 Nucleation may take place 
homogeneously between solute molecules in solution or heterogeneously where nucleation is 
facilitated by small particles or bubbles. Crystallisation proceeds by growth of these critical 
nuclei until the solution is no longer supersaturated and an equilibrium state is reached. 
Crystallisation from bulk solution is typically under kinetic control, with metastable 
polymorphs crystallising first due to a lower energy barrier to nucleation.
144
 As the level of 
supersaturation decreases such crystals become unstable with respect to slower growing but 
more thermodynamically stable forms which replace them. This process was recognised in 
1897 by Ostwald who coined his famous rule of stages.
145
  
  
a) b) c) 
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Polymeric gels have been utilised for over a century for the growth of crystals.
146-150
 The gel 
matrix is often considered to be inert with crystal growth occurring within the macropores 
between gel fibres. The nature of the gel structure is such that solvent is ‘trapped’ by gel 
fibres preventing macroscopic flow of solvent whilst allowing diffusion between pores. This 
has the effect of suppressing convection currents resulting in continuous, diffusion limited 
growth of crystal faces. The gel also acts as a soft matrix preventing sedimentation or 
aggregation of the crystals which can arbitrarily disrupt crystal growth along faces in contact 
with the vessel walls or other crystals. Heterogeneous nucleation can either be repressed by 
an inert gel matrix, making homogenous nucleation dominant,
 
or enhanced by an activating 
gel structure.
150
  
 
A combination of these factors means gels have been utilised for the growth of protein 
crystals for single crystal structure determination where the size and quality of crystals is 
particularly important (Figure 15a-b). The lack of sedimentation in gels allows for spatial 
control of nucleation. This was exploited by Alexander and co-workers who used a laser to 
induce nucleation in a supersaturated solution of potassium chloride immobilised by an agar 
gel to spell out the word ‘laser’ (Figure 15c).151  
 
  
Figure 15  Crystallisation of the protein thaumatin from a) solution and  b) silica gel.
152
 c) Laser induced 
nucleation of KCl in agarose gel.  
 
b) 
a) c) 
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The gel environment has been shown to influence a number of other aspects of crystal growth 
such as the polymorphism, habit and enantiomorphism of crystals grown from gels. 
Considerable recent work has been done to try and understand the mechanisms by which gels 
influence crystallisation in order to gain greater control over the crystallisation process. 
 
1.5.2 Influencing Polymorphism 
 
 
 
 
 
  
Figure 16: Growth of modafinil in TMS/methanol/water gels of varying ratios.
153
  
 
A lack of heterogeneous nucleation in gels can lead to higher degrees of supersaturation 
resulting in conditions far from equilibrium. This potentially allows the formation of single 
crystals of unstable polymorphs which form outside thermodynamic equilibrium conditions 
as precipitates using conventional solution based techniques. (±)-2-
((diphenylmethyl)sulfinyl)-N-acetamide, marketed as (±)-modafinil, is one such compound. 
Solution crystallisations close to thermodynamic equilibrium yield stable racemic form I as 
single crystals whilst metastable racemic form III can only be formed as a powder far from 
equilibrium (precipitation). Morgan Pauchet et al. were able to crystallise form III from a 
tetramethoxysilane (TMOS) methanol/water gel. By varying the solvent ratio of 
methanol:water they were able to control the level of supersaturation within the gel (Figure 
16). Crystals grown with a 2/7/7 ratio of TMOS/water/methanol were found to give mainly 
form III alongside some single and twinned crystals of form I. They note that the size and 
connectivity of the pores, and so the degree of supersaturation, vary within a single gel which 
may explain the co-existence of different forms. Perhaps of crystallographic interest, the 
‘stacking fault’ which gave rise to the form I twin is repeated periodically to produce form 
III. The similarity between the structures further explains their concomitant crystallisation. 
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Figure 17: Scheme showing proposed influence of chitosan chains on packing of calcium carbonate ions
154
 
 
Conversely, heterogeneous nucleation may occur on gel fibres with different crystal forms 
being templated compared to solution. Xiao et al
.154
 have investigated the effect of chitosan, a 
linear polysaccharide able to form hydrogels at pH >6, on the crystallisation of calcium 
carbonate. In the sol, nanoparticles of the thermodynamically favourable calcite form were 
found with crystal growth thought to be inhibited by surface binding of the polycationic 
chitosan chains. In the gel phase however, hexagonal plates of the less stable vaterite form 
were produced. The authors attribute this to heterogeneous nucleation of the CaCO3 on the 
gel fibres which then stabilise the normally soluble vaterite form. They suggest that the –NH2 
and –OH groups on the chitosan chain form strong hydrogen bonds with the carbonate anions 
which in turn attract calcium cations. This generates a local supersaturated microenvironment 
at the chitosan gel interface which resembles the alternating layers of ions found in vaterite. 
This arrangement also stereochemically matches, and so stabilises, the high energy (001) face 
of vaterite such that it becomes the dominant product.  
 
The crystallisation of model pharmaceutical compounds carbamazepine and ROY were 
undertaken from cubic polyethylene glycol diacrylate (PEGDA) microgels with different 
mesh sizes.
155
 A number of differences were noted between the polymorphism of the 
compounds crystallised from solution and microgels with different mesh sizes. The 
differences are rationalised in Figure 18 which illustrates how at small mesh sizes polymer-
solute interactions dominate hindering the solute-solute interactions essential for nucleation. 
When the mesh size is too large, the nucleation-templating effect of the polymer is less 
significant. At an intermediate mesh size polymer-aided solute-solute interactions were 
optimised to bring about nucleation. Optimum mesh sizes were found to enhance selectivity 
 24 
 
for the R form of ROY by twenty times and for the nucleation of form II of carbamazepine in 
the absence of form I as observed in solution.  
 
 
 
Figure 18 Optical micrographs showing a) cubic PEG microgels b) carbamazepine crystallising in the microgels 
(shown in red), c) graph showing occurance of different polymorphs of ROY grown from gels with different 
molecular weights of PEG, (d-f) schematic illustrating the effect of mesh size on nucleation. At small mesh sizes 
(d) polymer-solute interactions dominate inhibiting solute-solute interactions, at larger mesh sizes (f) solute-
solute interactions dominate, at intermediate sizes (e) polymer-solute interactions and spatial confinement 
jointly facilitate solute-solute interactions creating optimum conditions for nucleation (highlighted by yellow 
background).  
 
In an interesting adaptation of the gel phase method, Leng et al. further slowed down the rate 
of crystallisation by using alginate, an anionic polysaccharide which forms a metallo-gel in 
the presence of calcium ions. 
156
 Diffusion of gaseous carbon dioxide into these gels results in 
the slow release of calcium ions and crystallisation of calcium carbonate. The mineral is 
crystallised as micron-sized lens like particles composed of fused nanoparticles of vaterite, 
stabilised for long periods of time by the alginate.  
 
c) 
e) d) f) 
b) a) 
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1.5.3 Influencing Crystal Habit 
A comparison of the effect on the habit of asparagine crystals by crystallisation from various 
polymeric hydrogels was made by Swift and co-workers.
157
 Asparagine crystallises from 
aqueous solutions as a monohydrate with a prismatic morphology determined by up to 
eighteen different faces. The effects of the different gelators on crystal habit are shown in the 
table in Figure 19. The dominance of the {012} face in crystals grown from agarose gels was 
interpreted in terms of hydrogen bonding interactions between the agarose side chains and the 
crystal surface. The fact that this morphology is dominant for both aqueous and binary 
water/DMSO mixtures in the presence of agarose, solvent systems that give very different 
morphologies in solution phase crystallisations, indicates a dominance of gelator effects. 
Further evidence of the importance of the gel phase was demonstrated by the addition of D-
galactose, a monomeric unit of the agarose polymer, which at comparable concentrations 
showed no modification of the crystal habit. The dominance of {101} faces in crystals from i-
carrageenan gels was thought to be due to presence of sulphate groups, a hypothesis which 
appears substantiated by solution growth experiments in the presence of sulphate ions. The 
complex functionality of gelatin polymers makes such functional group analysis difficult, 
indeed it was suggested that the size and poor definition of the crystals may be due to the 
diverse functionalities interacting with different faces.  
 
      
Figure 19: Effect of gel media on crystal morphology and corresponding molecular packing of key faces.
157
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Figure 20 SEM images of K2Cr2O7 crystals grown at increasing gel densities a) 5 g/100 ml, b) 25 g/100 ml and 
c) 35 g/100 ml of gelatin. d) Growth of the crystal occurs fastest asymmetrically along the z direction. However, 
under the diffusion limited conditions present at high gelator concentration, depletion of material from the 
surrounding gel means growth of a twin in the direction of the higher concentration gradient, A, becomes 
favourable. e) Growth therefore occurs along a new direction, Z2, until the process is reversed leading to the 
formation of alternating stacks of twinned crystals.  
 
The crystallisation of a range of inorganic salts was undertaken by Oaki and Imai from a 
range of aqueous gels in order to investigate the effect of gel density on crystal 
morphology.
158
 They observed that as the gel density increased, the morphology of the 
crystals changed from polyhedral single crystals exhibiting specific habits into dendritic 
forms consisting of irregularly branched polycrystalline aggregates (Figure 20). This was 
observed regardless of the type of inorganic compounds or gelling agents. The formation of 
dendrites was ascribed to instability of the growing surface under the diffusion limited 
conditions formed in the viscous gel media. It was also speculated that increasing the density 
of the gel media increases the random noise for crystal growth because the polymer backbone 
of gel matrixes disturbs the progress of the growing surface. Helical twisting was observed 
for potassium chromate grown from gelatin (Figure 20b) which was attributed to ‘twisted 
twins’. 159 Figure 20d shows how asymmetric crystal growth occurring along the Z direction 
depletes the surrounding gel material. Eventually, under the diffusion limited conditions, 
growth of the twin crystal becomes favourable leading to growth in a second direction Z2 and 
a b c 
d) e) f) 
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so the formation of twisted stacks of twin crystals.  In an extension of this work Oaki and co-
workers found that the handedness of the helices, consisting of achiral crystals, could be 
controlled by the addition of  d- and l- glutamic acids under the diffusion limited conditions 
of the gel.
160
  
 
In a study by Estroff and co-workers, hydrogels have been coupled with self assembled 
monolayers to control the crystallisation of calcium carbonate.
161
 The ordered surface of the 
carboxylate terminated self assembled monolayer (SAM) regulates the orientation of the 
crystals and favours selection of the calcite form. The gel changes the growth kinetics, and 
thus the morphology of the calcite crystals, resulting in a decrease in the aspect ratio with 
increasing gel concentration. Etching of gels grown inside the gels indicated incorporation of 
the gel fibres into the single crystals. The incorporation of gel fibres into crystals has been 
observed in a number of other systems and can be used to produce composite materials with 
enhanced physical properties.
127, 162, 163
 
 
 
 
 
Figure 21 a) Scheme showing crystal growth in gels. SEM images of calcite crystals grown on 
carboxylateterminated SAMs in (b) solution (c) 1 % w/v agarose gel (d) 2 % w/v agarose gel. 
 
 
 
 
 
a) 
b) c) d) 
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1.5.4 Influencing Enantiomorphism 
 
 
 
 
 
 
 
 
 
Figure 22: Scattergram showing the percentage l-crystals grown by the diffusion of methanol at 24ºC into a gel 
of 0.75 wt% agarose.
164
 
 
Another interesting feature of crystal morphology over which gels have been shown to exert 
some influence is the enantiomorph of molecules which crystallise in a chiral space group. 
NaClO3 is an achiral molecule in solution which crystallises in space group P213 leading to 
equienergetic d- and l- crystal forms. Although individual crystallisations often deviate from 
the expected ratio, repeated crystallisations under the same conditions tend towards a 50:50 
mixture of the two enantiomorphs. Swift and co-workers
164
 carried out a large number of 
crystallisations of NaClO3 from varying concentrations of agarose in water, at different 
temperatures and with the addition of methanol. They noted that with higher concentrations 
of gelator the crystals became distorted from their normally cubic morphology and fewer 
crystals formed. Most interestingly, they found statistically significant enantiomeric excesses 
(ee) of the d- or l-enantiomorph under different conditions. At low temperatures (6ºC) and 
high concentrations of agarose (0.75wt%) they found a bias towards d-NaClO3 of up to ee = 
22%. Surprisingly, they found that adding methanol resulted in a bias as high as ee = 53% 
(24ºC, methanol added after 45 days) in favour of l-NaClO3. The reasons for these 
differences are poorly understood but explanations are offered in terms of the structure of 
agarose which has been shown to adopt a variety of left handed, single and double helices. 
 
1.5.5 Supramolecular gels as a medium for crystal growth  
The examples given in sections 1.5.1-1.5.4 refer to crystallisation from polymeric gelators. 
Despite a number of allusions to the concept,
165-167
 the potential of LMWGs as a medium for 
crystal growth remains largely unexplored with the exception of some elegant work on the 
use of LMWGs for the growth of calcium carbonate
168
 and other inorganic minerals
169
 as part 
 
Agarose 
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of biomineralisation studies. Related work includes the templation of inorganic-organic 
hybrid materials and nanoparticles as discussed in section 1.4.3. 
 
The control of crystallisation is commercially important to a wide range of industries 
including the cosmetic, food and paint sectors. In particular, the control of polymorphism and 
crystal habit is important in the pharmaceutical industry owing to biological, manufacturing 
and legal implications. Compared with simple inorganic compounds in which there is little 
difference between the faces of their crystals, more complex pharmaceutical compounds 
often crystallise in structures with very different functionalities along different faces. This 
could potentially allow gels to exert much more profound changes in the habit and packing of 
growing crystals. 
 
Supramolecular gels offer a number of inherent advantages as a medium for crystallisation 
over their polymeric counterparts.
170
 The reversible nature of the gels allows for easy 
recovery of crystals from the viscous gel matrix. The addition of a suitable chemical or 
physical stimulus can be used to break down the gel liberating the crystals to be collected 
using conventional solution based techniques such as filtration.  The diverse array of 
chemical species which have been found to form gels provides a ready library of gelators 
which can be matched to the compound being crystallised.
24, 25
 In addition to forming 
hydrogels, a wide variety of LMWGs can form organogels, greatly extending the range of 
crystallisation conditions than can be generated. This is particularly important for 
pharmaceutical compounds, many of which are poorly soluble in aqueous solvents. LMWGs 
are generally readily synthesised and can be inexpensive and biologically compatible making 
them commercially attractive. The supramolecular nature of the gel fibres may mean that 
unlike polymeric gels they do not become incorporated into the growing crystals. It is also 
possible that supramolecular gels will provide a qualitatively different environment for 
crystal growth which proves to exert novel effects not observed in polymeric systems.  
 
1.6 Conclusion  
Low molecular weight gels provide a fascinating example of supramolecular self-assembly 
and posess a number of unusual properties which present opportunities for use in a variety of 
high-tech applications. LMWGs are complex, hierarchical materials which require analysis at 
a range of dimensions using a variety of techniques. Hydrogen bonding interactions between 
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urea moieties provide the one-dimensional aggregation required to bring about gel formation 
and a diverse array of urea derived gelators have been developed. Disruption of these 
hydrogen bonding patterns by the addition of anions provides a mechanism for tuning the 
gels’ rheology. The responsive and reversible nature of supramolecular gels, their unusual 
combination of liquid and solid-like properties and the ordered gel matrix mean they have 
found uses in a wide variety of applications. Polymeric gels have been used extensively to 
influence the morphology and form of crystals, predominantly inorganic compounds 
crystallised from aqueous media. Supramolecular gels offer a number of potential advantages 
as a medium for crystal growth, particularly of pharmaceutical compounds.  
 
1.7 Project aims and overview 
The aim of this thesis is to create novel urea derived low molecular weight gelators, 
investigate their structure and properties and develop them for use in a variety of 
applications, particularly as a medium for crystal growth. In the first three chapters a series of 
amino acid derived bis-urea compounds are developed. Chapter 2 seeks to establish the 
relationships between the structure and gelation behaviour of compounds in the series. X-ray 
crystallography, X-ray powder diffraction, infrared spectroscopy, electron microscopy and 
rheometry are used to probe different levels of the gel structure. The different gelators are 
then mixed together in order to further investigate the relationship between the different 
gelators. The series of gelators is expanded in Chapter 3 to include structurally related 
pyrenylalanine derivatives with the aim of utilising their fluorescent properties to further 
investigate gelation behaviour in the series. Anions are introduced in order to disrupt gelation 
and the process is monitored in solution by NMR spectroscopy and in the gel phase at the 
macroscopic level by rheology and on a molecular level using fluorescence spectroscopy.  In 
Chapter 4 the different nano-scopic morphologies of gelators in the series are exploited to 
produce meso-porous polymers with different pore shapes. Electron microscopy and gas 
adsorption measurements are utilised to characterise and compare the resulting materials.  
 
The second half of the thesis develops the novel application of low molecular weight gelators 
as a crystallisation medium for pharmaceutical compounds. The basic methodology and proof 
of principle for the viability of LMWGs as a medium for crystal growth is developed in 
Chapter 5. The use of anions as a means of recovering crystals grown in low molecular 
weight gels is also investigated. In Chapter 6 a crystal engineering approach is taken to 
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designing supramolecular gelators which incorporate functionalities mimicking those of the 
compound under investigation. The influence of such a ‘designer’ gelator on polymorphism 
is compared with generic gelators and forms obtained from solution. A collaboration with 
GlaxoSmithKline sought to apply the use of LMWGs as part of an industrial polymorph 
screening procedure, the results of which are detailed in Chapter 7. The focus is on 
developing a generic methodology which can be incorporated into existing screening 
procedures.  
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Chapter 2: Gelation-structure relationships in a series of amino acid 
derived bis-urea gelators 
2.1 An arrested crystallisation 
The gel state is characterised by solid-like flow properties in a material which is largely 
liquid in composition. Gel formation can be brought about in a number of distinct ways and 
four different classes of gel have been distinguished: lamellar structures, disordered covalent 
polymeric networks, polymeric networks formed through physical aggregation and 
particulate, disordered structures.
1
 Many low molecular weight gelators (LMWGs) fall into 
this final class of gelators.
19
 Gelation in these systems can be thought of as an arrested 
crystallisation where crystal growth occurs predominantly in one direction resulting in the 
formation of fibrous aggregates.
24
 As with other small molecules they have the potential to 
pack together in a variety of ways leading to different polymorphs, some of which form gels 
and others which do not.
17, 30-33
 
 
Bis-ureas are one of a number of well-established motifs which frequently aggregate in the 
highly anisotropic morphologies necessary for gel formation.
38
 However, fibre formation in 
itself is insufficient to bring about gelation and physical entanglement of fibres must occur to 
create a three dimensional sample-spanning network capable of trapping solvent through 
surface tension. Subtle differences in gelator structure, solvent properties and the conditions 
under which the gel is formed can all play an important role in determining gel formation. 
 
In this chapter we present a systematic study investigating the effects of different substituent 
groups on the solid state and gel phase behaviour of a series of amino-acid derived bis-urea 
gelators. Evidence for a variety of different structural motifs is gathered from electron 
microscopy, crystallographic and solid state analytical data. X-ray single crystal and powder 
diffraction (XRPD), infrared spectroscopy (IR), differential scanning calorimetry (DSC), 
scanning electron microscopy (SEM), rheometry and bench top observations are all brought 
together in order to understand the complex behaviour of this series of gelators and the gels 
they form.  
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2.2 Design and Synthesis 
Building on previous work within the Steed group
38, 51, 52, 61, 171
 and others,
46, 47, 167, 172
 a 
number of design features were deliberately incorporated into the gelators’ chemical structure 
to aid gel formation. Ureas are readily synthesised through the nucleophilic addition of an 
amine to an isocyanate in good yield. Amino acids are a readily available and cost efficient 
source of amines which are of particular interest due to their biological importance. The 
substituent groups (R) of the amino acids provide a varied, but well defined, range of 
functionalities which can be systematically altered in order to study their effect on gel 
formation.
8, 11, 173
  Amino acids also provide a well resolved source of chirality which can 
frustrate crystallisation by limiting the choice of space groups to Sohnke groups potentially 
aiding gelation.
8, 47, 51, 174, 175
 Methyl ester protected amino acid derivatives were used in order 
to prevent strong competing hydrogen bonding interactions from the carboxylic acid groups. 
The length of the oligomethylene spacer (where n = number of methylene units) can also be 
important in bis-urea gelators with compounds possessing an even number of methylene units 
forming stronger gels due to the anti-parallel arrangement of the bis-urea tapes that they 
form.
51
  
 
A series of bis-urea compounds were synthesised by the reaction of di-isocyanato alkanes of 
varying length with two equivalents of the methyl-ester protected l-amino-acid to give the 
corresponding bis-urea, compounds 16-31 (Scheme 1). Full synthetic details are provided in 
the experimental section. In general, the amino acid methyl ester hydrochloride salt is stirred 
in chloroform and a slight excess of triethylamine added. The solubility of the mixture 
depends on the amino acid being used with some compounds dissolving readily at room 
temperature and others requiring heating, sonication and a greater excess of triethylamine. 
Small amounts of undissolved material were not found to be problematic and generally 
dissolved upon the addition of the isocyanate. The isocyanate was dissolved in chloroform 
and added dropwise to the stirred solution and the mixture was heated under reflux overnight. 
Individual reactions were never optimised but the initial conditions of heating under reflux 
for 18 hours proved excessive and shorter reaction times were used for cases where the 
gelator precipitated from solution upon addition of the isocyanate.  
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Scheme 1 A series of bis-urea gelators functionalised with different methyl ester protected amino acids and 
number of methylene units (n) in the spacer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 n = 6 R = H (Gly) 24 n = 4 R = Me (Ala) 
17 n = 6 R = Me (Ala) 25 n = 4 R = iBu (Leu) 
18 n = 6 R = iPr (Val) 26 n = 4 R = Bn (Phe) 
19 n = 6 R = iBu (Leu) 27 n = 4 R = CH2C6H6OH (Tyr) 
20 n = 6 R = Bn (Phe) 28 n = 4 R=  C9H8N (Try) 
21 n = 6 R = CH2C6H6OH (Tyr) 29 n = 2 R = iPr (Val) 
22 n = 6 R=  C9H8N (Try) 30 n = 8 R = Bn (Phe) 
23 n = 4 R = H (Gly) 31 n = 12 R = iBu (Leu) 
 
Work-up of the reaction largely depends on the solubility of the resulting compound. In cases 
where the product precipitates from the chloroform it can be isolated by filtration, washed 
with cold dichloromethane and diethyl ether then dried in a drying pistol. In some cases 
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additional washing with water was required to fully remove the triethylamine hydrochloride. 
Where the compound remains dissolved in the reaction mixture, the volume of the 
chloroform was reduced under vacuum, the impurities extracted with water and the 
chloroform layer dried and evaporated to give the clean product. In some cases addition of 
water induced a fine precipitate of the product in the reaction mixture making extraction 
difficult. In such cases the chloroform was completely removed by evaporation to leave a 
solid which was ground and washed repeatedly with warm water before filtering and drying. 
Many of the compounds retained solvent strongly and drying in a heating pistol was required 
to ensure clean products.  
 
 
 
 
 
 
l-Lysine methyl ester, with the amine of the R-group Boc protected, was used to successfully 
synthesise compound 17. Attempts to remove the Boc protecting group using 1:1 TFA:DCM 
produced a complex mixture of products. As 17 does not form part of the series of amino acid 
derived gelators no further work was undertaken on this compound. However, 17 proved to 
gel a range of solvents without deprotection forming stable gels in toluene and ethyl acetate. 
Gels initially formed in water but proved unstable with time and quickly broke down.  
Deprotecting the amine and reacting it with isocyanates or other functional groups to produce 
extended gelator molecules provides a potentially interesting future line of inquiry, as does its 
gelation behaviour.
8
  
2.3 Characterisation of gelation behaviour  
2.3.1 Effect of R-group and solvent on gelation 
Hexylene spaced gelators 16-22 were screened for gelation behaviour against a range of 
solvents across the polarity spectrum. An amount corresponding to 1 % weight to volume (% 
w/v) of the compound relative to the solvent was weighed into a small vial and heated in 1ml 
of solvent until fully dissolved. The samples were cooled rapidly by placing the vials in a 
water bath at room temperature and sonicating them briefly when the first signs of 
precipitation were observed.
176
 The results upon cooling to room temperature are recorded in 
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Table 1. Gel formation was characterised by a simple vial inversion test; if the solvent was 
fully immobilised it was considered to have gelled. The term partial gel was ascribed to 
samples where only partial trapping of the solvent occurred. Heating took place in sealed 
vials using a heat gun and in some cases the dissolution temperature of the compound was 
above the boiling point of the solvent at atmospheric pressure.  
 
Table 1 Compounds 16-22 screened against a range of solvents for gelation behaviour by heating 1 % w/v of 
the compound in the corresponding solvent until fully dissolved and recording the results upon cooling 
P = precipitate, S = solution, G = Gel, PG = partial gel, O = oil, I = insoluble with heating,  [a] = gel unstable, 
breaks down over time.  
 
Figure 23 Photograph showing 1 % w/v gels of alanine derived gelator 17 in (left to right) water, acetonitrile, 
THF, chloroform, ethyl acetate and toluene. 
Small changes in R-group across the series result in large changes in the properties of the 
compounds. Glycine derived gelator 16 rapidly forms strong translucent gels in toluene but 
precipitates from other solvents. In contrast, alanine derived gelator 17 forms robust gels in 
Solvent 
Compound (n=6 and amino acid from which derived) 
16 17 18 19 20 21 22 
Gly Ala Val Leu Phe Tyr Try 
Water P G
a
 I P I P P 
DMSO S S S S S O S 
Acetonitrile P G P S G O S 
Methanol P S S S S O S 
Ethanol P G
[a]
 S S S S S 
Acetone P G P S G O S 
THF P G S S S O P 
DCM P PG S S S O P 
Ethyl acetate P G G P G O I 
Chloroform P G S S S O S 
Diethyl ether I I I P I O I 
Toluene G G P G G O I 
Hexane I I I I I O I 
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toluene, chloroform, ethyl acetate, THF, acetone and acetonitrile and partial gels in DCM. 
Gels are also produced in ethanol and water but are unstable, particularly the hydrogels, and 
rapidly break down to give a precipitate. Moving from a methyl to an isopropyl group, valine 
derived compound 18 produces only weak gels in ethyl acetate.  Leucine derived gelator 19 is 
markedly more soluble than other compounds remaining in solution in most of the solvents 
tested. Gels gradually form in toluene over a period of several hours with the viscosity of the 
solution increasing gradually; a markedly different process to the rapid gelation observed for 
the other compounds. Phenylalanine derived compound 20 produced robust gels from toluene 
and ethyl acetate. Weaker, more opaque gels also form in acetone and acetonitrile, however 
gel formation was poorly reproducible with precipitates or partial gels often obtained using 
the same procedure. Compound 20 also forms robust gels in a number of aqueous solvent 
mixtures, namely 1:1 DMSO:water, 3:2 Methanol:water, 1:4 THF:water.   
 
Figure 24 Photograph showing 1 % w/v gels of phenylalanine derived gelator 20 in (left to right) 3:2 
MeOH:H2O, 1:4 THF:H2O, 1:1 DMSO:H2O, CH3CN,  Ethyl acetate, Acetone, Benzene, Toluene 
 
Tyrosine derived compound 21 produces immiscible oils in most of the solvents tested. The 
oil droplets are transparent and stick to the sides of the vial which makes it difficult to 
ascertain whether they dissolve at high temperatures. Oils form upon the addition of very 
small amounts of solvent to the dry compound. During the synthesis of 21, the product is 
obtained from the chloroform reaction mixture as immiscible oil which NMR spectroscopy 
indicates contains only small amounts of solvent. A fine white powder could be obtained by 
drying the oil in a heating pistol or by recrystallization from water. Tryptophan derived 
compound 22 also showed no evidence of gelation remaining soluble or producing 
precipitates from all of the solvents tested.  
 
Gelators 16-22 are all capable of forming gels, but only do so in certain solvents. Thermally 
induced gelation requires the compound to be soluble in the solvent at high temperature, but 
insoluble at low temperature. The gelation behaviour reported in Table 1 refers to mixtures 
 38 
 
with 1 % w/v of gelator to aid comparison, however further tests at higher and lower 
concentrations failed to produce gels in any further solvents. Most of the compounds are 
poorly soluble in water or apolar solvents such as hexane and diethyl ether. Toluene proved 
the best solvent for this class of gelator producing the most robust and translucent gels in 
each series, apart from compound 18 where only ethyl acetate formed gels. In general, gels 
formed in more polar solvents tended to be more opaque and required sonication and higher 
concentrations of gelator to ensure complete gelation.  
2.3.2 Effect of spacer length on gelation behaviour 
Spacer length can play an important role in determining gel formation and an alternation 
effect is well established for alkylene-spaced compounds,
53, 177
 including bis-urea gelators of 
this type.
51, 52
 A number of analogues with different (even) lengths of alkylene spacers (n) 
were investigated.  
 
Table 2 Compounds 23-28 screened against a range of solvents for gelation behaviour by heating 1 % w/v of 
the compound in the corresponding solvent until fully dissolved and recording the results upon cooling. 
Solvent 
Compound (n=4 and amino acid from which derived) 
23 24 25 26 27 28 
Gly Ala Leu Phe  Tyr Try 
H2O P P P P P P 
DMSO S S S S S S 
CH3CN P P S S S P 
MeOH P P S S S S 
EtOH P P S S S S 
Acetone P G S S S P 
THF P G S S S P 
DCM P G
[a]
 S S O P 
EtOAc P G P S O P 
CHCl3 P G
[a]
 P S O PG 
Et2O I I P I O I 
Toluene G G
[a]
 P S O I 
Hexane I I I I O I 
P = precipitate, S = solution, G = Gel, PG = partial gel, O = oil,  I = insoluble with heating,  [a] = gel unstable, 
breaks down over time.  
 
In contrast to the hexylene spaced analogues 16-22, butylene spaced compounds 23-28 
showed much less prevalent, and generally weaker, gelation behaviour. Like compound 16, 
the butylene-spaced glycine derived compound 23 forms gels only in toluene, although the 
gels are much weaker and not always stable to inversion. During heating of compound 23 in 
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toluene a gelatinous aggregate gradually forms in the vial which eventually dissolves upon 
further heating. Alanine derived 9 also behaved similarly to its hexylene-spaced analogue but 
with many of the gels (referenced [a]) being unstable and precipitating over time.  
 
No gelation was observed either for leucine derived 25 or phenylalanine derived 26 despite 
gelation by their hexamethylene spaced analogues. Tyrosine derived compound 27 behaves 
similarly to 21 and formed oils in most of the solvents tested. A partial gel of tryptophan 
based compound 28 was observed in chloroform which was not seen for its hexamethylene 
spaced analogue. However, optimising this gel proved difficult and electron microscopy 
failed to show fibre formation so no further work was undertaken to investigate this system. 
 
A number of other analogues with different spacer lengths were also synthesised. A valine 
derived gelator with two methylene units in the spacer, 29, proved highly soluble in most 
solvents tested and failed to form any gels. Octylene spaced phenylalanine gelator 30 does 
not form gels in any of the solvents tested. It is interesting to note that the butylene- and 
octylene-spaced phenylalanine gelators do not form gels whilst the hexylene spaced analogue 
shows strong gelation in a number of solvents. The dodecylene-spaced leucine derivative 31 
is also highly soluble and failed to form gels in any of the solvents tested.  
2.4 Characterisation of Gel Structure 
2.4.1 Crystal Structures 
Single crystal X-ray structures of some of the gelator molecules provide valuable insights 
into the behaviour of these compounds and highlight key features in gel design. The tendency 
of the compounds to form highly anisotropic crystals (fine needles or plates) made obtaining 
suitable single crystals particularly challenging and for some systems only gels or fine 
precipitates were ever obtained. Crystallisations were undertaken from the full range of 
solvents by slow evaporation and by leaving samples in sealed vials, typically for several 
weeks and up to a year. In general the less strongly gelling and less flexible butylene-spaced 
analogues proved more crystalline and single crystals were more readily obtained.  
 
Single crystals suitable for XRD measurements were obtained for compounds 16, 17, 23, 24, 
and 25 and their structures solved. Compound 23 was found to exhibit two different 
polymorphic modifications in the same sample which were designated forms A and B. The 
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other compounds also exhibit polymorphism (as discussed in section 2.4.2) but suitable 
crystals for single crystal XRD could not be obtained.  
 
Figure 25 Antiparallel urea tape (N1O3 distance 2.87 Å) and CHO interactions (C3O2 distance 3.25 Å) 
shown for compound 23 form A.  
 
Figure 26 CHO interactions (C1O2 distance 3.31 Å) result in parallel C(5) tapes shown for compound 16. 
 
Glycine derivatives 16 and 23 form A show the same molecular conformation and crystal 
packing arrangement with slight differences in unit cell dimensions resulting from the 
difference in spacer length. The compounds crystallise in     with half of the molecule in the 
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asymmetric unit. The oligomethylene chain adopts an all trans conformation with the carbon 
atoms laying in the same plane as the urea carbonyl groups. The bis-urea groups form anti-
parallel   
     urea tapes typical for this class of compound (Figure 25).38 There is an 
additional CHO interaction within these stacks between the methyl ester groups and the 
hydrogen atom on the central (i.e. asymmetric or in the case of glycine derivatives prochiral) 
carbon atom of the amino acid (C3O2 distance 3.25 Å, Figure 25). At the pro-chiral centre 
of the amino acid, the methyl ester is bent out of this plane allowing for the CHO 
interaction between adjacent urea stacks. In compounds 16 and 23, CHO interaction takes 
place between methyl esters in adjacent urea stacks leading to a C(5) chain in graph set 
nomenclature (Figure 26).
45
  
 
Figure 27 The methyl ester of 24 is disordered between two positions (O1A and O1B, 0.45:0.55) due to 
competing interactions between the methyl R-group (C3) of the molecule below in the urea stack (C3-O1B 
3.24Å) and the methyl ester (C14) of a molecule in an adjacent urea stack (C14-O1A 3.23 Å). Anti parallel bis-
urea tapes and CHO interactions (C11-O6 3.23 Å) are also shown.  
 
The presence of the methyl R-group in alanine derivative 24 breaks the symmetry of the 
molecule changing the space group to P1 with the whole molecule in the asymmetric unit 
consistent with the presence of the resolved chiral centre. The absolute configuration is not 
determined crystallographically in these light atom structures, however, as all of the 
compounds were synthesised from the natural l-amino acids the chiral centres are assumed to 
correspond to the S-enantiomer. The two sides of the molecule are no longer equivalent and 
the hydrogen atom attached to the chiral centre of the amino acid is only orientated to interact 
with the methyl ester of the molecule below on one side (Figure 27, C11-O6 3.23 Å). The 
ester group on the other side of the molecule is disordered and has been modelled with C2 
and O1 occupying two positions with an occupancy which refined to 0.45:0.55 O1B:O1A 
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(Figure 27). The origin of this disorder appears to be competing CHO interactions between 
the carbonyl oxygen (O1A) and either the methyl R-group (C3) in the same urea stack or the 
methyl ester (C14) of the adjacent stack.  
 
 
The structures obtained for crystals of hexamethylene spaced alanine analogue 17 show the 
molecule adopts a very similar conformation to that seen for 24. The molecules pack together 
through urea tapes which further align into offset sheets. However the space group is    , not 
   , and adjacent sheets of urea stacks are rotated to give herringbone packing (Figure 28). 
The molecule is not disordered in this conformation, with 17 adopting the same packing as 
the major component of 24 (shown in Figure 27 as O1A). CHO interactions take place 
between methyl ester groups (O5C14 distance is 3.66 Å) at one end of the molecule and 
between the methyl ester and both the carbonyl and R-group at the other (C14O2 3.52 Å, 
O2C1 3.61 Å). Further interactions take place between adjacent urea stacks (C15O1 3.5 
Å). The data is of low precision due to poor crystal quality (conventional R value 14.2 %) but 
the gross molecular structure and crystal packing arrangement is unambiguous. 
Figure 28 CHO interactions between urea stacks of compound 17 along the c-axis, O5C14 3.66 Å, 
C14O2 3.52 Å, O2C1 3.61 Å, C15O1 3.5 Å. 
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Figure 29 Compound 25 viewed along (100) showing back–to-back packing of urea stacks (O8C8 3.23 Å, 
O20AC17 3.39Å) and interdigitation of isobutyl R-groups. Only disordered component A is shown for clarity.  
 
Leucine derived compound 25 adopts a similar conformation to those described for 
compounds 16, 17, 23a and 24, although the oligomethylene chain is bent out of the plane of 
the urea groups, presumably in order to better accommodate the bulky R-groups. Anti-
parallel bis-urea tapes are formed which are arranged back-to-back to create pairs of urea 
tapes. This arrangement enables CHO interactions to take place between the methyl ester 
groups (O8C8, 3.23 Å) and a hydrogen atom in the butylene spacer (O20AC17, 3.39 Å) 
as shown in Figure 29. The urea stacks are offset such that the CHO interactions take place 
at one end of the molecule with the compound below and at the other with the compound 
above forming a helix. The isobutyl R-groups are positioned on the outside of the helix where 
they interdigitate with isobutyl groups of neighbouring spirals. The isobutyl groups at one 
end of the compound are disordered between two positions. 
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Figure 30 CHO interactions along the 21 screw axis in form B of compound 23:  C1O2 distance 3.38 Å 
 
Compounds in the crystals described so far adopt different packing motifs as a result of 
different R-groups but the molecule adopts the same all trans oligomethylene conformation 
in each case. Fine needle-like crystals were found growing among the plates of 23 form A 
and identified as a second polymorph of 23, form B. The compound crystallised in 
monoclinic space group P21/n with half of the molecule in the asymmetric unit. In this form 
the antiparallel urea tape motif is conserved, however the oligomethylene spacer is syn to the 
urea groups. CHO interactions take place between methyl ester groups along the screw axis 
leading to herringbone packing (Figure 30). 
 
Compounds in this series are clearly able to pack together in variety of different ways. The 
steric and electronic effects of different R-groups impact upon the way the urea chains are 
able to pack together and a variety of CHO interactions can take place. The oligomethylene 
chains are conformationally flexibile and can be either trans or syn with respect to the urea 
tape. Anti-parallel bis-urea stacks are conserved between all the structures reported here. 
However, the urea tapes are not always conserved and in crystals of the previously reported 
ethylene-spaced valine derivative 29 each molecule bonds via its urea groups to four different 
molecules resulting in two dimensional hydrogen bonded sheets.
178
 It is likely that many of 
 45 
 
the packing features observed in the known crystal forms are shared by other compounds in 
the series for which single crystal structures could not be obtained.  
 
2.4.2 Solid state analysis 
Studies were undertaken to investigate the molecular basis for the gelation of compounds 16-
20 and 23-24 from a range of different solvents. The objective is to understand whether 
differences in polymorphism are responsible for gelation and non-gelation behaviour for the 
same compound in different solvents, and to investigate the instability observed in some of 
the gels.  
 
Samples were prepared in four solvents (acetonitrile, acetone, ethyl acetate and toluene) 
representing a range of polarities and gelling/non-gelling behaviour by the compounds. 
Unless otherwise stated, samples were prepared by heating 1 % w/v of the compound in a 
sealed 1.75 ml vial with 1 ml of solvent until a clear solution was formed. The samples were 
rapidly cooled in a water bath and briefly sonicated to ensure homogeneous gel formation 
where applicable. Xerogels or precipitates were obtained from freshly cooled samples and the 
solvent was removed rapidly under vacuum to minimise the likelihood of solid form 
conversion during the drying process.  
 
The solids were ground and analysed by IR, XRPD and DSC. Calculated powder patterns for 
the known crystal forms were matched with experimental data where possible. Different 
forms of a particular compound are identified as form A, B, C etc. but there is not necessarily 
any correlation between the crystal structures of different forms assigned with the same letter. 
A summary of the solid state forms obtained from a selection of different solvents is provided 
in Table 3. Solids obtained from gelling samples are highlighted in green, other samples are 
obtained from precipitates or solution. Where a second form is present as a minor product it 
is included in brackets; e.g. A(+B) means form A is the major product with form B present as 
a minor product. In some cases the compound converted from one form to another over time 
and this is indicated by an arrow, e.g. A(→B) means form A converts to form B over time.  
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Table 3 Solid state form obtained from samples of gelators 16-20 and 23-24 prepared from different solvents.   
Solvent 
Compound (corresponding amino acid and spacer length n) 
16 17 18 19 20 23 24 
Gly Ala Val Leu Phe Gly Ala 
6 6 6 6 6 4 4 
Toluene B B A(+B) A
 
A A B(→A) 
Ethyl acetate A(+B) B A A A A B 
Acetone A B C (+D) A A A A 
Acetonitrile A B D A A A A(+B) 
Water  B(→C)      
Green shading indicates sample obtained from a gel, right arrow indicates conversion of sample to a different 
form over time, + indicates minor form present 
 
The non-gelling precipitates of 16 obtained from acetone and acetonitrile gave XRPD 
patterns which match those generated for the known crystal structure of 16, form A. XRPD 
patterns for the xerogels of 16 obtained from toluene do not match those of form A and are 
assigned as a new form, form B. XRPD pattern for the precipitate of 16 obtained from ethyl 
acetate show peaks which match the patterns of both forms A and B. The relative intensities 
of the different peaks indicate that the ethyl acetate sample of 16 is predominantly form A, 
with form B as a minor component. Compound 23 shows the same XRPD pattern across all 
of the different solvents which match the generated XRPD pattern for the known crystal 
structure, 23 form A (Figure 31). Although the XRPD pattern observed is the same, gels only 
form in the toluene solvent system. The single crystal X-ray structures obtained for glycine 
derived compounds 16 and 23 form A show the gelators adopt very similar molecular 
conformations and crystal packing to one another. It is therefore interesting that this packing 
arrangement can give rise to gels for butylenes spaced compound 23 but not for hexylene 
spaced compound 16.  
 
In section 2.3.2 it was noted that heating of compound 23 in toluene produces a gelatinous 
material before the compound fully dissolves. XRPD patterns of this gelatinous material 
indicate it consists predominantly of Form B, with small amounts of form A also present. The 
transition is also observed in the solid state by DSC with xerogels of form A showing a 
melting peak at 180°C followed by recrystallization then a second melting peak at 196°C. 
Xerogels of form B show only one melting peak at 196°C.  
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Figure 31 XRPD patterns showing recrystallisation of 1 % w/v 23 from: a) toluene- form A (orange), b) ethyl 
acetate- form A (blue), c) acetone- form A (red), d) acetonitrile- form A (green), e) in toluene at high 
temperatures- form B(+A) (purple). Calculated crystal structures of f) 23 form A (mid blue) and g) form B 
(pink). 
 
Two different polymorphs of 24 appear to give rise to gelation. Xerogels obtained from 
acetone matched the known crystal form of 24 (form A), whilst xerogels obtained from 
toluene and ethyl acetate showed different XRPD patterns and were assigned as form B. The 
precipitate obtained from acetonitrile was found to be an approximately 1:1 mixture of forms 
A and B. A number of the other gels formed by this compound in DCM, CHCl3 and toluene 
proved to be unstable over a period of hours. Toluene gels allowed to evaporate slowly over 
several days produced powder patterns matching those of Form A, in contrast to rapidly dried 
fresh samples which show patterns assigned as Form B. This indicates conversion of form B 
to form A over time or with drying. It is possible that conversion of form B to form A in the 
acetone and acetonitrile samples is responsible for the different forms observed in the 
xerogels.  
a) 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
c) 
 
 
 
 
d) 
 
 
e) 
 
 
 
 
 
 
f) 
 
 
g) 
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Figure 32 XRPD patterns showing recrystallisation of 1 % w/v 17 from: a) toluene- form B (blue), b) ethyl 
acetate- form B (red), c) acetone- form B (green), d) acetonitrile- form B (purple), e) water– form B(+C) (light 
blue), f) broken down gel from water- form C (orange). g) Calculated crystal structures of 17 form A (grey) 
 
Hexylene spaced alanine gelator 17 gels all four of the solvents. The XRPD patterns for 
xerogels of 17 show a pattern which is different to that of the known crystal form A, so are 
assigned form B. The ethanol and water gels of 17 were observed to be unstable, rapidly 
breaking down to give precipitates. An XRPD pattern taken for a freshly formed and rapidly 
dried water gel showed a mixture of the gelling form B and a new form C. Samples of the 
precipitate formed when the water gel degraded were identified as form C. In water the 
gelling form B rapidly converts to a non-gelling form C. Form C shares a number of peaks 
(most notably at 9.5°) with the known crystal structure, Form A, but appears to be a distinct 
form (Figure 32).  
 
Valine derived gelator 18 only gels ethyl acetate and the XRPD pattern of the xerogel shows 
a single form, designated form A. The same set of peaks are seen in the toluene xerogels by 
XRPD with some additional peaks of similar intensity which may be due to higher 
crystallinity in the sample or the presence of a second form (form B). XRPD patterns for the 
acetonitrile and acetone samples indicate two further forms which are assigned C and D 
respectively. However, some of the peaks in the acetonitrile pattern match those of form D 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
c) 
 
 
d) 
 
 
e) 
 
 
 
 
 
 
 
 
f) 
 
 
g) 
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and a mixture of forms may be present in this sample. Repeats of the samples produced 
equivalent XRPD patterns with no clear changes in the ratio of peaks observed.  
 
 
Figure 33 XRPD patterns showing recrystallisation of 1 % w/v 18 from: a) toluene- form A(+B) (blue), b) ethyl 
acetate- form A (red), c) acetone- form C(+D) (green), d) acetonitrile- form D (purple) 
 
Leucine derived gelator 19 comes out of solution as the same form, designated form A, from 
all of the solvents but only gives rise to gels in toluene. Compound 19 was resynthesised 
following the same method as the original batch of gelator and shown to be of high purity by 
NMR spectroscopy, mass spectrometry and elemental analysis. However, when this batch of 
gelator was used, gels no longer formed in toluene at 1 % w/v of 19 with small amounts of 
precipitate forming instead. The precipitates from toluene showed the same peaks by XRPD 
as the other samples, but additional peaks were also observed indicating the presence of a 
second form, designated form B. Gels could be formed in toluene at higher concentrations of 
gelator (2 % w/v) or if a small amount of the original batch of gelator was added to the 
sample. It was suspected that a trace impurity in the new batch of gelator, possibly seeds of 
form B, was nucleating form B and preventing gel formation. However, all attempts to 
remove such an impurity by recrystallisation and filtration proved ineffective and no gels 
could be formed at 1 % w/v 19 from toluene using the second batch of gelator.  
 
a) 
 
 
 
 
 
 
 
 
b) 
 
 
 
c) 
 
 
 
d) 
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XRPD patterns for xerogels of 20 formed from acetonitrile and acetone closely match one 
another. However, the XRPD patterns for the toluene and ethyl acetate samples are weakly 
diffracting and an assignment could not be made on the basis of the broad, poorly defined 
XRPD patterns. IR spectra for all of the samples show a strong match and on this basis the 
xerogels are all assigned as form A (Figure 34). Xerogels produced from gels of 20 in a 
number of binary solvent mixtures were also investigated. DMSO:water (1:1) and THF:water 
(1:4) samples gave XRPD patterns which match those obtained from acetonitrile and acetone 
(form A), whilst xerogels formed from gels of methanol:water (3:2) gave different XRPD 
patterns, assigned as form B.   
 
Figure 34 IR spectra showing recrystallisation of 1 wt% 20 a) from toluene (blue), b) ethylacetate (red), c) 
acetone (green), d) acetonitrile (purple). 
 
This investigation highlights the extent of polymorphism displayed by this series of gelators 
with at least two different forms identified for each compound. Only one polymorph is 
associated with gel formation for all of the compounds except 24 where both forms A and B 
appear to give rise to gels. The gradual break down observed for toluene gels of 23 and 24 
and water gels of 17 was found to be the result of a polymorphic transition in which the 
metastable gelling form converts to a more stable non-gelling form. Although the crystal 
structures obtained for compounds 16, 17 and 23 form A showed similar conformations and 
packing arrangements, the behaviour of these forms in terms of their stability and ability to 
a) 
 
 
 
 
 
b) 
 
 
 
 
c) 
 
 
 
 
 
 
d) 
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form gels differed considerably. However, the formation of a particular polymorph does not 
guarantee gel formation, as seen for gels of 19 and 23 where the same form gives gels in 
some solvents but not others. The morphology of gel fibres and the way they crosslink in 
order to create a sample spanning structure are also important in determining gel formation.   
2.4.3 Gel morphology 
LMWGs can adopt a number of morphologies including fibrous, helical, ribbon-like, tubular, 
lamellar and vesicular structures.
24
 Different morphologies can arise due to differences in 
molecular packing and the size and shape of fibres can be correlated with the strength and 
opacity of gels.  Samples were prepared by applying a small amount of gel to a silicon wafer 
chip using a cocktail stick. The solvent evaporated rapidly under ambient conditions leaving a 
xerogel. The samples were placed under high vacuum and coated with 5 nm of platinum. 
SEM was used to image the morphology of different xerogels. 
 
Compounds 16-19 and 23-24 all showed two dimensional, ribbon-like fibres. There was 
greater variation in the dimensions of the fibres within samples than between them with the 
thickness of the ribbons typically 10-100nm, the width between 100 nm-5 μm and lengths 
from 100 nm-<100 μm. The ribbons formed physically entangled networks with separate 
fibres weaving and wrapping around each other. The ribbons are often observed stacked on 
top of each other (Figure 35b) indicating attraction between the faces of the ribbons and this 
is thought to be the main source of crosslinking in the networks. The ribbons can also split 
along their length branching into two separate fibres (Figure 35c) which may provide a 
further means of crosslinking.  
 
 
Figure 35 SEM images of xerogels formed from 1 % w/v gels of a) 17 in toluene, b) 17 in THF and c) 16 in 
toluene. Note the differences in scale between a) and b), stacking of ribbons in b) and splitting of ribbons in c).  
 
a                b                         c 
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The alanine gelators 17 and 24 typically exhibit a xerogel morphology comprising of smaller, 
less linear fibres than other gelators which corresponds to the more robust and more 
translucent gels observed. There was little variation in the morphology of xerogels of 17 
formed from different solvents (Figure 36). The larger, more rigid plates observed for 17 in 
water are likely to be due to the rapid polymorphic transition (form B transforms to form C) 
that occurs for this system and the images are of the non-gelling precipitate.  
 
Two distinct morphologies are observed concomitantly for samples of 23 prepared from the 
gelatinous aggregates formed when 23 is heated in toluene; large plate-like ribbons and 
smaller rod-like structures (Figure 38f).  Only the larger, plate-like ribbons are seen in 
samples prepared from toluene gels of 23 (Figure 38g). The different morphologies are 
thought to correspond to the two different polymorphs of 23 with the plate-like structures 
form A and the rod-like structures form B.  
 
 
Figure 36 SEM images of 1 % w/v 17 fibres in a) toluene b) acetonitrile c) tetrahydrofuran d) chloroform e) 
ethyl acetate f) water. 
 
a b c 
d e f 
 53 
 
 
Figure 37 Xerogels formed from 1 % w/v gels of 20 in a) ethylacetate, b) acetonitrile c) acetone d) 1:4 
THF:water, e) 1:1 DMSO water and f) 3:2 Methanol:water
179
 
 
In contrast to the two dimensional structures formed by the other gelators, 20 forms randomly 
entangled networks of one-dimensional fibres. Individual fibrils are cylindrical and microns 
in length with a relatively consistent diameter of approximately 50 nm. These fibrils appear 
to wrap around each other in a helical manner to form larger fibres, a phenomenon often seen 
for chiral gelators.
174, 175, 180
 There is considerable variation in the aggregation behaviour of 
these fibres. The fibres from toluene are more randomly orientated than the acetonitrile and 
acetone samples where the fibres tend to be bunched together into partially aligned clumps.  
 
The fibrils from 1:4 THF:water mixture wrap around each other forming needle shaped 
structures which clearly show a helical twist. The structure of the DMSO:water gel consists 
of thinner fibres composed of individual fibrils which branch off and recombine with other 
fibres. This aligning and physical entanglement of fibrils and fibres appears to be the 
mechanism for crosslinking to give a sample spanning network. SEM images of the 
methanol:water (3:2) xerogels show significantly larger (250 nm) needle-like structures. 
XRPD showed the methanol:water xerogels have a different molecular packing (form B) to 
the other xerogels which share the same packing (form A).  
 
a b c 
d e f 
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Figure 38 Xerogels of a) 16 b) 17 c) 18, d) 19, e) 20 f) 23 high temperature sample, g) 23 low temperature 
sample, h) 24. All xerogels are formed from gels 1 % w/v in toluene except c) which is from gels of 18 in ethyl 
acetate. 
a                                         b 
  
 
 
 
 
 
 
 
 
 
 
c                                   d 
 
 
 
 
 
 
 
 
 
 
 
e                                       f 
 
 
 
 
 
 
 
 
 
 
g                                h 
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2.5 Characterisation of Gel Properties 
Within this series of compounds there are considerable differences in the properties of the 
gels. The strength of the gels, temperature at which they set and amount of gelator required to 
form a gel varies significantly with gelator and solvent. A qualitative description of some of 
these observations has already been reported in section 2.3; attempts to quantify some of this 
behaviour are reported in this section. 
 
Toluene samples containing 1 % w/v of gelators 16, 17, 19, 20, 23 and 24 were studied by 
rheometry. The response of the elastic (G′) and loss (G′′) moduli to changes in frequency, 
stress and strain were measured.  The high temperature at which some of the gels form meant 
that samples had to be prepared in sealed vials and transferred using a spatula onto the 
rheometer which was used in a flat plate geometry. A total of 4 ml of each sample was used 
in each case. The gels were prepared in 7 ml vials except for compounds 16, 17 and 24 where 
several smaller vials (1.75 ml) had to be combined as a build up of pressure with heating led 
to the escape of solvent in the larger vials. Compression of the samples between the plates 
resulted in loss of some solvent meaning the results may not accurately reflect a 1 % w/v gel. 
These limitations, along with the general challenges of getting reproducible rheometric data 
for LMWGs,
24
 mean only general observations can be made about the behaviour of the 
samples. 
 
Rheological measurements confirmed gel-like behaviour in 1 % w/v samples of 16-20 and 24 
in toluene. The elastic modulus (G′) is greater than the viscous modulus (G′′) by 
approximately one order of magnitude for all samples.  Application of increasing stress or 
strain to the samples eventually results in the gel yielding, with G′′ becoming greater than G′. 
The general trend in gel strength and yield stress matches bench top observations, with 17 
and 20 forming strong robust gels and 16, 19 and 24 weaker more fragile gels.  
 
As well as the regular gels of 23 in toluene, whose structure is assigned as Form A by XRPD, 
the gelatinous material formed upon heating a sample of 23 in toluene, predominantly form B 
with small amounts of form A present, was also tested. The form B material gives strong gels 
with high G′ values which failed to yield at an applied stress of 300 Pa. Form A gels in 
contrast were much weaker readily breaking down to solutions with low applied stress (2 Pa).  
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Figure 39 Oscillitory stress sweep comparing amino acid derived gelators at a constant frequency of 1 Hz.; 
open circles 20, closed circles 17, open squares 16.  
 
 
 
Table 4 Summary of rheometric data for 1 % w/v toluene gels of various compounds 
 Compound 
 Measurement 16 17 19 20 23 form A 23 form B 24 
G′ (Pa) 4.5x103 4.6 x104 7.5 x103 2.5 x105 7.6 x102 1.3 x105 5.2 x103 
G′′ (Pa) 3.4 x102 3.1 x103 2.3x103 2.1 x104 8.9 4.6 x103 9.9 x102 
G′/G′′ (Pa) 13.3 15.2 3.3 12.2 8.6 27.7 5.3 
Yield stress (Pa) 25 126 32 N/A
 
2 NA 20 
N/A = Sample did not yield below 300 Pa 
 
 
 
 
  
 57 
 
  
Figure 40 Frequency sweep comparing amino acid derived gelators at a constant stress of 10 Pa; 1 Hz.; open 
circles 23 form A, open squares 23 form B, closed circle 24.  
 
The G′ and G′′ values of gels are characteristically unchanged over a wide range of 
frequencies. Gels of 17 and 20 showed no significant variation in G′ or G′′ across the full 
range of frequencies investigated (0.1-100 Hz, 10 Pa osc. stress). Gels of 16, 19 and 23 form 
B showed no variation of G′ or G′′ in the frequency sweep up to 10 Hz after which a sudden 
dip then gradual increase in both values is observed. A similar dip then rise is observed much 
more strongly for gels of 23 form A at a much lower frequency, around 1 Hz. This non-linear 
behaviour is explained by the low yield stress of this gel which is below that of the applied 
stress. 
 
Using the dropping ball method, toluene gels with 1 % w/v 20 was found to have a Tgel of 
87°C with an error estimated to be ± 2°C in each case. Toluene gels with 1 % w/v of 17 
measured using the dropping ball method in a sealed vial continued to support the ball 
bearing at temperatures of 110°C. No Tgel was recorded due to safety concerns regarding the 
build up of pressure upon heating the sample above the boiling of toluene for prolonged 
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periods of time. Toluene gels with 1 % w/v of 16, 19, 23 and 24 could not be tested using this 
method as they were not able to support the ball bearings. Qualitatively, toluene gels of 16, 
23 and 24 require prolonged heating with a heat gun at temperatures well above 110°C whilst 
toluene gels of 19 dissolve readily with moderate heating.  
 
Compounds 17 and 20 form gels in toluene at concentrations well below the 1 % w/v of 
gelator used in the rheometry. The minimum amount of gelator required to form a sample 
stable to the inversion test, the critical gelation concentration (CGC), is 0.025 % w/v and 
0.015 % w/v for compounds 17 and 20 respectively. This correlates to 330 molecules of 
toluene gelled for every molecule of 20 and 140 toluene molecules gelled for each molecule 
of 17.  
 
Ethyl acetate gels of 20 measured using the flat plate geometry with 8 ml of gel were found to 
give reproducible stress sweep curves showing strong gels which failed to break down up to 
oscillatory stress values of up to 1000 Pa. The effect on rheometry of the addition of anions to 
1:9 acetonitrile:toluene and ethyl acetate gels of 20 and chloroform gels of 17 are reported in 
section 3.4.2 of Chapter 3.  
 
2.6 Mixed Gelators 
As well as gels formed by a single low molecular weight organic compound, a variety of 
systems in which multiple components come together to form gels have been described. 
Interactions with a second organic component,
14
 metal ions
19
 or nanoscopic materials
109
 can 
be used to bring about gelation and the ratio of different components changed to fine tune the 
gel properties. Different components may interact in well defined ways with a specific 
stoichiometry,
42
 form statistical or random co-polymers,
101
 or form completely independent 
but interpenetrated networks.
39
   
 
In order to further investigate the behaviour of this class of compounds, mixtures of different 
gelators were investigated. The crystal structures obtained for compounds 16, 17, 23, 24 and 
25, and by inference those of other gelators in the series, share many similarities. Most 
notable is the presence of alpha urea tapes which are conserved across all of the structures 
and are thought to be responsible for fibre formation. The extent of polymorphism found 
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across the series indicates that individual gelators are able to adopt a number of low energy 
conformations whilst conserving the urea -tape hydrogen bonding motif. However, small 
changes in substituent group can lead to subtle differences in the way the molecules pack 
together resulting in differences in fibre morphology, interactions between fibres and 
ultimately gel formation. It is therefore interesting to explore how different gelators interact 
with each other and the effect this has on gel structure and morphology with a view to further 
tuning gel properties using co-gels.  
 
A number of binary combinations of gelators 16, 17, 19, 20, 23 and 24 with a total 1 % w/v 
of gelator in toluene solution were investigated by SEM and XRPD. All of the combinations 
investigated formed gels at all of the ratios tested. On one hand this is unremarkable in that 
the CGC of many of the gelators is well below 0.5 % w/v. On the other hand, given the 
similarities of the compounds to each other, but their differences in crystal packing 
arrangement, it is perhaps surprising that gel formation was not disrupted. A key question is 
whether phase separation occurs such that the mixed gels comprise separate networks with 
each gelator by itself or whether the individuals fibrils comprise of both gelators, either in an 
ordered, statistical or random arrangement, to give true co-gels. 
 
As discussed in section 2.4.3, SEM images of gels formed by compound 20 show cylindrical 
fibres whereas ribbons are observed for other gelators. Figure 41 provides a summary of the 
morphology of xerogels formed from binary 1:1 mixtures of various gelators in toluene. 
Mixtures of butylene-spaced gelators 23 and 24 contain flat ribbon-like structures similar to 
those seen for the pure compounds. Mixtures of the corresponding hexylene spaced gelators, 
16 and 17, also show two-dimensional ribbons like the parent compounds. However, these 
ribbons adopt a marked twist not observed for the achiral gelator 16 nor observed to the same 
extent for chiral gelator 17. This type of twisting is well known and often associated with 
chiral building blocks.
174, 181
 The chiral alanine derived gelator molecules may induce a twist 
which is exaggerated by the achiral derived glycine gelator molecules which don’t twist.  
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Figure 41 Mixed 1:1 toluene gels (1 % w/v) 
interpreted as showing a) helical mixed fibres of 16:17 
b) separate ribbons of 16:24 c) separate ribbons and 
cylindrical fibres of 20:16 d) and 20:23 e) cylindrical 
ribbons of 20:17 f) separate ribbons and cylindrical 
fibres of 20:24 g) and mixed cylindrical fibres of 
20:19 
a  b 
 
 
 
 
 
 
 
 
 
 
 
 
c  d 
 
 
 
 
 
 
 
 
 
 
 
 
e  f 
 
 
 
 
 
 
 
 
 
 
 
g 
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SEM images of mixtures of 20 and 16 clearly show separate fibres with the distinct 
cylindrical and ribbon-like morphologies of 20 and 16, respectively. In contrast, 1:1 mixtures 
of 20 and 17 show almost exclusively cylindrical morphology, with only the occasional 
ribbon-like structures observed by SEM. Predominantly cylindrical fibres are also seen for 
mixtures of 20 and 19. These observations indicate compounds 17 and 19 interact strongly 
with 20 to produce a single morphology, whilst 16 and 20 don’t interact in the same way and 
so produce separate fibres with the morphology of the pure compounds.  
 
Hexylene spaced gelator 20 was also combined with butylene spaced gelators 23 and 24 to 
assess the impact of spacer length on co-gel formation. As with its hexylene analogue (16), 
glycine derivative 23 showed separate ribbon- and fibre-like structures. Separate ribbons and 
fibres were also clearly seen for mixtures of 20 with alanine derived gelator 24. It is 
interesting to note that with the same spacer length, mixtures of 20 and 17 show a single 
morphology where as with different spacer lengths 20 and 24 show separate fibres and 
ribbons. This is readily rationalised in terms of compounds with the same spacer length being 
able to form bis-urea tapes more readily than those with different spacer lengths, so favouring 
homo-fibre formation. 
 
In order to gain insight into molecular packing in the mixed gels, XRPD patterns were 
collected for xerogels formed from binary mixtures of gelators at molar ratios of 1:0 2:8, 4:6, 
1:1, 6:4, 8:2 and 0:1.  
 
The crystal structures described in section 2.4.1 for both butylene glycine gelator 23 (Form 
A) and alanine gelator 24 (Form A) show very similar packing motifs. The analysis in section 
2.4.2 shows that this packing is observed in toluene gels of compound 23 (form A) but not 
toluene gels of 24 which show a second packing motif (form B). Figure 42 shows the XRPD 
pattern for mixtures of 23:24 with the ratio of 23 decreasing from top to bottom. The XRPD 
patterns for mixtures ranging from 1:0-2:3 23:24 match that of the pattern for the pure 
glycine gelator 23 (form A). Small shifts occur in a number of peaks, most noticeably a shift 
in one peak from 17-15°, with increasing concentration of 24. This indicates a co-gel is 
formed which adopts the packing of 23 form A with incorporation of 24 resulting in small 
changes in the average unit cell dimensions. At a 1:4 ratio, an additional set of peaks which 
matches those of 24 form B are observed in addition to those of 23 form B. This indicates 
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separate fibres with packing corresponding to that of 24 form B also form, but only at high 
concentrations of 24.   
 
 
Figure 42 XRPD patterns corresponding to xerogels formed from toluene of 23:24 in a ratio of a) 1:0 (blue), b) 
4:1 (red), c) 3:2 (green), d) 2:3 (purple), e) 1:4 (light blue), f) 0:1 (orange).  
 
Figure 43 shows XRPD patterns for mixtures of 16:17 with the ratio of 16 decreasing from 
top to bottom.  XRPD patterns for the mixed samples show a single set of peaks which do not 
match those of either pure 16 (form B) or 17 (form B). The positions of the peaks assigned to 
the new mixed phase vary significantly depending on the composition of the mixture while 
retaining the same basic pattern. The strong low angle peaks in the mixtures around 5° and 
10° more closely resemble those of alanine gelator 17 and there is generally less correlation 
of the mixed phase with the pattern for 16. However the 1:1 mixture does not follow this 
trend and a different pattern to other xerogels in the series. Whilst the evidence here is less 
clear, the behaviour is different from the butylene spaced, glycine and alanine derived co-gels 
(23:24) which clearly show packing similar to that of the glycine gelator. This difference in 
behaviour shows how small changes in the spacer length, as well as R-group, can impact 
upon gel structure and properties.  
 
a) 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
c) 
 
 
d) 
 
 
 
e) 
 
 
 
 
 
 
 
 
 
f) 
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Figure 43 XRPD patterns corresponding to xerogels formed from toluene of 16:17 in a ratio of a) 1:0 (blue), b) 
4:1 (red), c) 3:2 (green), d) 1:1 (dotted black), e) 2:3 (purple), f) 1:4 (light blue), g) 0:1 (orange).  
 
XRPD patterns for the 17:20 mixtures show a gradual transition in peak shape from well 
resolved peaks matching compound 17 to broad peaks corresponding to the pattern of 5 
(Figure 44). However, the pattern for the 4:6 mixture of 17:20 does not fit with this trend and 
shows well resolved peaks different from either parent compound. XRPD patterns for the 
20:19 mixture show a new set of well resolved peaks which do not correspond to either 
parent compound indicating a new packing motif. However, experiments taken at different 
compositions showed almost no change in peak shape or position, apart from the 1:1 mixture 
where only broad peaks were observed. Further work is therefore required to understand the 
behaviour in these mixed gel systems and the cause of the change in morphology observed by 
SEM.  
 
The SEM and XRPD results obtained indicate that different gelators in the series interact with 
each other in different ways. The morphology of the resulting gel fibres may be the same as 
that of the pure gelators, show only a single fibre type or contain new features not seen for 
either of the pure compounds. XRPD results indicate that one compound may become 
incorporated into the packing of a second compound or form completely new packing motifs. 
As with the pure gelators, the mixed gels may be unstable and rearrange upon drying or 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
c) 
 
 
 
 
d) 
 
 
e) 
 
 
 
f) 
 
g) 
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consist of a mixture of different packing motifs and further work is required to fully 
understand these complex systems.  
 
 
 Figure 44 XRPD patterns corresponding to xerogels formed from toluene of 17:20 in a ratio of  a) 1:0 (blue), 
b) 4:1 (red), c) 3:2 (green), d) 1:1 (purple), e) 2:3 (dotted black), f) 1:4 (orange) and g) 0:1 (grey). 
 
2.7 Conclusion 
A series of amino acid derived supramolecular gelators were synthesised by the reaction of 
methyl ester protected amino acids with alkylene spaced diisocyanates of different lengths. 
Many of the compounds were found to form gels, some in a wide range of solvents and at 
low concentrations. Subtle changes in amino acid substituent group and spacer length have a 
profound impact on the range of solvents gelled and the stability, strength and appearance of 
the gels formed. There was no overall trend in gelation behaviour with increasing size of 
substituent group or spacer length. Instead, a number of discrete, effective gelator structures 
were found with deviation from the structures detrimental to gel formation.  
 
In X-ray crystal structures obtained for compounds 16, 17, 23, 24 and 25 the basic 
conformational and structural features are conserved: antiparallel urea tapes, a conformation 
involving all-trans oligomethylene spacers with the methyl ester groups bent out of the plane 
a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
g) 
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allowing interactions with neighbouring urea stacks. However, the introduction of 
increasingly bulky substituent groups subtly distorts the conformation of the molecules 
leading to different packing motifs. Form B of compound 23 contains a second molecular 
conformation with the oligomethylene spacer syn to the urea tape which leads to substantial 
differences in packing.  
 
Solid state analysis of xerogels formed from various solvents indicates that many of the 
gelators exhibit polymorphism. For some compounds gel formation appears to correlate with 
a particular solid form; in other compounds the same packing arrangement may result in gel 
formation in one solvent but not another. The instability observed for gels of 17 in water can 
be explained by the transformation of one packing form to another. The form A crystal 
structures for the alanine and glycine derived gelators show very similar conformations and 
packing. It therefore particularly interesting that this packing motif gives rise to the gelling 
form of 23, but not of compounds 16, 17 or 24 in toluene.  
 
Electron microscopy shows that all of the xerogels consist of entangled networks of fibres 
with distinct morphologies. Xerogels of 20 show fine one-dimensional fibrils twisted together 
into larger fibres whilst other gelators form two-dimensional ribbon-like structures. Distinct 
ribbon morphologies can be distinguished for the two different polymorphs of 23. The size, 
thickness and flexibility of the fibres correlate well with visual observations of the opacity 
and robustness of the gels.  
 
Rheometry confirmed gel-like behaviour for compounds 16, 17, 19, 20, 23 and 24 in toluene 
as well as 20 in ethylacetate. The stronger gels, 17 and 20, were found to set and break-down 
at high temperatures and with low critical gelation concentrations. They also showed similar 
gelation behaviour in a number of other solvent systems.  
 
Mixtures of compounds in this series were found to form co-gels which displayed different 
morphologies and packing different from those of the pure gelators. Mixtures of compounds 
23 and 24 adopted the packing of glycine gelator 23, whilst the packing in mixtures of 16 and 
17 more closely matched that of alanine gelator 17. Equally remarkably, mixtures of very 
similar compounds were able to self-assemble into separate fibres showing the same 
morphology and packing as the pure compounds. Differences in spacer length meant that 
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mixtures of 20 and 17 formed co-gels with a single morphology, whilst mixtures of 20 and 24 
formed separate fibres with distinct morphologies.  
 
Gelation in this series of compounds can usefully be thought of as an arrested crystallisation 
with entangled networks of highly anisotropic crystals resulting from differences in packing 
at the molecular level. The extent of polymorphism observed for this class of compounds 
makes them both interesting and challenging systems to study. However, gels are complex 
hierarchical structures and the ‘right’ molecular packing is insufficient to ensure gel 
formation. Small changes in the molecular structure, solvent composition, sample preparation 
or the presence of other gelators can have a profound impact upon every level of the gel 
structure.  
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2.8 Experimental Section 
2.8.1 Source of compounds 
Compounds 17, 21, 23 and 27 are novel compounds synthesised as part of this work. 
Compounds 20, 26 and 30 were originally synthesised by Jonathan Foster as part of work 
submitted for a masters in Chemistry at the University of Durham. The photographs used in 
Figure 24 and SEM images used in Figure 37 relating to compound 20 were also submitted as 
part of the dissertation. Compound 32 was synthesised by Jenifer Cuesta Bernal, a summer 
student, under the direct supervision of Jonathan Foster. Compounds 16, 18, 19, 22, 23, 25, 
28 and 31 were synthesised by MChem student Gary Cameron under the supervision of 
Jonathan Foster. Compound 29 was synthesised by Dr. Gareth Lloyd.
178
 Methods for the 
production of all of the compounds are included for completeness.  
 
2.8.2 Materials and methods 
All solvents and reagents were obtained from standard commercial sources.  The drying 
pistol was evacuated using anaspirator and heated by toluene under reflux. All NMR spectra 
were performed on a Varian Mercury-400 (400 MHz for 1H), Varian Inova-500 machine 
(500 MHz for 1H, 126 Hz for 
13
C{
1
H}) or a Varian DD-700 (700 MHz for 1H, 176 MHz for 
13
C) and were referenced to residual solvent. Mass spectroscopy for compounds which 
dissolve in methanol was undertaken using a Thermo-Finnigan LTQ FT machine running in 
positive electron spray (ES) mode. Insoluble compounds were measured using a Waters Xevo 
QTOF spectrometer equipped with an Atmospheric Solids Analysis Probe (ASAP). 
Elemental analysis was performed using an Exeter Analytical inc. CE-400 Elemental 
Analyser.   
 
Fourier transform infrared spectra were recorded with a Perkin Elmer Spectrum 100 ATR 
instrument (Perkin-Elmer, Norwalk, Ct., USA). For each spectrum, 16 scans were conducted 
over a spectral range of 4000 to 600 cm
-1
 with a resolution of 4 cm
-1
. Powder diffraction was 
performed on glass slides using a Brucker D8 or D5000 X-Ray Diffractometers using CuKα 
radiation at a wavelength of 1.5406 Å. Differential scanning calorimetry was undertaken on a 
Perkin Elmer Pyris 1 DSC or TA instruments Q1000 DSC using 1 mg of sample weighed 
into the centre of an aluminium pan and heated from 0-220°C at 10°C per minute.  
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Suitable single crystals were mounted using perflouropolyether on a thin glass fibre or 
preformed tip. Crystallographic measurements were carried out using a Bruker SMART 6K 
(6000 CCD), Oxford Diffraction Gemini or Kappa Rigaku Saturn 724+.  The instruments are 
equipped with a graphite monochromatic Mo-Kα radiation (λ = 0.71073) or synchrotron 
radiation (λ = 0.68890) . The data collection temperature was maintained using by an open 
flow N2 Oxford Cryostream device. Integration was carried out using SAINT, CrysAlisPro or 
Crystal Clear software. Data sets were corrected for Lorentz and polarization effects and for 
the effects of absorption. Structures were solved using direct methods (SHELXS-97)
182
 and 
developed using alternating cycles of least-squares refinement and difference Fourier 
synthesis using OLEX2.
183
 All non-hydrogen atoms were treated as anisotropic. Hydrogen 
atoms were fixed in idealised positions and allowed to ride on the parent atom to which they 
are attached. Hydrogen atom thermal parameters were tied to those of the parent atom. Where 
possible N-H and O-H hydrogen atoms were located experimentally and their position and 
displacement parameters refined or their position parameters constrained to ideal distances 
from the parent atoms. Molecular graphics were produced using the program OLEX2. 
 
Samples prepared for SEM were applied directly to silicon wafer chips (Agar Scientific) 
using a cocktail stick for gels or pipettes for liquids and the solvent allowed to evaporate. 
Samples were stored under vacuum at 1x10
-5 
mbar then sputter coated with 5nm platinum in a 
Cressington 328 coating unit, at 40mA (density 21.09 and tooling set at 1) with rotation and a 
30
0
 angle of tilt. Samples were imaged using a Hitachi S-5200 field emission scanning 
electron microscope at 1.5kV. 
 
Rheology experiments were performed using a TA Instruments Advanced Rheometer 2000. 
A 40 mm steel plate geometry was used with a gap of 500 μm and 4 ml of sample in each 
case. Samples were prepared by weighing 0.04 g of gelator into an 7 ml glass vial along with 
4 ml of toluene (1 % w/v). The vials were sealed and heated until the gelator had fully 
dissolved (care must be taken due to pressure build up). The samples were rapidly cooled in a 
water bath and briefly sonicated at the first sign of precipitation to ensure homogeneous gel 
formation. The gel was transfered onto the centre of the plate of the rheometer using a spatula 
and the plate squashed the gel resulting in the loss of some solvent. Samples of 16, 23 form A 
and 24 were prepared by combining four separate 1.7 ml vials each containing 1 ml of gel. 
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The high temperature form of 23, form B, was prepared by heating the solid gelator in 
toluene until a patially gelling precipitate formed which was then applied to the slide using a 
spatula. Experiments were measured at 20°C and a solvent trap was used to reduce solvent 
evaporation. Frequency sweep measurements were performed over a range of 1 to 100 Hz 
with a constant osc. stress of 10 Pa. Oscillatory stress measurements were performed over a 
range of 0.01-100 % strain at a constant frequency of 1 Hz. Oscillatory stress sweep 
measurements were preformed over a range of 0.01-300 Pa with a constant frequency value 
of 1 Hz.  
 
2.8.3 Synthesis 
Methyl 2-[6-[(2-methoxy-2-oxo-ethyl)carbamoylamino]hexylcarbamoylamino]acetate (16) 
Glycine methyl ester hydrochloride (1.00 g, 7.96 mmol) was suspended in 30 ml of 
chloroform and an excess of triethylamine was added, whereupon the suspension dissolved. 
1,6-diisocyanatohexane (0.67 g, 3.98 mmol) in 20 ml chloroform solution was added 
dropwise and the reaction was then left to heat under reflux for 18 hours, after which period a 
white suspension formed. The suspension was filtered, washed with water and methanol and 
dried in a heat pistol at 110°C for 1 hour. Compound 16 was isolated as a white powder (1.22 
g, 3.50 mmol, 88 %): 
1
H NMR (500MHz, DMSO-d6, J/Hz): 6.15–6.08 (4H, m, C*NH), 3.75 
(4Η, d, J 6.0, COCH2NH), 3.60 (6Η, s, OCH3), 2.96 (4Η, dd, J 6.7, 12.8, NCH2), 1.38-1.31 
(4Η, m, NCH2CH2), 1.27-1.20 (4Η, m, CH2CH2CH2). 
13
C{
1
H} NMR (126MHz, DMSO-d6, 
J/Hz): 172.5 (s, COO), 158.6 (s, NCO), 52.2 (s, CH3), 42.1 (s, NCH2), 40.7–39.7 (NCH2CH2 
under DMSO residual solvent peak), 30.6 (s, NCH2CH2), 26.8 (s, CH2CH2CH2). m/z (ES
+
-
MS): 347.3 ([M+H]
+
, 40%), 369.1 ([M+Na]
+
, 58%), 370.0 ([M+H+Na]
+
, 100%), 715.5 
([2M+Na]
+, 26%). Anal. calc’d for C14H26N4O6: C, 48.55; H, 7.57; N, 16.17. Found: C, 
48.22; H, 7.47; N, 16.00%.  
 
Crystal data for Compound 16 form A, C14H26N4O6, M = 346.39, colourless plate, 0.01 × 
0.008 × 0.002 mm
3
 crystallised from water, triclinic space group,     (No. 2), a = 
4.635(3) Å, b = 5.659(4) Å, c = 17.929(12) Å, α = 83.189(7)°, β = 83.317(7)°, γ = 
69.800(8)°, V = 436.8(5) Å
3
, Z = 1, Dc = 1.3167 g/cm
3
, F000 = 186, Kappa Rigaku 
Saturn724+, synchrotron radiation, = 0.6889 Å,  T = 150.15 K, 2max = 51.0º, 3661 
reflections collected, 1691 unique (Rint = 0.0419).  Final GooF = 1.073, R1 = 0.0522, wR2 = 
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0.135 (all data), R indices based on 1243 reflections with I≥2(I) (refinement on F2), 160 
parameters, 0 restraints.  Lp and absorption corrections applied, = 0.097 mm-1. 
 
Methyl (2S)-2-[6-[[(1S)-2-methoxy-1-methyl-2-oxo-ethyl]carbamoylamino]hexylcarbamoyl 
amino]propanoate (17) 
L-alanine methyl ester hydrochloride (3.96 g, 28.5 mmol) was dissolved in 100 ml 
chloroform and an excess of triethylamine (3 g, 29.7 mmol) was added. 1,6-
diisocyanatohexane (2.39 g, 14.25 mmol) was added  dropwise then  heated under reflux. 
After 1 hour, the solution was cooled to room temperature and the geletenous precipitate 
filtered and washed twice with 25 ml of DCM and then once with 25 ml diethyl ether. The 
resulting solid was sonicated in warm water for 30 minutes then filtered, then recrystallized 
from methanol, filtered and washed with diethyl ether. The compound was dried in a drying 
pistol for 30 minutes and the product, 17, obtained as a white powder (4.12 g, 11.0 mmol, 77 
% yield) 
1
H NMR (700 MHz, DMSO-d6, J/Hz): 6.16 (2 H, d, J 7.7, C*NH), 5.93 (2 H, t, J 
5.6, NHCH2), 4.11 (2 H, p, J 7.3, C*H), 3.58 (6 H, s, OMe), 2.99 – 2.86 (4 H, m, NHCH2), 
1.30 (4 H, d, J 6.4, NHCH2CH2), 1.23 – 1.17 (4 H, m, CH2CH2CH2,  C*CH3). 
13
C{
1
H} NMR 
(176 MHz, DMSO-d6, J/Hz) 174.75 (s, COO), 157.79 (s, NCO), 52.09 (s, OCH3), 48.55 (s, 
C*), 40.7–39.7 (NCH2CH2 under DMSO residual solvent peak), 30.36 (s, NCH2CH2), 26.51 
(s, CH2CH2CH2), 18.45 (s, C*CH3). m/z (ES
+
-MS): 375.4 ([M+H]
+
, 20%), 397.4 ([M+Na]
+
, 
100%), 771.7 ([2M+Na]
+, 18%). Anal. calc’d for C16H30N4O6: C, 51.32; H, 8.08; N, 14.96. 
Found: C, 51.25; H, 8.26; N, 14.59%.  
 
Crystal data for 17 form A, C16H30N4O6, M = 374.44,  clear colourless plate, 0.01 × 0.008 × 
0.003 mm
3 
crystallised from methanol, monoclinic space group     (No. 4), a = 
4.6814(19) Å, b = 35.331(15) Å, c = 6.149(3) Å, β = 108.562(4)°, V = 964.1(7) Å3, Z = 2, Dc 
= 1.2897 g/cm
3
, F000 = 404, Kappa Rigaku Saturn724+, synchrotron radiation, = 0.6889 Å,  
T = 150.15 K, 2max = 55.5º, 8115 reflections collected, 3855 unique (Rint = 0.0627).  Final 
GooF = 1.758, R1 = 0.145, wR2 = 0.399 (all data), R indices based on 3504 reflections with 
I≥2(I) (refinement on F2), 244 parameters, 0 restraints. Lp and absorption corrections 
applied, = 0.093 mm-1.  Absolute structure parameter = -2(3)   
 
Methyl (2S)-2-[6-[[(1S)-1-methoxycarbonyl-2-methyl-propyl]carbamoylamino] hexyl 
carbamoylamino]-3-methyl-butanoate (18) 
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L-valine methyl ester hydrochloride (1.00 g, 5.97 mmol) was suspended in 30ml of 
chloroform and an excess of triethylamine was added until the suspension dissolved. 1,6-
diisocyanatohexane (0.50 g, 2.98 mmol) in 20ml chloroform solution was added dropwise 
and the reaction was then heated under reflux for 18 hours. The solution was washed with 
water and the chloroform reduced on a rotary evaporator, after which the product was 
isolated by the addition of a small amount of hexane. The remaining solvent was removed by 
rotary evaporation and then in a drying pistol. Compound 18 was isolated as a white powder 
(0.76 g, 1.77 mmol, 59%): 
1
H NMR (500MHz, DMSO-d6, J/Hz): 6.11 (2H, d, J 8.9, C*NH), 
5.97 (2H, t, J 5.6, NHCH2), 4.06 (2H, dt, J 5.5, 8.9, CH), 3.61 (6H, s, OCH3), 2.96 (4H, dt, J 
6.6, 5.6, NHCH2), 1.99–1.92 (2H, m, CH(CH3)2), 1.36–1.31 (4H, m, NHCH2CH2), 1.26–1.21 
(4H, m, CH2CH2CH2), 0.85 (6H, d, J 6.8, CH(CH3)2), 0.82 (6H, d, J 6.9, CH(CH3)2). 
13
C{
1
H} 
NMR (126MHz, DMSO-d6, J/Hz): 174.0 (s, COO), 158.4 (s, NCO), 58.3 (s, C*), 52.2 (s, 
OCH3), 40.7–39.7 (NCH2CH2 under DMSO residual solvent peak), 31.1 (s, CH(CH3)2), 30.6 
(s, NHCH2CH2), 26.8 (s, CH2CH2CH2), 19.7 (s, CH(CH3)2), 18.6 (s, CH(CH3)2). m/z (ES
+
-
MS): 431.3 ([M+H]
+
, 34%), 453.4 ([M+Na]
+
, 100%), 454.3 ([M+H+Na]
+
, 44%), 883.6 
([2M+Na]
+, 44%). Anal. calc’d for C20H38N4O6: C, 55.79; H, 8.90; N, 13.01. Found: C, 
55.58; H, 8.89; N, 12.93%.  
 
Methyl (2S)-2-[6-[[(1S)-1-methoxycarbonyl-3-methyl-butyl]carbamoylamino]hexyl 
carbamoylamino]-4-methyl-pentanoate (19) 
L-leucine methyl ester hydrochloride (1.00 g, 5.50 mmol) was dissolved in 30 ml of 
chloroform and an excess of triethylamine added. 1,6-diisocyanatohexane (0.46 g, 2.75 
mmol) in 20ml chloroform solution was added dropwise and the reaction was then left 
stirring at 70°C for 18 hours. The solution was washed with water and the chloroform 
reduced on a rotary evaporator, after which the product was isolated by the addition of a 
small amount of diethyl ether. The remaining solvent was removed by rotary evaporation and 
then in a heat pistol. Compound 19 was isolated as a white powder (1.24g, 2.70mmol, 98%): 
1
H NMR (500 MHz, DMSO-d6, J/Hz): 6.14 (2H, d, J 8.0Hz, C*NH), 5.90 (2H, t, J 
5.6,NHCH2), 4.15 (2H, dt, J 8.0, 7.0, C*H), 3.60 (6H, s,OCH3), 2.95 (4H, dd, J 6.6, 12.9, 
NHCH2), 1.60 (2H, dp, J 13.3, 6.6, CH2CH(CH3)2), 1.42 (4H, t, J 7.3, CH2CH(CH3)2), 1.35–
1.30 (4H, m, NHCH2CH2), 1.24–1.20 (4H, m, CH2CH2CH2), 0.87 (6H, d, J 6.6, 
CH2CH(CH3)2), 0.84 (6H, d, J 6.6, CH2CH(CH3)2). 
13
C{
1
H} NMR (126MHz, DMSO-d6, 
J/Hz): 175.0 (s, COO), 158.3 (s, NCO), 52.3 (s, OCH3), 51.6 (s, C*H), 41.6 (s, 
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CH2CH(CH3)2), 40.7–39.7 (NCH2CH2 under DMSO residual solvent peak), 30.6 (s, 
NCH2CH2), 26.8 (s, CH2CH2CH2), 25.0 (s, CH2CH(CH3)2), 23.4 (s, CH2CH2CH2), 22.2 (s, 
CH2CH2CH2). m/z (ES
+
-MS): 459.4 ([M+H]
+
, 90%), 481.5 [M+Na]
+
, 100%), 482.6 
([M+H+Na]
+
, 24%), 939.7 ([2M+Na]
+
, 14%). Anal. calc’d for C22H42N4O6: C, 57.62; H, 
9.23; N, 12.22. Found: C, 57.55; H, 9.18; N, 12.15%.  
 
Methyl (2S)-2-[6-[[(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoylamino]hexylcarbamoyl 
amino]-3-phenyl-propanoate (20) 
L-phenylalanine methyl ester dihydrochloride (1.30 g, 6 mmol) was dissolved in 150 ml 
chloroform by the slow addition of a slight excess of triethylamine (0.62 g, 6.1 mmol). 
Following heating and sonication of the mixture a hot filtration was carried out to remove un-
dissolved amino acid. 1,6 di-isocynatohexane (0.50 g, 3.0 mmol) was dissolved in 50 ml 
chloroform and slowly added over a period of 1 hour. The solution was heat under reflux at 
70˚C for 24hrs. The chloroform was reduced under vacuum and the compound washed with 
warm water for 1hour. The suspension was filtered, washed with ethyl acetate and dried in a 
heat pistol for 30minutes. A white powder (1.26 g, 2.4 mmol, 80%) was obtained and 
identified as 5: 
1
H NMR (700MHz, DMSO-d6, J/Hz): 7.28 (4H, t, J 7.6, ArH), 7.21 (2H, t, J 
7.6, ArH), 7.15 (4H, d, J 7.2, ArH), 6.12 (2H, d, J 8.3, C*NH2), 6.06 (2H, t, J 5.8, CH2NH), 
4.36 (2H, td, J 5.5, 8.1,13.6, C*H), 3.59 (6H, s, OCH3), 2.98-2.90 (6H, m, C*CH and 
NHCH2), 2.87 (2H, dd, J 8.0, 13.8, C*CH’), 1.34-1.24 (4H, m,NHCH2CH2), 1.24-1.14 (4H, 
m, NHCH2CH2CH2). 
13
C{
1
H} NMR (176 MHz, DMSO-d6, J/Hz): 173.8 (s, NCO), 158.0 (s, 
COO), 137.8 (s, ArC), 129.9 (s, ArC), 129.0 (s, ArC), 127.3 (s, ArC), 54.7 (s, C*), 52.4 (s, 
OCH3), 41.0-39.5 (m, DMSO +NHCH2), 38.3 (s, C*CH2), 30.6 (s, NHCH2CH2), 26.8 (s, 
NHCH2CH2CH2). m/z (ES
+
-MS): 527.3 ([M+H]
+
, 78%), 549.4 ([M+Na]
+
, 88%), 1052.6 
([2M+H]
+
, 13%), 1074.8 ([2M+Na]
+
, 100%). Anal. Calcd for C28H38N4O6: C, 63.86; H, 7.27; 
N, 10.64. Found: C, 63.58; H, 7.24; N, 10.77%.  
 
Methyl (2S)-3-(4-hydroxyphenyl)-2-[6-[[(1S)-1-[(4-hydroxyphenyl)methyl]-2-methoxy-2-oxo-
ethyl]carbamoylamino]hexylcarbamoylamino] (21) 
L-tyrosine methyl ester hydrochloride (1 g, 4.31 mmol) was dissolved in 30 ml chloroform 
and triethylamine (0.5 g, 5 mmol) added. 1,6- diisocyanatohexane (0.36 g, 2.15 mmol) was 
added dropwise as a dilute solution in 10 ml chloroform and the mixture heat under reflux at 
70°C. After 18 hours an immiscible oil was formed and the chloroform was poured off. The 
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oil was dissolved in a small volume of methanol and water was added resulting in a white 
precipitate. The precipitate was dried in a drying pistol and the dry product, 21, was obtained 
as a clean white powder (0.5 g, 0.90 mmol) 42%)  
1
H NMR (700MHz, DMSO-d6, J/Hz): δ H 
(700 MHz, dmso-d6) 9.20 (1 H, s, OH), 6.90 (2 H, d, J 8.3, ArH), 6.63 (2 H, d, J 8.4, ArH), 
6.03 (1 H, t, J 5.5, NHCH2), 6.00 (1 H, d, J 8.1, C*NH), 4.28 (1 H, dd, J 13.7, 7.8, C*H), 
3.55 (3 H, s, OCH3), 2.90 (2 H, dd, J 12.6, 6.5, NHCH2), 2.79 (1 H, dd, J 13.9, 5.7, ArCH2), 
2.73 (1 H, dd, J 13.7, 7.7, ArCH2), 1.32 – 1.24 (2 H, m, NHCH2CH2CH2), 1.22 – 1.13 (2 H, 
m, NHCH2CH2CH2). 
13
C{
1
H} NMR (176 MHz, DMSO, J/Hz) 173.64 (s, NHCONH), 157.77 
(s, COO), 156.43 (s, Ar-OH), 130.49 (s, Ar-CH2), 127.42 (s, Ar-H), 115.47 (s, Ar-H), 54.68 
(s, CH), 51.99 (s, OCH3), 40.62 – 39.30 (m, DMSO+CH2),37.32 (s,Ar-CH2), 30.32 (s,CH2), 
26.51 (s, CH2). Ms: 581.4 (100%, [M+Na]
+
), 559.1 ([M+H]
+
) Expected: C 60.20, H 6.86, N 
10.03,  Found: C 59.66, H 6.85, N 9.98; m/z (ES
+
-MS): 581.4 ([M+Na]
+
, 100%) 
 
Methyl (2S)-3-(1H-indol-3-yl)-2-[6-[[(1S)-1-(1H-indol-3-ylmethyl)-2-methoxy-2-oxo-ethyl] 
carbamoylamino]hexylcarbamoylamino]propanoate (22) 
L-tryptophan methyl ester hydrochloride (1.00 g, 4.19 mmol) was suspended in 30ml of 
chloroform and an excess of triethylamine was added, whereupon the suspension dissolved. 
1,6-diisocyanatohexane (0.35 g, 2.09 mmol) in 20 ml chloroform solution was added 
dropwise and the reaction was then left stirring at 70°C for 18 hours. The chloroform was 
reduced on a rotary evaporator and hexane added to force the product out of solution. The 
remainder of the solvent was then removed and the product was washed thoroughly with 
water and dried in a heat pistol. Compound 22 was isolated as a white powder (0.82 g, 
1.36mmol, 65%): 
1
H NMR (500 MHz, DMSO-d6, J/Hz): 10.89 (2H, s, ArNH), 7.44 (2H, d, J 
7.8, ArH), 7.33 (2H, d, J 8.1, ArH), 7.09 (2H, d, J 2.2, ArH), 7.05 (2H, t, J 7.6, ArH), 6.97 
(2H, t, J 7.4, ArH), 6.11 (2H, t, J 5.5, CH2NH), 6.06 (2H, d, J 8.0, C*NH), 4.45 (2H, dt, J 
7.0, 8.0, C*H), 3.55 (6H, s, OCH3), 3.10–3.00 (4H, m, C*CH2), 2.96–2.91 (4H, m, NHCH2), 
1.35–1.28 (4H, m, NHCH2CH2), 1.24–1.18 (4H, m, NHCH2CH2CH2). 
13
C{
1
H} NMR 
(126MHz, DMSO-d6, J/Hz): 174.1 (s, COO), 158.1 (s, NCO), 136.8 (s, ArC), 128.0 (s, ArC), 
124.4 (s, ArC), 121.6 (s, ArC), 119.1 (s, ArC), 118.8 (s, ArC), 112.1 (s, ArC), 109.9 (s, ArC), 
54.2 (s, C*), 52.3 (s,OCH3), 40.7–39.7 (NHCH2 under residual solvent peak), 30.6 (s, 
NHCH2CH2), 28.6 (s, C*CH2), 26.8 (s, NHCH2CH2CH2). m/z (ES
+
-MS): 102.6 ([Et3N+H]
+
, 
100%), 605.3 ([M+H]
+
, 20%), 627.3 ([M+Na]
+
, 10%), 706.5 ([M+Et3N]
+
, 54%), 707.4 
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([M+H+Et3N]
+, 30%). Anal. calc’d for C32H40N6O6: C, 63.56; H, 6.67; N, 13.90. Found: C, 
61.56; H, 7.14; N, 13.36%.  
 
Methyl 2-[4-[(2-methoxy-2-oxo-ethyl)carbamoylamino]butylcarbamoylamino]acetate (23) 
Glycine methyl ester hydrochloride (1.00 g, 7.96 mmol) was suspended in 30 ml of 
chloroform and an excess of triethylamine was added, whereupon the suspension dissolved. 
1,4-diisocyanatobutane (0.56 g, 3.98 mmol) in 20 ml chloroform solution was added 
dropwise and the reaction was then left stirring at 70°C for 18 hours, after which period a 
white suspension formed. The suspension was filtered, leaving a white solid which was then 
washed with water and dried in a heat pistol. Compound 23 was isolated as a white powder 
(0.96 g, 3.02 mmol, 76%): 
1
H NMR (700MHz, DMSO-d6): 6.13–6.08 (4H, m, NH), 3.73 
(4H, d, J 6.0, COCH2), 3.58 (6H, s, OCH3), 2.95–2.93 (4H, m, NHCH2), 1.32–1.30 (4H, 
m,NHCH2CH2). 
13
C{
1
H} NMR (176MHz, DMSO-d6): 172.1 (s, COO), 158.3 (s, NCO), 51.9 
(s, OCH3), 41.8 (s, COCH2), 40.3–39.6 (NHCH2 under residual solvent peak), 27.9 (s, 
NHCH2CH2). m/z (ES
+
-MS): 102.0 ([Et3N+H]
+
, 50%), 319.2 ([M+H]
+
, 10%), 341.2 
([M+Na]
+
, 100%), 420.3 ([M+Et3N]
+
, 30%), 659.4 ([2M+Na]
+, 24%) Anal. calc’d for 
C12H22N4O6: C, 45.28; H, 6.97; N, 17.60. Found: C, 45.17; H, 6.98; N, 17.17%.  
 
Crystal data for 23 form A: C12H22N4O6, M =318.34, colourless plate, 2.02  0.36  0.02 
mm
3
, oversized uncut crystal due to break up of layers on cutting, crystallised from methanol, 
triclinic space group     (No. 2), a = 4.5954(10) Å, b = 5.7140(12) Å, c = 15.744(3) Å, α = 
96.491(18)°, β = 91.594(17)°, γ = 111.21(2)°, V = 381.86(14) Å3, Z = 1, Dc = 1.384 g/cm
3
, 
F000 = 170, Xcalibur, Sapphire3, Gemini ultra, Mo K radiation, = 0.7107 Å,  T = 100.0 K, 
2max = 58.2º, 5401 reflections collected, 1808 unique (Rint = 0.0390).  Final GooF = 1.055, 
R1 = 0.0421, wR2 = 0.102, R indices based on 1492 reflections with I ≥(I) (refinement on 
F
2
), 144 parameters, 0 restraints 
 
Crystal data for 23 form B: C12H22N4O6, M =318.34, colourless needle, 0.3  0.001  0.001 
mm
3
, crystallised from methanol, monoclinic space group       (No. 14), a = 
4.554(3) Å, b = 17.528(13) Å, c = 10.104(7) Å, β = 101.686(8)°, V = 789.8(10) Å3, Z = 2, Dc 
= 1.339 g/cm
3
, F000 = 340, Kappa Rigaku Saturn724+, synchrotron radiation, = 0.6889 Å,  
T = 393(2) K, 2max = 48.5º, 5648 reflections collected, 1369 unique (Rint = 0.0869).  Final 
GooF = 0.936, R1 = 0.0665, wR2 = 0.166, R indices based on 844 reflections with I 
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≥2sigma(I) (refinement on F2), 101 parameters, 2 restraints.  Lp and absorption corrections 
applied, = 0.108 mm-1. 
 
Methyl (2S)-2-[4-[[(1S)-2-methoxy-1-methyl-2-oxo-ethyl]carbamoylamino]butylcarbamoyl 
amino]propanoate (24) 
L-alanine methyl ester hydrochloride (0.94 g, 6.7 mmol) was dissolved in 50 ml chloroform 
to give a clear solution. An excess of triethylamine (0.7 g, 6.7 mmol) was added resulting in a 
cloudy suspension which remained at 70°C. 1,4-diisocyanatobutane (0.47 g, 3.3 mmol) was 
added  dropwise. After 1 hour, the solution was cooled to room temperature and a white 
precipitate filtered and washed with DCM and diethyl ether. The compound was dried in a 
drying pistol for 30 minutes to give a white powder (0.94 g, 2.7 mmol, 81 % yield). δ H 1H 
NMR (700 MHz, DMSO-d6): 6.16 (1 H, d, J 7.6, CHNH), 5.94 (1 H, t, J 5.7, NHCH2), 4.11 
(1 H, p, J 7.3, C*H), 3.58 (3 H, s, OCH3), 3.00 – 2.87 (2 H, m, NHCH2), 1.35 – 1.26 (2 H, m, 
CH2CH2CH2), 1.19 (3 H, d, J 7.3, C*CH3). 
13
C{
1
H} NMR (176 MHz, DMSO-d6) 174.74 (s, 
COO), 157.77 (s, NCO), 52.10 (s, OCH3), 48.55 (s, CH), 39.37 (NCH2CH2), 27.89 (s, 
CH2CH2CH2), 18.46 (s, C*CH3). m/z (ES
+
-MS): 369.4([M+Na]+, 100%), 715.5([2M+Na]+, 
30%), 242.4 ([fragment -2COOMe], 30%), 102.2 ([Et3N+H]
+, 2%) Anal. calc’d for C14H-
26N4O6: C, 48.55; H, 7.57; N, 16.17. Found: C, 48.20; H, 7.52; N, 15.95%. 
 
Crystal data for 24 form A: C14H26N4O6, M =346.39, colourless plate, 0.5  0.1  0.03 mm
3
, 
crystallised from methanol, triclinic, space group    (No. 1), a = 4.645(2) Å, b = 
6.0711(18) Å, c = 16.165(3) Å, α = 93.368(19)°, β = 95.51(2)°, γ = 109.60(3)°, V = 
425.4(2) Å3, Z = 1, Dc = 1.352 g/cm
3
, F000 = 186, Bruker SMART CCD 6000 area detector, 
MoK radiation, = 0.71073 Å,  T = 120K, 2max = 55.0º, 3525 reflections collected, 2807 
unique (Rint = 0.0849).  Final GooF = 0.955, R1 = 0.0806, wR2 = 0.213, R indices based on 
2901 reflections with I >2(I) (refinement on F2), 231 parameters, 27 restraints.  Lp and 
absorption corrections applied, = 0.106 mm-1.  
 
Methyl (2S)-2-[4-[[(1S)-1-methoxycarbonyl-3-methyl-butyl]carbamoylamino]butylcarbamoyl 
amino]-4-methyl-pentanoate (25) 
L-leucine methyl ester hydrochloride (1.00 g, 5.50 mmol) was dissolved in 30 ml of 
chloroform and an excess of triethylamine added. 1,4-diisocyanatobutane (0.39 g, 2.75 mmol) 
in 20 ml chloroform solution was added dropwise and the reaction was then left stirring at 
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70°C for 18 hours. The solution was washed with water and the chloroform reduced on a 
rotary evaporator, after which the product was isolated by the addition of a small amount of 
hexane. The remaining solvent was removed by rotary evaporation and then in a heat pistol. 
Compound 25 was isolated as a white powder (0.71g, 1.65 mmol, 60%): 
1
H NMR (700 MHz, 
DMSO-d6): 6.11 (2H, d, J 7.7, C*NH), 5.89 (2H, m, CH2NH), 4.13 (2H, dt, J 7.7, 7.7,C*H), 
3.58 (6H, s, OCH3), 2.93 (4H, m, NHCH2), 1.60–1.55 (2H, m, CH(CH3)2), 1.40 (4H, t, J 7.2, 
C*CH2), 1.29 (4H, s,NHCH2CH2), 0.85 (6H, d, J 6.6, CH(CH3)2), 0.82 (6H, d, J 6.5, 
CH(CH3)2). 
13
C{
1
H} NMR (176 MHz, DMSO-d6): 174.7 (s, COO), 158.0 (s, NCO), 52.0 (s, 
OCH3), 51.3 (s, C*H), 41.3 (s, C*CH2), 40.4–39.5 (NHCH2 under residual solvent peak), 
27.9 (s,NHCH2CH2), 24.7 (s, CH(CH3)2), 23.2 (s, CH(CH3)2), 22.0 (s, CH(CH3)2). m/z (ES
+
-
MS): 431.4 ([M+H]
+
, 26%), 453.4 ([M+Na]
+
, 100%), 454.3 ([M+H+Na]
+
, 30%), 885.4 
([2M+Na]
+
, 5%). Anal. calc’d for C20H38N4O6: C, 55.79; H, 8.90; N, 13.01. Found: C, 55.75; 
H, 8.94; N, 13.02%.  
 
Crystal data for 25 form A: C20H38N4O6, M =430.55, colourless plate, 0.01  0.008  0.003 
mm
3
 crystallised from acetonitrile, orthorhombic space group P212121 (no. 19), a = 
4.724(3) Å, b = 19.611(11) Å, c = 25.402(14) Å, V = 424.72 2354 (2) Å
3
, Z = 4, Dc = 1.2150 
g/cm
3
, F000 = 935.8280, Kappa Rigaku Saturn724+,  synchrotron radiation, = 0.6889 Å,  T 
= 150.15 K, 2max = 48.5º, 13222 reflections collected, 2333 unique (Rint = 0.0644).  Final 
GooF = 1.058, R1 = 0.0547, wR2 = 0.149, R indices based on 1812 reflections with I>=2(I) 
(refinement on F
2
), 349 parameters, 24 restraints. Lp and absorption corrections applied, = 
0.084 mm
-1
. 
 
Methyl (2S)-2-[4-[[(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoylamino]butylcarbamoyl 
amino]-3-phenyl-propanoate (26) 
L-phenylalanine methyl ester dihydrochloride (0.65 g, 3.02 mmol) was dissolved in 200 ml 
chloroform by the slow addition of a slight excess of triethylamine (0.32 g, 3.17 mmol). The 
mixture was filtered to remove undissolved amino acid. 1,4 di-isocynatobutane (0.22 g, 1.58 
mmol) was dissolved in 50 ml chloroform and slowly added over a period of 1 hour. The 
solution was heated under reflux at 70˚C for 60 h. The chloroform was reduced under 
vacuum and the compound washed with warm water for 1 hour. The suspension was filtered, 
washed with ethyl acetate and dried in a heat pistol for 30minutes. A white powder (0.58 g, 
1.16 mmol, 73%) was obtained and identified as 11.
 1
H NMR (700MHz, DMSO-d6, J/Hz): 
 77 
 
7.25 (4H, t, J 7.45, ArH), 7.18 (2H, t, J 7.31, ArH), 7.12 (4H, d, J 7.31, ArH), 6.09 (2H, d, J 
8.10, C*NH), 6.04 (2H, t, J 5.65, CH2NH), 4.37 (2H, dd, J 7.90, 13.6, C*H), 3.56 (6H, s, 
OCH3), 2.92 (2H, dd, J 5.5, 14.0,C*CH), 2.89 (4H, d, J 5.61, NHCH2), 2.85 (2H, dd, J 8.0, 
13.5, C*CH’), 1.25 (4H, s, NHCH2CH2). 
13
C{
1
H} NMR (700MHz, DMSO-d6, J/Hz): 173.5 
(s, COO), 157.7 (s, NCO), 137.6 (s, ArC), 129.6 (s, ArC), 128.7 (s, ArC), 127.0 (s, ArC), 
54.4 (s, C*H), 52.0 (s, OCH3), 39.3 (s, NHCH2), 38.1 (s, C*CH2, 27.8 (s, NHCH2CH2). m/z 
(ES
+
-MS): 499.3 ([M+H]
+
, 15%), 521.4 ([M+Na]
+
, 100%), 996.7 ([2M]
+
, 8%) Anal. Calcd 
for C26H36N4O6: C, 62.63; H, 6.87; N, 11.24. Found: C, 61.65; H, 6.91; N, 11.28 %. 
 
Methyl (2S)-3-(4-hydroxyphenyl)-2-[4-[[(1S)-1-[(4-hydroxyphenyl)methyl]-2-methoxy-2-oxo-
ethyl]carbamoylamino]butylcarbamoylamino]propanoate (27) 
 L-tyrosine methyl ester hydrochloride (1 g, 4.31 mmol) was dissolved in 30 ml chloroform 
and triethylamine (0.5 g, 5 mmol) added. 1,4- diisocyanatobutane (0.3 g, 2.15 mmol) was 
added dropwise as a dilute solution in 20 ml chloroform. An immiscible oil formed after 1 
hour and the chloroform was poured off. Attempts to purify the oil by precipitation from 
methanol by the addition of water produced a gluey precipitate. This was redissolved in 
methanol and dried with magnesium sulphate and filtered. Addition of diethyl ether produced 
a white precipitate which could not be filtered. Reduction of the mixture on a rotorary 
evaporator at 40°C initially produced an oil and eventually a white foam which was ground 
and dried in a drying pistol. The product, 27, was isolated as a white solid (0.6 g, 1.13 mmol) 
53%). 
1
H NMR (500MHz, DMSO-d6, J/Hz): 9.24 (1 H, s, OH), 6.902 (2 H, d, J 8.5, ArH), 
6.63 (2 H, d, J 8.5, ArH), 6.08 (1 H, t, J 5.6, NHCH2), 6.04 (1 H, d, J 8.2, C*NH), 4.30 (1 H, 
q, J 4.3, C*H), 3.57 (3 H, s, OCH3), 2.92 (2 H, d, J 5.7, NHCH2), 2.78 (1 H, qd, J 13.8, 6.6, 
ArCH2), 2.73 (1 H, dd, J 13.7, 7.7, ArCH2), 1.28 (2 H, m, NHCH2). 
13
C{
1
H} NMR (176 
MHz, DMSO, J/Hz) 173.91 (s, NHCONH), 158.01 (s, COO), 156.70 (s, Ar-OH), 130.75 (s, 
Ar-CH2), 127.66 (s, Ar-H), 115.74 (s, Ar-H), 54.94 (s, CH), 52.27 (s, OCH3), 40.62 – 39.30 
(m, DMSO+CH2), 37.59 (s,Ar-CH2), 28.09 (s,CH2). m/z (ES
+
-MS): 531.4([M+H]
+
, 15%) 
553.4 ([M+Na]
+
, 100%), 569.3 ([M+K]
+
, 15%). Anal. calc’d for C26H34N4O8: C, 58.86; H, 
6.46; N, 10.56%. Found: C, 58.17; H, 6.54; N, 10.45%.  
 
Methyl (2S)-3-(1H-indol-3-yl)-2-[4-[[(1S)-1-(1H-indol-3-ylmethyl)-2-methoxy-2-oxo-ethyl] 
carbamoylamino]butylcarbamoylamino]propanoate (28) 
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L- tryptophan methyl ester hydrochloride (1.00 g, 4.19 mmol) was suspended in 30 ml of 
chloroform and an excess of triethylamine was added, whereupon the suspension dissolved. 
1,4-diisocyanatobutane (0.29 g, 2.09 mmol) in 20 ml chloroform solution was added 
dropwise and the reaction left overnight at ambient temperature. The chloroform was reduced 
on a rotary evaporator and the solid product was isolated by the addition of hexane. The 
remaining solvent was removed by rotary evaporation and the solid washed thoroughly with 
water before drying in a heat pistol. 28 was isolated as an off-white powder (0.75 g, 1.30 
mmol, 62%): 
1
H NMR (500MHz, DMSO-d6): 10.88 (2H, s, ArH), 7.44 (2H, d, J 8.0, ArH), 
7.33 (2H, d, J 8.1, ArH), 7.09 (2H, d, J 2.3, ArH), 7.06 (2H, t, J 7.1, ArH), 6.97 (2H, t, J 7.4, 
ArH), 6.12 (2H, t, J 7.4, CH2NH), 6.07 (2H, d, J 8.1, C*NH), 4.45 (2H, dt, J 6.7, 8.1, C*H), 
3.55 (6H, s, OCH3), 3.05 (4H, m, C*CH2), 2.94 (4H, d, J 5.5, NHCH2), 1.30 (4H, m, 
NHCH2CH2). 
13
C{
1
H} NMR (126MHz, DMSO-d6): 174.1 (s, COO), 158.1 (s, NCO), 136.8 
(s, ArC), 127.9 (s, ArC), 124.4 (s, ArC), 121.6 (s, ArC), 119.1 (s, ArC), 118.8 (s, ArC), 112.1 
(s, ArC), 109.9 (s, ArC), 54.1 (s, C*H), 52.3 (s, OCH3), 40.7–39.6 (NHCH2 under residual 
solvent peak), 28.6 (s, C*CH2), 28.2 (s, NHCH2CH2). m/z (ES
+
-MS): 599.3 ([M+Na]
+
, 
100%). Anal. calc’d for: C30H36N6O6: C, 62.49; H, 6.29; N, 14.57. Found: C, 61.09; H, 6.40; 
N, 14.20%.  
 
Methyl (2S)-2-[6-[[(1S)-1-methoxycarbonyl-2-methyl-propyl]carbamoylamino]ethyl 
carbamoylamino]-3-methyl-butanoate (29)
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Methyl (2S)-2-[4-[[(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoylamino]octylcarbamoyl 
amino]-3-phenyl-propanoate (30) 
L-phenylalanine methyl ester dihydrochloride (1.099 g, 5.1 mmol) was dissolved in 150ml 
chloroform by the slow addition of a slight excess of triethylamine (0.515g, 5.1mmol). 
Following heating and sonication of the mixture, a hot filtration was carried out to remove 
un-dissolved amino acid. 1,6 di-isocynatohexane (0.50 g, 2.6 mmol) was dissolved in 50ml 
chloroform and slowly added over a period of 1 hour. The solution was heated under reflux at 
70˚C for 24 h. The chloroform was reduced under vacuum and the compound washed with 
warm water for 1hour. The suspension was filtered, washed with ethyl acetate and dried in a 
heat pistol for 30 minutes. A white powder (1.12 g, 2.0 mmol, 77%) was obtained and 
identified as 30: 
1
H NMR (700MHz, DMSO-d6, J/Hz): 7.27 (4H, t, J 7.2, ArH), 7.20 (2H, t, J 
7.2, ArH), 7.14 (4H, d, J 7.3, ArH), 6.10 (2H, d, J 8.1, C*NH), 6.04 (2H, t, J 5.4, CH2NH), 
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4.38 (2H, dd, J 7.9, 13.6, C*H), 3.58 (6H, s, OCH3), 2.97-2.86 (6H, m, C*CH and NHCH2), 
2.86 (2H, dd, J 8.1, 13.6, C*CH’), 1.33-1.24 (4H, m, NHCH2CH2), 1.24-1.13 (8H, m, 
NHCH2CH2CH2 and NHCH2CH2CH2CH2). 
13
C{
1
H} NMR (700MHz, DMSO-d6, J/Hz): 
173.8 (s, COO), 158.0 (s, NCO), 137.9 (s, ArC), 129.8 (s, ArC), 128.9 (s,ArC), 127.2 (s, 
ArC), 54.7 (s, C*H), 52.4 (s, OCH3), 40.8-39.8 (m, DMSO + NHCH2), 38.3 (s, C*CH2), 30.6 
(s, NHCH2CH2), 29.5 (s, NHCH2CH2CH2), 27.0 (s, NHCH2CH2CH2CH2). m/z (ES
+
-MS): 
555.4 ([M+H]
+
, 21%), 577.4 ([M+Na]
+
, 100%), 1130.9 ([2M+Na-2H]
+
, 68%). Anal. Calcd 
for C28H38N4O6: C, 64.96; H, 7.63; N, 10.10. Found: C, 64.73; H, 7.60; N, 9.93 %. 
 
Methyl 2-[6-[(1-methoxycarbonyl-3-methyl-butyl)carbamoylamino]dodecylcarbamoylamino] 
-4-methyl-pentanoate (31) 
L-leucine methyl ester hydrochloride (1.00g, 5.50mmol) was dissolved in 30 ml of 
chloroform and an excess of triethylamine added. 1,12-diisocyanatododecane (0.69 g, 2.75 
mmol) in 20 ml chloroform solution was added dropwise and the reaction was then left 
stirring at 70°C for 18 hours. The solution was washed with water and the chloroform 
reduced on a rotary evaporator, after which the product was isolated by the addition of a 
small amount of hexane. The remaining solvent was removed by rotary evaporation and then 
in a heat pistol. Compound 31 was isolated as a white powder (0.74 g, 1.36 mmol, 50%): 
1
H 
NMR (700 MHz, DMSO-d6): 6.09 (2H, d, J 7.7, C*NH), 5.86 (2H, t, J=5.6, CH2NH), 4.13 
(2H, dt, J 7.9, 7.7,C*H), 3.57 (6H, s, OCH3), 2.96–2.89 (4H, m, NHCH2), 1.61–1.55 (2H, m, 
CH(CH3)2), 1.40 (4H, t, J 7.3, C*CH2), 1.33–1.28 (4H, m, NHCH2CH2), 1.22–1.20 (16H, s, -
CH2-), 0.85 (6H, d, J 6.7, CH(CH3)2), 0.82 (6H, d, J 6.7, CH(CH3)2). 
13
C{
1
H} NMR 
(176MHz, DMSO-d6): 174.7 (s, COO), 158.0 (s, NCO), 52.0 (s, OCH3), 51.3 (s, C*H), 41.3 
(s,C*CH2), 40.3–39.6 (NHCH2 under solvent residual peak), 30.4 (s, -CH2-), 29.5 (s, -CH2-), 
29.2 (s, -CH2-), 26.8 (s, -CH2-), 24.7 (s, -CH2-), 23.2 (s, CH(CH3)2), 22.0 (s, CH(CH3)2). m/z 
(ES
+
-MS): 543.6 ([M+H]
+
, 100%), 566.5 ([M+Na]
+, 10%). Anal. calc’d for C28H54N4O6: C, 
61.96; H, 10.03;  N, 10.32. Found: C, 61.50; H, 9.92; N, 10.09%.  
 
Methyl (2S)-2-[[4-[[3,5-diethyl-4-[[(1S)-1-methoxycarbonyl-3-methyl-butyl]carbamoyl 
amino]phenyl]methyl]-2,6-diethyl-phenyl]carbamoylamino]-4-methyl-pentanoate (32) 
Nε-Boc-l-lysine methyl ester hydrochloride (0.5 g, 1.7 mmol) was dissolved in 75 ml 
chloroform by the slow addition of a slight excess of triethylamine (0.182 g, 1.80 mmol). To 
the clear solution was added 1,6 di-isocyanatohexane (0.135 g, 0.80 mmol) in 25 ml 
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chloroform and the resulting solution was heated under reflux for 18 hours. A solution was 
obtained which was washed with water (5 ml, twice), dried with MgSO4 and filtered. The 
chloroform was removed under vacuum and a yellow oil obtained. The oil was partially 
dissolved in DCM and diethyl ether added resulting in  a cloudy suspension which rapidly 
gelled. The mixture of solvents was reduced under vacuum and a white powder was 
recovered (0.39 g, 0.56 mmol, yield: 67 %) and identified as the product 32: 
1
H NMR 
(700MHz, DMSO-d6, J/Hz): 6.73 (1H, t, J 5.2, NHBoc), 6.14 (1H, d, J 8.3, CHNH), 5.93 
(1H, t, J 5.2, NHCH2), 4.02 (1H, dd, J 6.8, 13.0, CH), 3.14 (3H, s, OCH3), 2.91 (2H, dd, J 
8.0, 13.2 , NHCH2), 2.82 (2H, dd, J 6.8, 13.0, CH2NHBoc), 1.55 (2H, m, CHCH2),1.54 (9H, 
s, C(CH3)3), 1.46 (2H, m, -CH2-), 1.32 (2H, m, -CH2-), 1.30 (2H, m, NHCH2CH2), 1.19 (2H, 
m,CH2CH2CH2). m/z (ES
+
 MS): 711,4 ([M+Na
+
], 100%), 689,4 ([M], 20%). Anal. Cal for: 
C32H61N6O10: C 55,80; H 8,78; N 12,20. Found: C 54,83; H 9.00; N 12.01 
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Chapter 3: The use of 1- and 2-pyrenylalanine derived gelators as 
fluorescent probes in anion responsive supramolecular gels 
3.1 Introduction 
Incorporating fluorescent functionality into supramolecular gels has been used to gain 
insights into gel structure and formation and has led to a number of novel applications.
10, 85, 
109, 126, 184-189
 Aggregation of molecules from solution into the gel state can bring about 
changes in fluorescence such as a decrease,
190
 increase 
191, 192
 or shifts in the wavelength of 
particular bands observed in the emission spectrum.
184
 Fluorescent gelators have been utilised 
in a variety of sensing applications,
10, 85, 185, 186
 for light harvesting,
187
 in re-writable materials 
for fluorescence imaging
126
 and as models for drug delivery.
193
 
  
Pyrene derivatives have been used extensively as fluorophores in a variety of applications 
ranging from monitoring oxygen  levels
194
 and DNA charge transfer 
195
 in biological 
systems
196
 to uses in organic light emitting diodes (OLEDs) and organic field effect 
transistors (OFETs).
197
 The high sensitivity of the vibronic fine structure of pyrene and its 
derivatives to changes in chemical environment (the Ham effect),
198
 their long-lived 
fluorescence and the formation of fluorescent excimers via π-π interactions make pyrene 
particularly useful as a fluorescent probe. Extended aromatic ring systems such as pyrene 
have also been used to drive gel formation through π-stacking interactions.188, 189 
 
Pyrene is usually functionalised at the 1-, 3-, 6- or 8- positions where the maximum 
contributions of the HOMO lie making it most amenable to electrophilic aromatic 
substitution. Substitution of pyrene at the 2- or 7-carbon atoms is synthetically challenging as 
a nodal plane in both the HOMO and LUMO passes through these positions. However, by 
derivatising at these nodal positions, substituents interact less strongly with the pyrene 
orbitals than at other positions leading to more ‘pyrene-like’ fluorescence.199   
 
Chapter 2 describes the gelation behaviour of a series of oligo-methylene spaced bis-urea 
gelators functionalised with a number of amino acid derivatives. In this chapter we extend 
this series of natural amino-acids to include synthetic 1- and 2-pyrenylalanine derivatives, 35 
and 36. It was anticipated that use of the same bis-urea oligomethylene core would mean the 
pyrenyl derivatives would become incorporated into the urea backbone of the other gelators 
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to give mixed gels.
39, 51, 101, 200, 201
  The fluorescent pyrene functionality can then be used to 
provide additional information about the structure, properties and response to anions of the 
different mixed gels.  
 
3.2 1- and 2- Pyrenylalanine gelators  
3.2.1 Synthesis of gelators 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2 Synthesis of a) 2-bromo pyrene b) 1- and 2- pyrenylalanine derived amino acids 33 and 34 and 
gelators 35 and 36.  
  
The 2-bromo pyrene was synthesised by Dr. Andrew Crawford using an iridium catalysed 
borylation.
202, 203
  Selectivity for the 2-position was achieved due to the sterically crowded 
five-coordinate fac-tris(boryl)species. 1-Bromo pyrene was synthesised using aqueous 
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dtbpy= 4,4′-di-tert-butyl bipyridine 
pin = OCMe2CMe2 
dba = dibenzylideneacetone 
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hydrobromic acid and hydrogen peroxide.
204
 The 1- and 2- pyrenylalanine methyl esters 33 
and 34 were synthesised by Dr. Neil Colgin using a versatile strategy for the synthesis of 
artificial amino acids (Scheme 2). The l-iodoalanine precursor is prepared in four steps 
starting from l-serine.  A Negishi coupling reaction
205-207
 is then used to connect l-iodoalanine 
to either 1- or 2- bromo pyrene.   
 
 
 
 
 
 
 
 
 
 
Compounds 35 and 36 were synthesised from the corresponding 1- and 2- pyrenylalanine 
methylester BOC-protected amino acids. The BOC-groups are readily removed by dissolving 
33 or 34 in 1:1 DCM:trifluoracetic acid and stirring at room temperature for 30 minutes. 
Following removal of the solvent and neutralisation with triethylamine, the deprotected 
amine then reacts in a 2:1 ratio with 1,6-diisocyanatohexane to give compounds 35 and 36. 
The resulting products are insoluble and are filtered from the reaction mixture and washed 
with water. The products were isolated as beige solids, dried in a heating pistol and ground 
before use. Less than 100 mg of each compound was synthesised due to the difficulty in 
producing the pyrenylalanine amino acids. 
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3.2.2 Gelation behaviour 
The gelation behaviour of 35 and 36 was investigated at 1 % w/v in a range of solvents. 
Samples were tested using 0.2 ml of solvent in 1.75 ml vials owing to the small amount of 35 
and 36 available. The compounds were generally poorly soluble in most of the solvents tested 
and required high temperatures and sonication to fully dissolve. Once dissolved, samples 
were cooled rapidly and briefly sonicated to aid homogeneous gel formation. The results are 
summarised in Table 5 and compared with those obtained for glycine, alanine and 
phenylalanine derived gelators 16, 17 and 20 discussed in detail in Chapter 2.  
 
Table 5 Phase upon cooling of hot 1 % w/v solutions of 16, 17, 20, 35 and 36 in a range of solvents  
Solvent 
Compound (n=6 and amino acid from which derived) 
16 17 20 35 36 
Gly Ala Phe 1-Pyr 2-Pyr 
Water P G
a
 I I I 
DMSO S S S S S 
Acetonitrile P G G G G 
Methanol P S S PG G 
Ethanol P G
a
 S G G 
Acetone P G G G I 
THF P G S G G 
DCM P PG S G I 
Ethylacetate P G G PG I 
Chloroform P G S G G 
Diethylether I I I I I 
Toluene G G G G P 
Hexane I I I I I 
P = precipitate, S = solution, G = gel, PG = partial gel, O = oil, I = insoluble with heating, superscript a = gel 
unstable, breaks down over time.  
 
 
Figure 45 Gels containing 1 % w/v 35 in (left to right): acetonitrile, methanol, ethanol, acetone, tetrahydrofuran, 
dichloromethane, chloroform, ethyl acetate and toluene. 
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Figure 46 SEM images showing the morphology of 1 % w/v xerogels of 35 shown at various magnifications 
produced from : a) acetonitrile b) chloroform c) methanol, d) methanol. Arrow indicates position of twisted fibre 
seen in image d) in image c).  
 
The 1-pyrenylalanine derived gelator 35 formed gels in a wide range of solvents across the 
polarity spectrum. The gels were translucent with a light yellow colour which was more 
intense in the acetone sample. Some of the gels (acetonitrile, ethanol, acetone, THF, DCM, 
CHCl3) were robust, formed readily and were stable over a period of several weeks. Other 
gels, particularly methanol and ethyl acetate formed only weak, partial gels. SEM revealed a 
morphology consisting of an entangled network of fine, flexible fibres approximately 50nm 
in width (Figure 46). The fibres take the form of left handed helices, an effect attributed to 
the chirality of the molecules.
52, 174, 181
 The morphology is consistent across the range of 
solvents investigated.  
a)                                   b) 
 
 
 
 
 
 
 
c)                                   d) 
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Figure 47 Gels of 36 at 1 % w/v in (left to right): acetonitrile, methanol, ethanol, tetrahydrofuran, chloroform 
 
 
Figure 48  SEM images showing the morphology of 1 % w/v xerogels of 36 shown at various magnifications 
produced from: a) and b) toluene c) acetonitrile d) methanol 
 
The 2-pyrenylalanine derived gelator 36 also formed gels across a range of solvents. The 
compound is generally poorly soluble and there were difficulties dissolving the compound, 
particularly in volatile solvents such as acetone, DCM and ethyl acetate. It may be possible to 
form gels in acetone, DCM and ethylacetate if the method was scaled up as the large volume 
of the vials (1.7 ml) relative to the volume of solvent (0.2 ml) means that much of the solvent 
is in the gas phase. However, repeated attempts to form gels of 36 on a larger scale in toluene 
a)                                    b)
   
 
 
 
 
 
 
c)                                    d)
  
  87 
were unsuccessful. Electron microscopy revealed fine helical cylinders in xerogels of 36 
formed from acetonitrile, chloroform and methanol, similar to those observed in gels of 35 
(Figure 48). Fine fibres are also identifiable in SEM images of the non-gelling precipitate of 
36 formed in toluene, however they have a flatter, less well-defined shape (Figure 48a and b). 
It is interesting to note that a small difference in the orientation of the pyrene group between 
the two isomers translates into a difference in gelation behaviour and fibre morphology. 
 
3.2.3 Fluorescence of 1- and 2- pyrenylalanine gelators 
Pyrene shows a number of photophysical features which make it ideal as a fluorescent probe. 
The pyrene monomer shows vibrational fine structure with five characteristic vibronic bands: 
I = 373 nm, II = 379 nm, III = 383 nm, IV = 389 nm, V = 393 nm.
208
  The first band (I) 
belongs to a forbidden transition which can be enhanced in more polar solvent environments 
due to interactions between the excited single state and the solvent dipole, a phenomenon 
known as the Ham effect.
198
 By referencing the intensity of band I against a strong transition, 
such as band III, the III/I ratio can be used to give an indication of the polarity of the pyrene 
environment. For example, the III/I ratio of a dilute pyrene solution in hexane is 1.65 whilst 
in acetonitrile it is 0.54.
208
 Interactions between pyrene moieties can result in excimer 
formation which is observed as a broad structureless emission band centred at ca. 480-500 
nm.
209
 Excimer formation can occur at concentrations of pyrene above 10
-5
 mol dm
-3
 or when 
two pyrene derived moieties are less than approximately 10 Å away from each other.
210
 
Overlap of different components of the spectra and broadening of bands due to interactions 
with other molecules complicates the interpretation of these different phenomena.
211
  
The emission spectra of the BOC-protected pyrenylalanine amino acids (33 and 34) in dilute 
toluene solution (green spectra in Figure 49) show monomer emission with vibrational fine 
structure. A slight bathochromic shift in band I of 3 nm (214 cm
-1
) is observed in the 
emission spectra for both the 1- and 2- substituted compounds compared to those expected 
for pyrene.
208
 The five characteristic vibronic bands are labelled for compound 33 in Figure 
49a (I = 376 nm, II= 382 nm, III= 388 nm, IV = 395 nm, V= 397 nm). The position of these 
bands is conserved across all of the emission spectra measured for compounds 31-34. 
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Figure 49 Overlaid normalised emission spectra for (a) 1-pyrenylalanine amino acid 33 in dilute toluene 
solution (green), 1-pyrenylalanine gelator 35 in dilute solution (blue) and 35 as a 1 % w/v gel. Bands I-V are 
labelled. (b) 2-pyrenylalanine amino acid 34 in dilute toluene solution (green), 2-pyrenylalanine gelator 36 in 
dilute solution (blue) and 36 as a 1 % w/v precipitate. λex = 345 nm, spectra normalised to band III (386 nm) 
apart from the 1 % w/v samples of 35 and 36 which are adjusted to allow comparison between the spectra.  
 
In addition to monomer emission, a broad, featureless excimer band with a maximum around 
476 nm is observed in the emission spectrum of 35 as a dilute solution (blue spectra in Figure 
49a). As the excimer is observed in the dilute solution of the gelator 35, but not the starting 
amino-acid 33, this is thought to be due to intramolecular interactions between the pyrenyl-
moieties at either end of the compound.
211
 The hexamethylene spacer tethers the two pyrene 
functionalities together and must be flexible enough for the pyrene groups to mutally interact 
resulting in excimer formation. The same features are observed for 36 but with stronger 
excimer emission relative to monomer emission. This is thought to be due to the longer-lived 
excited state of the 2-pyrenylalanine allowing more time for excimer formation to take 
place.
199
 Geometrical considerations may also play a role with the more symmetric 2-pyrenyl 
groups achieving better overlap than the 1-pyrenyl analogues.  
 
Compound 35 forms robust gels in toluene at 1 % w/v whilst 36 forms fibrous precipitates 
which fail to gel. The emission spectra are dominated by a strong excimer band where only 
IV 
II 
V 
III 
I 
a) 
 
 
 
 
 
b) 
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the first vibrational band of the monomer emission is distinguishable. For 36, the excimer 
maximum is located at 466 nm, significantly blue shifted compared to the intramolecular 
excimer emission seen in dilute solution (476 nm). As fibre formation occurs in this system, 
the excimer band is thought to correspond to intermolecular excimer emission resulting from 
interactions between adjacent pyrene groups within urea hydrogen bonded stacks. The 
excimer emission band for the 1-pyrenyl alanine derivative 35 in the gel state is much weaker 
than for precipitates of 36. Taking into account overlap with monomer emission, the 
intermolecular-excimer emission maximum of 35 is estimated to be around 466 nm. It is 
interesting to note that gel formation by other pyrene derivatives has previously been found to 
quench
190
 as well as induce excimer formation.
192
  
 
3.3 Mixed Gels 
3.3.1 Fluorescence studies 
Compounds 16, 17 and 20 belong to a series of compounds whose behaviour, structure and 
properties are discussed extensively in Chapter 2. The three gelators adopt different 
molecular packing motifs in the gel state: glycine and alanine derivatives 16 and 17 show 
ribbon-like nanoscopic morphologies whilst phenylalanine derivative 20 shows fibre like 
architectures. All three compounds reliably form robust gels in toluene. Mixtures of the 
different gelators can produce gels with different packing and morphology to those of the 
pure compounds as discussed in section 2.6. Given the structural similarity of 35 and 36 to 
this class of compounds the formation of mixed gels with 16, 17 and 20 was undertaken. The 
fluorescent properties of 35 and 36 allow information about the behaviour and environment 
of different mixed gels to be monitored and compared. 
 
Gels were formed in toluene with 1 % w/v of a 1:9 binary mixture of gelators  35 or 36 with 
either 16, 17 or 20 (e.g. 1ml Toluene, 1mg 35, 9 mg 16). The samples were heated and 
sonicated until fully dissolved with gels forming upon cooling to room temperature. 
Compounds 35 and 36 were difficult to dissolve completely and a number of heating and 
cooling cycles were undertaken to ensure complete dissolution and homogenisation occurred.  
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Figure 50 Overlaid normalised spectra for (a) 35 (b) 36 in 1:9 mixed gels with 16 (green), 17 (purple) 20 (red) 
and as a dilute toluene solution (dotted blue). λex = 345 nm, spectra normalised to band III (386 nm). 
 
The emission spectra show considerably lower intensity excimer bands in the mixed gels 
compared to solution (Figure 50). This is thought to arise due to incorporation of the pyrenyl 
gelators into bis-urea tapes of the co-gelator. X-ray crystallographic studies in Chapter 2 
show that molecules in this series adopt an extended conformation as part of a bis urea 
hydrogen bonded stack. This conformation would prevent the pyrenyl molecule folding over 
to produce intramolecular excimers. Pyrenylalanine derived gelator molecules which happen 
to be adjacent in a urea stack may still be able to form intermolecular excimers, however 
since the fluorescent gelator is relatively dilute the number of adjacent fluorophores is likely 
to be relatively low.  
 
The excimer maximum at 463 nm in the 1:9 36:16 mixed gels is in good agreement with the 
intermolecular excimer observed for the 1 % w/v fibrous precipitate of 36 from toluene (466 
nm). This suggests the excimer present is due to intermolecular, rather than intramolecular 
excimer formation. Overlap with the monomer emission makes identifying the maximum for 
the excimer band of 35:16 difficult although the band appears substantially blue shifted 
relative to the intramolecular excimer of the solution sample. Decreasing the concentration of 
a) 
 
 
 
 
 
 
b) 
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35 relative to 20 in the mixed gel results in a decrease in the intensity of the excimer band 
(Figure 51). This provides further evidence that the excimer band is due to intermolecular 
interactions between pyrene molecules with a lower probability of two pyrenyl molecules 
being adjacent in the fibres at lower concentrations.  
 
 
Figure 51 Mixed 1 % w/v toluene gels with of 35:20 at different ratios: 1:9 (purple), 1:19 (green), 1:99 (red), 
saturated solution of 35 in 1 % w/v  gel of 20 (blue). Arrow shows effect of decreasing ratio of 35 relative to 20 
on excimer band. λex = 345 nm, spectra normalised to band III (386 nm). 
The intensity of the first vibronic band is much lower in intensity relative to band III in the 
mixed gels than it is for the pyrenyl gelators in toluene solution. Band I appears to increase 
relative to band III with decreasing concentration of gelator from 2.7 in a 1:9 mixture of 
35:20 to 0.8 in a 1:99 mixture. This corresponds to an enormous change in the environment 
of the pyrene moieties upon incorporation into the gel phase, with the observed ratio of 2.7 
much greater than the ratio of 1.65 seen in hexane.
208
 However, interpretation of the III/I ratio 
is complicated by overlap with the excimer band which overlaps band III more than band I. 
The same changes in III/I ratio would be expected solely on the basis of increased excimer 
formation with a higher concentrations of 35. The difficulty in deconvoluting the 
contributions of different effects from the emission spectra makes it difficult to draw any firm 
conclusions about the gel environment. Further experiments examining the effects of 
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different solvent environments on the emission spectra of dilute solutions of amino acid 
derivatives 33 and 34, where no intermolecular excimer formation takes place, would help 
establish the extent to which the Ham effect is responsible for the differences observed in the 
intensity of band I between spectra. 
 
3.3.2 Effects of sample preparation on mixed gelator emission spectra 
Sample preparation was found to have a significant influence on the emission spectra of the 
resulting mixed gels. All mixed gel samples were heated with a heat gun until a clear solution 
was formed. Two different cooling protocols were then adopted:  a fast cooling method in 
which the samples were imersed in a cool water bath at approximately 16°C and briefly 
sonicated for approximately 1 s, and a slow cooling method where the samples were simply 
placed on a wooden bench top and allowed to cool. Fast cooled samples generally formed 
gels in under a minute whilst slow cooled samples took up to 10 minutes for the gels to fully 
form. Repeats were carried out using the same samples with the gel reformed each time 
according to either the fast or slow cooling procedures. Heating of the samples took place in 
sealed vials as the temperature required to dissolve gelators 16 and 17 is greater than that of 
the boiling point of the solvent (toluene 110°C). It was found that a heat gun, rather than a 
thermostatically controlled heating block, allowed the gelator to be rapidly dissolved without 
damaging the plastic caps of the vials. Consequently, the temperature to which each sample is 
heated will differ slightly for each repeat which may explain the variation seen within the 
results from each protocol. The resulting emission spectra are shown in Figure 52 with fast 
cooled samples shown in blue and slow cooled samples in red.  
 
In the mixed gels of 35 and 36 with 17, fast cooling consistently results in a less intense 
excimer band than slow cooling. The opposite behaviour is seen for both mixed gels of 16 
where a consistently more intense excimer band is seen for the fast cooled samples compared 
to the slow cooled ones. The excimer band is thought to be the result of intermolecular 
interactions between pyrene groups on adjacent molecules. Slow cooling must therefore lead 
to more adjacent pyrene groups in the alanine system (i.e. a more phase separated sample) but 
fewer in the glycine system.  
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Figure 52 Overlaid fluorescence emissions spectra for fast (blue) and slow (red) cooled 1 % w/v 1:9 toluene 
gels of: a) 25:16 b) 36:16 c) 35: 17 d) 36:17 e) 35:20 f) 36:20. λex = 345 nm, spectra normalised to band V (399 
nm). 
 
In 1:9 35:20 mixed gel samples, fast cooling leads to slightly more excimer emission than 
slow cooling but the difference is less pronounced than for the other systems. No difference is 
observed with preparation method for the 1:9 36:20 samples. This indicates that the 
pyrenylalanine gel incorporates readily into the phenylalanine structure with the 
2-pyrenylalanine isomer incorporating more easily than the 1-pyrenylalanine analogue. As 
well as the extent of incorporation, it may be that the packing of the molecules in the 
phenylalanine gelators does not allow for intermolecular excimer formation by 35 and 36 as 
easily as in the alanine and glycine mixed gels.  
a)     b) 
 
 
 
 
 
 
c)        d) 
 
 
 
 
 
 
 
e)        f) 
 
  94 
Mixed gels of 1:9 35:20 and 36:17 appear to be homogeneous with no significant differences 
observed in emission spectra taken of different sides of the same sample. The samples were 
also tested for stability over time. One week old samples showed greater III/I ratios than 
freshly prepared samples but typically similar excimer emissions. Measurements over shorter 
time periods showed variations in some samples, but no particular trends could be established 
and the differences were within those seen between repeats carried out using the fast and 
slow cooling methods.  
 
3.3.3 Stuctural Studies 
The decrease in the excimer band observed in the emission spectra of the mixed gels 
compared with solution is taken to indicate the incorporation of 35 and 36 into the gel fibres 
of 16, 17 and 20 preventing intramolecular excimer formation. However, the variations 
observed in the extent of intermolecular excimer formation with gel composition and 
preparation indicate mixing of the different gelators is not uniform. Scanning electron 
microscopy and X-ray powder diffraction were used to examine the mixed gel structures and 
gain insights into the observations made by fluorescence spectroscopy.  
 
SEM was used to image the morphology of xerogels formed from 1:9 mixed toluene gels of 
35 or 36 with 16, 17 and 20 formed by both the fast and slow cooling methods. Fast cooled 
mixed gel samples were further investigated by XRPD and compared with patterns obtained 
for the pure gelators under the same conditions. XRPD patterns of both the pure 1- and 2- 
pyrenylalanine xerogels showed broad, poorly defined peaks consistent with the small fibre 
size observed by SEM. Further details about the morphology and packing of gelators 16, 17 
and 20 can be found in Chapter 2.  
 
Fine cylindrical fibres were seen in SEM images of the 1:9 mixed gels of phenylalanine 
derived gelator 20 with 35 which are similar to those seen for xerogels of both pure 
compounds (Figure 53). The same morphology is also observed for 1:9 mixed gels of 20 and 
36 with no evidence of the irregular ribbons observed in the toluene precipitates of 36. Both 
pyrenylalanine mixed gels with 20 showed broad, poorly defined XPRD patterns with similar 
shapes to each other (Figure 54). The shape of the pattern for the mixed gels most closely 
resembles that of the major component, 20. However, separate fibres of 20 and 35 or 36 
a)  
  
       b) 
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cannot be ruled out by either SEM or XRPD due to the similarities in xerogel morphology 
and poor crystallinity of the gel fibres.  
 
 
Figure 53 SEM images of xerogels formed from a total of 1 % w/v mixed gels in toluene with a ratio of  a) 1:9 
35:20 slow cooled, b)1:9 36:20 fast cooled. 
 
 
 
Figure 54 XRPD patterns for xerogels prepared from fast cooled toluene gels with 1 % w/v: a) 35 (dark blue), 
b) 36 (red), c) 1:9 35:20 (green), d) 1:9 36:20 (purple), e) 20 (light blue). 
 
a)                                    b) 
a) 
 
b) 
 
c) 
 
d) 
e) 
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Figure 55 SEM images of xerogels formed 1 % w/v 1:9 mixed gels from a) slow cooled 35:17 b) slow cooled 
36:17 c) slow cooled 35:17 d) slow cooled 36:17.  
 
Alanine-derived gelator 17 forms two-dimensional ribbons in toluene. However, in slow 
cooled mixed gels of 17 with 35 or 36, much smaller ribbons are observed which are similar 
in size to those of the pyrenylalanine gels (Figure 55). Only occasional larger ribbons 
comparable with those observed for 17 are seen in the SEM images.  In the fast cooled 
samples the same smaller fibres are observed alongside larger flat ribbons similar to those 
seen for pure 17. The ribbons and fibres appear to merge into and branch off from each other 
with a large variation in widths observed. The samples are inhomogeneous with areas 
dominated by different morphologies. In a sample prepared using less than 0.1mg/ml 36 in 
17, the majority of the sample consists of ribbons, however large regions of fibres are also 
observed. This indicates that even very small amounts of 35 or 36 can have a significant 
effect on the morphology of gels of 17.  
a)                                     b) 
 
 
 
 
 
 
 
c)                                     d) 
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Figure 56 XRPD patterns for xerogels prepared from fast cooled toluene gels with 1 % w/v: a) 35 (dark blue), 
b) 36 (red), c) 1:9 35:17 (orange), d) 1:9 36:17 (light blue), e) 17 (pink). 
XRPD patterns for both fast cooled mixed gels of 17 show a number of well resolved peaks 
which closely match those found in the pattern for pure gelator 17 (Figure 56). This indicates 
that although a dramatically different fibre morphology is seen, the underlying packing still 
resembles that of the alanine gelator. Broadening of peaks at 2θ angles of 5.2° and 10.0° but 
not at 12.3° may be due to the bulky pyrenyl groups varying the spacing in the urea tapes.  
 
Xerogels of 16 from toluene adopt straight, ribbon-shaped structures. Three different 
morphologies are observed in the mixed gels of 35 and 16. The majority of the material is in 
the form of straight ribbons, similar to those seen for 16. Attached to these ribbons are 
isolated clumps of fine cylindrical fibres, similar to those seen for xerogels of 35. There are 
also ribbons of a similar size to the straight ones, but with a clear left handed twist not seen in 
the straight ribbons. Compound 16 is achiral and as this type of microscopic twisting is 
normally associated with chiral molecules, it is likely that the twisting is induced by the 
incorporation of the chiral l-pyrenylalanine derived gelators. The same effect is observed in 
mixed gels of 16 and 17 as discussed in Chapter 2 section 2.6. In the mixed gels of 36:16, the 
majority of the ribbons appear to be twisted and there are fewer clumps of fine fibres 
compared to the 35:16 gels. This implies fibres containing a mixture of gelators are more 
easily formed by 16 with 36 than 35.  
a) 
 
 
 
 
 
b) 
 
c) 
 
 
 
d) 
 
 
e) 
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Figure 57 SEM images of xerogels formed from 1 % w/v 1:9 mixed toluene gels of a) and b) slow cooled 
35:16, c) fast cooled 35:16, d) and e) slow cooled 36:16 f) fast cooled 36:16 
 
a)                                     d) 
 
 
 
 
 
 
 
b)                                     e) 
 
 
 
 
 
 
 
c)                                     f) 
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 Figure 58 XRPD patterns for xerogels prepared from fast cooled toluene gels with 1 % w/v: a) 35 (dark blue), 
b) 36 (red), c) 1:9 35:16 (green), d) 1:9 36:16 (purple), e) 16 form B (light blue). f) Pattern for non-gel forming 
precipitate from acetonitrile of 16, form A (grey). 
 
Hexamethylene spaced glycine derived compound 16 has two known crystal forms, the 
gelling form B which is produced in toluene and non-gelling form A which is observed from 
other solvents including acetonitrile (Table 3, Chapter 2). A number of peaks are resolved for 
XRPD patterns of 16:35 and 16:36 mixed gels which do not match the patterns of gels of 16 
formed from toluene (form B). A closer match is found with the non-gelling form A of 16 
obtained from acetonitrile (Figure 58). Some additional peaks matching those of 16 form B 
are observed in the mixed gels with 35 and more weakly with 36. It is likely that the different 
morphologies observed by SEM contain different packing motifs; straight ribbons of 16 form 
B, fine fibres of 35 or 36 and twisted ribbons of mixed composition with packing similar to 
that of 16 form A.  
  
 
 
 
 
a) 
 
b) 
 
c) 
 
d) 
 
 
e) 
f) 
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3.4 Anion modification of gel rheology 
The hydrogen bonding functionality of ureas allows them to interact strongly with anions and 
ureas have been utilised in a variety of anion sensors.
212, 213
 In Chapter 2, gelators in this 
series were shown to stack together through hydrogen bonds between urea-moieties to form 
α-urea tapes. The addition of anions can be used to disrupt these urea-urea interactions 
weakening, and ultimately preventing gel formation. Controlled addition of anions to gels has 
therefore received considerable interest as a means of tuning the rheometry of gels.
19, 60, 214
 
 
A number of studies were undertaken to investigate the effect of anions on gel formation and 
structure. Solution based NMR spectroscopy is used to establish the interaction of individual 
gelator molecules with anions whilst rheometry is used to examine the macroscopic effects of 
anions on gel properties. These investigations are complemented by exploiting the fluorescent 
properties of 35 and 36 to gain greater understanding of the gel-sol transition upon the 
addition of anions. Acetate was selected for investigation as it has previously been shown to 
bind strongly to urea functionalities due to its high basicity. Tetrafluoroborate was selected as 
a reference anion as it is only weakly interacting with ureas. The anions were used as tetra-n-
butyl ammonium (TBA) salts due to the cation’s weakly co-ordinating properties and high 
solubility in organic solvents.
51, 215
 
 
3.4.1 Solution studies 
In order to establish and quantify the interactions between the different gelators and anions, 
solution based NMR spectroscopic titration studies were undertaken. As anion binding is 
rapidly reversible on the NMR spectroscopic time scale, the observed chemical shift of the 
urea NH protons change with the addition of increasing concentrations of anions reflecting an 
average of the chemical shifts for the bound and unbound states (Figure 59). These chemical 
shift changes can be analysed to provide binding constants and determine the ratio in which 
the components bind (Figure 60).
66, 212, 216, 217
 Studies are undertaken in DMSO, a relatively 
competitive solvent, due to the poor solubility of the gelators in other solvents. A summary of 
the findings are given in Table 6. 
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Figure 59 NMR titration data for TBA-acetate with gelators 16 (blue diamond), 17 (red square) and 20 (green 
triangle) in DMSO-d6.  
 
Figure 60 Speciation plot showing experimental data for 
1
H NMR spectroscopy titrations for the binding of 
TBA acetate by 16 in DMSO fitted using a 1:1 and 1:2 host guest binding model: black circles- experimental 
measurements, black line- fit of model to data, red line- free host in solution, blue line- 1:1 host:guest binding, 
brown line- 1:2 host:guest binding. 
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Table 6 Binding constants determined by 
1
H NMR spectroscopic titrations in DMSO-d6 
Compound Log β11 Log β12 
16 1.96(2) 2.91(2) 
17 1.30(6) 2.53(4) 
20 1.77(4) 2.61(5) 
 
The anion binding titrations indicate weak 1:1 binding is dominant with additional 
contributions from 1:2 gelator:anion binding interactions (Table 6). The binding constants are 
broadly comparable between the different compounds with 16 showing the strongest binding 
and 17 the weakest. Equivalent titrations with the addition of BF4
-
 showed no shift in the urea 
protons by NMR spectroscopy with the addition of anion.  
 
 
Figure 61 Job plot showing the addition of TBA-acetate to a solution of 20 in DMSO-d6 
 
Job plots
66, 216, 217
 for compound 20 (Figure 61) show a maximum around 0.5 suggesting that 
the 1:1 species is predominant. The 2:1 complex is not observed in the Job plot as the weak 
binding means very little 2:1 complex formation takes place, particularly under the dilute 
concentrations used in the Job plot (about 2 mmol dm
-3
). NMR spectra obtained for 
compounds 16 and 17 showed peak broadening and splitting on addition of acetate which 
varied unpredictably across the series and it was not possible to produce a meaningful plot. 
The shape of the peaks were reproducible when the samples were remade with the same stock 
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solutions whilst a repeat using higher concentrations of 17 only showed line broadening with 
the addition of acetate. The origin of the line broadening and splitting is thought to be due to 
host self-aggregation effects or other more complex behaviour, and requires further 
investigation.  
 
Due to the small amount of material available, analogous NMR measurements were not 
carried out on 35 and 36. Instead the effect of anions on the fluorescence of solutions of 35 
and 36 were investigated. The experiments were carried out in DMF due to the narrow 
absorption window of DMSO and the low solubility of the compounds in other solvents. 
Solutions of TBA-acetate or TBA-tetrafluoroborate in DMF (1.3 x10
-4
 mol dm
-3
) were 
gradually added to a solution of gelators 35 or 36 in DMF (2.6 x10
-8
 mol dm
-3
) and the 
emission spectra recorded. 
 
 
Figure 62 Emission spectra for a solution of (a and b) 35 or (c and d) 36 in DMF  (2.6 x10
-8
 mol dm
-3
) to which 
increasing equivalents of (a and c) TBA-OAc or (b and d) TBA-BF4 solution (1.3 x10
-4
 mol dm
-3
) are added: 0 
eq. (blue), 50 eq. (red) 250 eq. (green) 500 eq. (purple) 1000 eq. (light blue) 1500 eq (orange) 2000 eq. (pink) 
2500 eq. (grey). Arrow shows effect of the addition of increasing equivalents of anions on excimer band. λex = 
345 nm, spectra normalised to band V (398 nm). 
The solution phase emission spectra in DMF shows enhanced excimer emission relative to 
the comparable toluene solutions. Addition of TBA acetate results in a drop in the intensity of 
a)                                     b) 
 
 
 
 
 
 
c)                                      d) 
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the excimer band with no change in the relative intensities of the monomer bands (Figure 62). 
The decrease in the intensity of the excimer emission is thought to be due to conformational 
changes in the gelator upon binding to the anions preventing the pyrene groups associating to 
form an intramolecular excimer. Because binding is weak in a competitive solvent such as 
DMF, and the concentration of gelator is very low, a large number of equivalents of anions 
are required to bring about this change (2500 eq.). Dilution of the final samples with DMF 
resulted in an increase in excimer emission intensity which is attributed to the reduced 
proportion of bound bis(urea)due to the decrease in anion concentration. Addition of non-
binding BF4
-
 anions results in no change in the fluorescence emission over the same 
concentration range.  
 
3.4.2 Rheometric studies 
Varying equivalents of TBA-acetate were added to 1 % w/v of gels of 20 in 1:9 
acetonitrile:toluene mixtures in a concentric cylinder couette apparatus. In the absence of 
anions, strong gel-like behaviour was seen with G′ values an order of magnitude higher than 
G′′, an effect which persists even at high oscillatory stresses of 300 Pa. Gels formed in the 
presence of increasing equivalents of TBA-acetate showed a lower value of G′ and a smaller 
difference in magnitude between G′ and G′′ (Figure 63). The stress with which the gels broke 
down to give liquid-like behaviour, the yield stress, also decreased with increasing 
concentrations of anion. With 1.5 equivalents of TBA acetate, the gel fails to form and the 
viscous modulus G′′ becomes greater than the elastic modulus G′. Interestingly G′ is slightly 
higher in the 1:9 acetonitrile:toluene gel than for the pure toluene gel (10,000 Pa) of 20 when 
measured under the same conditions. 
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Figure 63 Oscillatory stress sweep for 1 % w/v 20 in 1:9 CH3CN:toluene at increasing concentrations of TBA-
acetate: 0 equiv. (open circle) 0.5 equiv. (closed circle) 1 equiv. (open squares) 1.5 equiv (closed square) at 
frequency of 1Hz. Data curtailed after yield stress for clarity. 
 
The same trends are observed for 1 % w/v 20 in ethyl acetate and results are shown in Figure 
64. The gels have similar G′ and G′′ values to the acetonitrile:toluene system and increased 
anion concentration results in lower G′ values and yield stresses. Only 0.8 equivalents of 
TBA-acetate are required to prevent gel formation indicating stronger acetate binding to the 
gelator in ethyl acetate than the toluene:acetonitrile mixture or weaker gelator-gelator 
interactions. 
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Figure 64 Plot of rheometric study showing G′ (red) and G′′ (blue) values for 1% w/v ethyl acetate gels of 20 at 
various oscillatory stresses with varying equivalents of anions: 0 (open circles), 0.2 (closed circles), 0.4 (open 
squares), 0.6 (closed squares), 0.8 (open diamonds). Data curtailed after yield stress for clarity.  
 
The temperature at which gels of 16 and 17 form in toluene and ethyl acetate is greater than 
the boiling point of the solvents meaning it was not possible to transfer a sol from a sealed 
vial into the rheometer cup. Studies were therefore undertaken for 17 in chloroform where the 
compound is generally more soluble and gel formation slower and weaker. These 
observations were reflected in the rheometry with G′ values an order of magnitude lower than 
for the phenylalanine gels. The presence of increasing concentrations of anions resulted in the 
same decrease in G′ and yield stress observed for gels of 20 (Figure 65). As 16 only forms 
gels in toluene it was not possible to undertake studies on this compound.  
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Figure 65 Plot of rhometric study showing G′ (red) and G′′ (blue) values for 1% w/v chloroform gels of 17  at 
various oscillatory stresses with varying equivalents of anions; 0 (open circles), 0.1 (closed circles), 0.2 (open 
squares), 0.3 (closed squares), 0.4 (open diamonds), 0.5 (closed diamonds). Data curtailed after yield stress for 
clarity.  
 
3.4.3 Mixed gel fluorescence studies 
The NMR spectroscopic and fluorescent studies in section 3.3.1 provide information about 
the solution phase interactions of isolated gelator molecules with anions whilst the rheometric 
measurements of section 3.4.2 describe the effect of anions on the macroscopic structure of 
the gel. In this section the fluorescent properties of 35 and 36 are exploited to probe the 
influence of anions on the gel structure at a molecular level. Rheometry indicates that at 1.5 
equivalents of TBA-acetate gels of 20 fail to form in toluene. However, rheometry gives a 
measurement of the macroscopic integrity of the gel therefore it would be interesting to probe 
the gel-sol transition on a molecular level. It would also be interesting to monitor the effects 
of anions on aggregation in the gelator mixtures once the gels appear to have fully dissolved.  
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Toluene was selected because compounds 16, 17 and 20 all form strong gels in this solvent. 
Low concentrations of the pyrenylalanine gelators were used in order to minimise 
intermolecular excimer formation and simplify interpretation of the resulting spectra. 
Compounds 35 and 36 are only sparingly soluble in toluene at room temperature. Saturated 
solutions at room temperature were therefore used with a concentration estimated to be <0.01 
mg/ml (1.3 x 10
-5
 mol dm
-3
). However, anions are poorly soluble in toluene so a second 
solvent is required to ensure the anions remain in solution. Acetonitrile was selected as the 
co-solvent because TBA-acetate and tetrafluoroborate are highly soluble in this solvent so 
relatively small volumes can be added. Concentrated solutions of anion were made such that 
0.02 ml of solution contained 1 mole equivalents of anion relative to 20 in a 1 % w/v gel. 
Preliminary tests indicated that toluene gels of 16, 17 and 20 still formed in the presence of 
low concentrations of acetonitrile.  
 
Stock solutions of toluene saturated with either 35 or 36 at room temperature were used to 
prepare 1 % w/v of gels of 16, 17 or 20. The samples were heated and sonicated repeatedly 
with a heat gun until all solids were fully dissolved. All gels were formed using the fast 
cooling procedure described in section 3.3.1. TBA-acetate or TBA-BF4 was added as a 
solution in acetonitrile (0.95 mmol dm
-3
) using a micro-syringe. Samples were redissolved 
following the addition of anion and the gels reformed before a new measurement was taken. 
All samples were reheated regardless of whether gel formation was apparent. The phases of 
the samples at the time of measurement are recorded in Table 7.  
Reference experiments using dilute solutions of 35 and 36 in toluene without co-gelator 
(Figure 66) showed the addition of acetate results in a decrease in the intensity of the excimer 
band (λmax = 470 nm). This is consistent with the behaviour observed in DMF solution and is 
thought to be due to conformational changes upon binding of the gelator to the anion 
inhibiting intramolecular excimer formation. The loss of excimer is more pronounced in 
toluene than in DMF with only two equivalents of anion required to extinguish excimer 
emission. No loss of excimer band intensity is observed with the addition of the 
tetrafluoroborate solution consistent with the weaker binding of the gelators to this anion. 
Indeed, a small increase in the intensity of the excimer band occurs presumably due to the 
change in solvent composition favouring excimer formation. The position of the excimer 
band is also shifted significantly from 457 nm to 471 nm with the addition of 0.1 ml of the 
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BF4
-
 solution, presumably due to the change in solvent environment. These competing factors 
complicate interpretation of the spectra for the mixed gels. 
 
 
  
Figure 66 Fluorescence emission spectra recorded for saturated toluene solutions of (a and b) 35 (c and d) 36 
upon the addition of (a and c) TBA-Acetate solution or (b and d) TBA-tetrafluoroborate solution (0.95 mmol 
dm
-3
): 0 ml (blue), 0.02 ml (green), 0.04 ml (purple). Further additions of BF4 solution were made: 0.01 ml 
(turquoise), 0.1 ml (orange), 0.2 ml (light blue), 0.4 ml (pink). Arrows show the effect of increasing 
concentration of anion solution on excimer band intensity. λex = 345 nm, spectra normalised to band III (386 
nm). 
 
Table 7 Phase of mixed gels upon the addition of increasing equivalents of TBA-acetate. 
Mixed Gel 
1:9 
Anion TBA-Acetate solution 
0 0.5 1 1.5 2 5 10 20 
35 
16 
AcO
- 
G G WG S S S S - 
BF4 G G G G G PG PG PG 
17 
AcO
-
 G G WG S S S S - 
BF4 G G G G G G G  WG 
20 
AcO
-
 G G WG S S S S - 
BF4 G G G G G G G  WG 
36 
16 
AcO
- 
G G WG S S S S S 
 BF4 G G G G G PG PG PG 
17 
AcO
-
 G G WG S S S S S 
BF4 G G G G G G G WG 
20 
AcO
-
 G G WG S S S S S 
BF4 G G G G G G G WG 
G= gel, WG= weak gel, PG= partial gel, S= solution.  
a)  b) 
 
 
 
 
 
 
c)  d) 
  110 
 
 
Figure 67 Emission spectra showing the addition of anion solutions to 1 % w/v 1:9 mixed gels of 35 with a) 
16+AcO
-
,  b) 16+BF4
-
, c) 17+AcO
-
 , d) 17+BF4
-
, e) 20+AcO
-
, f) 20+BF4
-
: 0 eq. (blue), 0.5 eq (red), 1 eq.  
(green), 2 eq. (purple), 5 eq. (turquoise), 10 eq (orange), 15 ml (light grey), 20 eq (pink). Arrows shows the 
effect of increasing concentration of anion solution on the excimer band. λex = 345 nm, spectra normalised to 
band III (386 nm). 
 
Only monomer emission is observed in the mixed gels of 16, 17 and 20 with 35 and 36 before 
the addition of anions (Figure 67 and Figure 68). This indicates that 35 and 36 are 
incorporated into gel fibres preventing intramolecular excimer formation whilst the dilute 
conditions prevent intermolecular excimer formation. The addition of increasing 
concentrations of TBA acetate results in the breakdown of the gels (Table 7) and a gradual 
increase in the excimer emission bands. By inhibiting fibre formation, the anions release the 
pyrenylalanine gelators to undergo intramolecular excimer formation. This effect is in 
competition with binding of the acetate anions to the pyrenylalanine gelator in solution and 
a)  b) 
 
 
 
 
 
 
c)  d) 
 
 
 
 
 
 
e)  f) 
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hence prevention of intramolecular excimer formation, as observed in the solution anion 
complexation experiments. However, there is a large excess of non-fluorescent gelators (16, 
17 or  20) which can also bind and effectively sequester the acetate, limiting the amount of 
acetate available to bind to the released pyrenyl derived gelators.  
 
 
 
 
Figure 68 Emission spectra showing the addition of anion solutions to 1 % w/v 1:9 mixed gels of 36 with a) 
16+AcO
-
,  b) 16+BF4
-
, c) 17+AcO
-
 , d) 17+BF4
-
, e) 20+AcO
-
, f) 20+BF4
-
: 0 eq. (blue), 0.5 eq (red), 1 eq.  
(green), 2 eq. (purple), 5 eq. (turquoise), 10 eq (orange), 15 ml (light grey), 20 eq (pink). Arrows shows the 
effect of increasing concentration of anion solution on the excimer band.  λex = 345 nm, spectra normalised to 
band III (386 nm). 
 
 
a)  b) 
 
 
 
 
 
 
c)  d) 
 
 
 
 
 
 
e)  f) 
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Below one equivalent of acetate there is relatively little change in the excimer band compared 
to the absence of anion. Above 1-2 equivalents of acetate the excimer emission increases 
substantially with the addition of further equivalents of anion. This corresponds well with the 
break-down of the gels which occurs around 1.5 equivalents of TBA-acetate for all of the 
mixed gels. It is interesting that excimer emission continues to increase with further additions 
of anions long after the gel has broken down. This indicates that acetate continue to disrupt 
aggregation which must still be taking place even after the three-dimensional gel structure 
has broken down. Much greater increases in the intensity of the excimer emission are 
observed for the mixed gels containing 36 compared to those with 35, consistent with the 
longer lived excited state of this isomer.
199
 Excimer emission is also more intense relative to 
monomer emission in mixed gels of 20 than those of 16 or 17 indicating greater dissolution of 
the gels of 20 by acetate. In some cases, for example the 1:9 gel of 16:36 (Figure 68a), the 
increase in excimer levels off at higher concentrations of acetate, presumably as a result of 
complete disaggregation, and hence full dissolution of the pyrenyl gelators.  
 
An increase in the intensity of the excimer band is also seen with the addition of TBA-
tetrafluoroborate solution. For most of the mixed gel systems, the increase in the excimer is 
much larger with the addition of acetate than tetrafluoroborate solution. However, gels of 35 
with 1 show stronger excimer emission with the addition of BF4
-
 than AcO
-
. Gel formation is 
seen in the mixed samples of 35 or 36 with 17 or 20, even with 20 equivalents of BF4
- 
as 
shown in Table 7. However, the rate of gel formation is noticeably slower, and the gels 
formed weaker, the higher the concentration of BF4
-
 solution. As the solution studies show 
little binding to TBA-BF4, this is attributed to higher solubility of the gelators in the 
toluene:acetonitrile mixtures. In contrast, mixed gels of 35 or 36 with 16 begin to precipitate 
above five equivalents of tetrafluoroborate solution and only partial gels are formed. This 
may be because 16 forms a non-gelling precipitate in acetonitrile (form A) with a different 
XRPD pattern to its gelling form in toluene (form B) whilst compounds 17 and 20 both form 
gels in acetonitrile with the same XRPD patterns as the corresponding toluene gels. In either 
case, the change in solvent composition disrupts the gel resulting in an increase in excimer 
formation.  
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Table 8 Summary of the competing effects of different components on gel formation and excimer emission 
Species TBA acetate Acetonitrile TBA tetrafluoroborate 
 
16/17/20 
- Disrupts gel formation 
- Increases solubility of gelators 
- Favours non-gelling form A in 16 
- No effect 
 
35/36 
- Releases gelator to undergo 
intramolecular excimer formation 
- Binding of gelator to acetate 
quenches excimer 
- Solubilises gelator to undergo 
intramolecular excimer formation 
 
- No effect 
 
The increase in the intensity of the excimer band with the addition of anion is not always 
consistent and in some cases spectra corresponding to higher concentrations of anion have 
lower intensity excimer bands than the previous measurement. This may be in part due to the 
stochastic nature of gel formation and small differences in sample preparation. However, the 
emission spectra of the final samples were re-measured after one day and in several cases a 
considerable decrease in excimer emission bands was observed. This indicates that the gel 
systems were not fully equilibrated after the approximately 5 minute cooling period allowed 
between measurements. A longer equilibration period between experiments may therefore be 
required, particularly with higher concentrations of anion where gel formation is considerably 
slowed. 
 
Disruption of the gel by the change in solvent composition makes it difficult to isolate the 
effect of acetate on excimer formation and the experiment would be greatly simplified by 
keeping the solvent composition constant.  Analysis is further complicated by binding of the 
pyrenyl gels to acetate, but not tetrafluoroborate, inhibiting excimer formation. Nevertheless, 
the general explanation that the addition of acetate leads to the gradual breakdown of gel 
fibres releasing trapped pyrenyl co-gelators to undergo excimer formation is still thought to 
hold true. The results indicate that even when acetate prevents the formation of a 
macroscopic gel, aggregation still occurs which traps the pyrenylalanine gelators and limits 
excimer formation. Addition of higher equivalents of anion therefore further breakdown these 
aggregates releasing more fluorescent gelators and causing an increase in excimer emission 
intensity.   
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3.5 Conclusion 
In general the synthetic 1- and 2-pyrenylalanine gelators behave similarly to the other amino 
acid derivatives in the series. Both compounds form gels by themselves and as mixed gels 
with other amino acid derived gelators. Differences in the range of solvents gelled, fibre 
morphology and XRPD patterns indicate that conformational differences between the 
pyrenylalanine isomers impacts upon the structure of the gel fibres they form. The general 
trends in fluorescence emission exhibited by both the 1- and 2-pyrenylalanine derived 
gelators are the same. However, stronger excimer emission is observed for the 2-
pyrenylalanine gelator (35) which is attributed to its longer lived excited state.
199
  
 
In free solution, the two pyrenyl ends of gelators 35 and 36 are able to mutually interact in 
their excited state to form an intramolecular excimer. In mixed gels with compounds 16, 17 
and 20, intramolecular excimer formation is prevented as the pyrenyl gelators become 
incorporated into bis-urea tapes. As the proportion of pyrenylalanine gelator is increased, a 
new intermolecular excimer band forms due to association between adjacent pyrenylalanine 
gelators. The emission spectra of the 1:9 mixed gels are sensitive to the method of gel 
preparation. Rapid gel formation results in a decrease in intermolecular excimer emission for 
1:9 mixtures of 35 or 36 with 17 but an increase in excimer emission with 16 compared with 
slow cooled samples. 
 
Compounds 35 and 36 appear to incorporate well into the gel structure of 20, resulting in 
little excimer formation and no observable differences in gel morphology or XRPD patterns 
compared to pure gels of 20. However, the presence of 35 or 36 changes the morphology of 
the normally large ribbon-like strands of 17 to give much smaller, narrower ribbons. Mixtures 
of the two morphologies are seen in different samples with increasing concentration of 36 
producing a higher proportion of the smaller ribbons. However, XRPD data indicates that 
despite the change in morphology there is no change in the underlying packing which is 
similar to that of pure 17. Three different microscale morphologies are observed for 16 with 
35 or 36 which XRPD indicates correspond to three different packing arrangements. In 
addition to the straight ribbons and fine fibres attributed to the pure gelators, twisted fibres 
are also seen which are thought to correspond to mixed gels with packing similar to form A 
of 16. The differences observed in the intensity of the excimer band with sample preparation 
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are likely to be the result of changes in the ratio of these different components as a result of 
differences in sample cooling rate. 
 
Compounds 17 and 20 display gel-like rheology which weakens with the addition of TBA-
acetate until liquid-like behaviour is observed. NMR studies show TBA-acetate undergoes 
weak 1:1 and 2:1 binding with the urea functionalities of compounds 16, 17 and 20. Binding 
of acetate to 35 and 36 in DMF or toluene solution results in a loss of intramolecular excimer 
emission, thought to result from conformational changes in the gelators upon binding to the 
anions preventing association of the pyrenyl end groups. Addition of acetate to mixed gels of 
compounds 16, 17 and 20 breaks down the gels, releasing the pyrenylalanine gelators to 
undergo intramolecular excimer emission. Little increase in the intensity of the excimer band 
is seen until the gel is observed to breakdown at 1.5 equivalents. Excimer emission continues 
to grow with the addition of higher equivalents of acetate indicating that the aggregation of 
the gelators continues to be disrupted at anion concentrations well above those required to 
prevent macroscopic gel formation. However, an increase in excimer emission is also 
observed with the addition of TBA-BF4 which is attributed to disruption of the gels by the 
addition of acetonitrile.  
  
The approach taken of incorporating a fluorescent functionality into a known gelator motif 
and forming mixed gels with related gelators allows valuable insights to be gained into gel 
formation and dissolution. However, differences in molecular packing and morphology 
induced in some of the gel systems indicate that the pyrenylalanine gels are not simply 
passive probes. This work highlights the sensitivity of the gel state to apparently small 
differences in gelator structure, sample preparation and solvent composition.  
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3.6 Experimental Section 
3.6.1 Materials and Methods 
The syntheses of compounds 16, 17 and 20 are reported in section 2.8. 1- and 2- 
pyrenylalanine gelators 35 and 36 were synthesised from their corresponding BOC-protected 
amino acids which were supplied by Dr. Neil Colgin (Durham University). 2-Bromo pyrene 
was synthesised by Dr. Andrew Crawford and Robert Edkins (Durham University).
202
 
Commercial reagents were used as supplied without further purification. Instrumentation and 
procedures for the characterisation of compounds and gels are as described in the 
experimental section of Chapter 2.  
 
3.6.2 Synthesis 
Methyl (2S)-2-[6-[[(1S)-2-methoxy-2-oxo-1-(pyren-1-ylmethyl)ethyl]carbamoylamino] 
hexylcarbamoylamino]-3-pyren-1-yl-propanoate (35) 
BOC-protected 1-pyrenylalanine methylester, 33, (0.07 g, 0.17 mmol) was stirred at room 
temperature in 4 ml 1:1 dry TFA:DCM. NMR indicated deprotection occurred after 1 hour 
and the solvent was removed under vacuum and the product re-suspended in chloroform 
(10ml). Triethylamine was added dropwise to produce a neutral solution, as monitored using 
indicator paper. 1,6-diisocyanatohexane (0.013 g, 0.08 mmol) was added dropwise and the 
solution was heated under reflux for 18hours. The mixture was cooled and the fine precipitate 
filtered and washed with cold chloroform then diethylether. The precipitate was sonicated as 
a suspension in 5ml of distilled water, filtered and dried in a heating pistol for 30minutes. The 
product was obtained as a cream solid (Yield 0.039 g, 0.05 mmol, 30 %) 
1
H NMR (700MHz, 
DMSO-d6): 8.39 (2 H, d, J 9.2, Ar-H), 8.32 (4 H, t, J 8.6, Ar-H), 8.26 (4 H, dd, J 17.1, 8.5, 
Ar-H), 8.18 (4 H, s, Ar-H), 8.11 (2 H, t, J 7.5, Ar-H), 7.92 (2 H, d, J 7.8, Ar-H), 6.38 (2 H, d, 
J 8.2, C*NH), 6.07 (2 H, t, J 5.3, NHCH2), 4.70 (4 H, dd, J 15.0, 7.6, C*H), 3.79 (2 H, dd, J 
14.1, 6.2, C*CH), 3.67 (2 H, dd, J 13.8, 7.9, C*CH’), 3.67 (6 H, s, OCH3), 2.94 (4 H, dd, J 
13.1, 6.5, NHCH2), 1.32 – 1.24 (4 H, m, NHCH2CH2), 1.20 – 1.11 (4 H, m, CH2CH2CH2).
 
13
C{
1
H} NMR (700MHz, DMSO-d6, J/Hz): 173.8 (s, COO), 158.1 (S, NCO), 138.4 (s, ArC), 
131.6 (s, ArC), 131.1 (s, ArC), 130.6 (s, ArC), 129.5 (s, ArC), 129.1(s, ArC), 128.2 (s, ArC), 
128.1 (s, ArC), 127.6 (s, ArC), 126.9 (s, ArC), 125.9 (s, ArC), 125.7 (s, ArC), 125.4 (s, ArC), 
124.9 (s, ArC), 124.8 (s, ArC), (s, ArC), 123.9 (s, ArC), 55.1 (s, C*), 52.5 (s, OCH3), 40.3 (s, 
NCH2 under DMSO peak), 36.1 (s, C*CH2), 30.6 (s, NCH2CH2), 26.8 (s, NCH2CH2CH2). 
  117 
m/z (ASAP+, 650°C): 215.1 ([PyCH2]
+
, 100%),  710.3 ([M-2H2O]
+
, 55%) Anal. calc’d for 
C48H46N4O6: C, 74.40; H, 5.98; N, 7.23 Found: C, 72.98; H, 5.94; N, 7.11%. 
 
Methyl (2S)-2-[6-[[(1S)-2-methoxy-2-oxo-1-(pyren-2-ylmethyl)ethyl]carbamoylamino] 
hexylcarbamoylamino]-3-pyren-2-yl-propanoate (36) 
BOC-protected 2-pyrenylalanine methylester, 34, (0.12 g, 0.296 mmol) was stirred at room 
temperature in 4 ml dry 1:1 TFA:CDCl3. NMR spectroscopy indicated deprotection had 
occurred after 1 hour and the solvent was removed under vacuum and the product re-
suspended in chloroform (10ml). Triethylamine was added dropwise to produce a neutral 
solution, monitored using indicator paper. 1,6-diisocyanatohexane (0.025 g, 0.148 mmol) was 
added dropwise and was heated under reflux at 70°C for 18 h. The mixture was cooled and 
the precipitate filtered and washed with cold chloroform then diethylether. The product was 
obtained as a creamy precipitate (Yield 0.072 g, 0.093 mmol, 31%) 
1
H NMR (700MHz, 
DMSO-d6): 8.28 (4 H, d, J 7.5, Ar-H), 8.17 (4 H, d, J 7.5, Ar-H), 8.12 (4 H, d, J 7.5, Ar-H), 
8.10 (4 H, s, Ar-H), 8.05 (2 H, t, J 7.5, Ar-H), 6.26 (2 H, d, J 8.2, C*NH), 6.03 (1 H, t, J 5.4, 
NHCH2), 4.67 (2 H, dd, J 13.8, 8.1, C*H), 3.64 (6 H, s, OCH3), 3.44 (2 H, dd, J 13.8, 5.5, 
C*CH), 3.34 (2 H under H2O solvent peak, C*CH’) 2.87 (4 H, dd, J 12.9, 6.5, NHCH2), 1.23 
– 1.19 (4 H, m, NHCH2CH2), 1.10 – 1.08 (3 H, m, CH2CH2CH2). 
13
C{
1
H} NMR (700MHz, 
DMSO-d6, J/Hz): 173.8 (s, COO), 158.0 (s, NCO), 136.0 (s, ArC), 131.2 (s, ArC), 131.1 (s, 
ArC), 128.1 (s, ArC), 127.8 (s, ArC), 126.6 (s, ArC), 126.5 (s, ArC), 125.7 (s, ArC), 124.3 (s, 
ArC), 123.3 (s, ArC), 55.1 (s, C*), 52.4 (s, OCH3), 46.4 (s, NCH2), 38.9 (s, C*CH2), 30.5 (s, 
NCH2CH2), 26.6 (s, NCH2CH2CH2). m/z (ASAP+, 550°C): 215.1 ([PyCH2]
+
, 100%),  439.2 
([M-C20H17NO2-H2O]
+
, 35%), 710.3 ([M-2H2O]
+
, 5%) Anal. calc’d for C48H46N4O6: C, 
74.40; H, 5.98; N, 7.23. Found: C, 69.88; H, 5.79; N, 6.68%. 
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3.6.3 Experimental procedures 
3.6.3.1 1H NMR spectroscopic titrations 
NMR spectra were performed on a Varian Mercury-400 (400 MHz for 
1
H). All chemical 
shifts are reported in ppm and referenced to the residual protic solvent. A solution of the host 
species of known concentration, typically 0.02–0.03 mM, was made up in an NMR tube 
using DMSO-d6 (0.5 ml). Solutions of TBA Acetate (1 ml) were made ten times the 
concentration of the host solution. The guest solution was typically added in 10 μl aliquots, 
representing 0.2 equivalents of the guest with respect to the host. Larger aliquots were used 
above 2 equivalents of guest. Spectra were recorded after each addition. Results were 
analysed using the curve-ﬁtting program HypNMR 2006.218  
 
Figure 69 NMR titration data and fit for binding of TBA acetate by 16 in DMSO: black circles- experiemental 
measurements, black line- fit of model to data, red line- free host in solution, blue line- 1:1 host:guest binding, 
brown line- 1:2 host:guest binding. 
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Figure 70 NMR titration data and fit for binding of TBA acetate by 17 in DMSO: black circles- experiemental 
measurements, black line- fit of model to data, red line- free host in solution, blue line- 1:1 host:guest binding, 
brown line- 1:2 host:guest binding. 
 
3.6.3.2 Job plots 
Stock solutions of 20 (0.0255 g in 5 ml DMSO-d6) and TBA-acetate (0.0146 g in 5 ml 
DMSO) were prepared in glass vials. The solutions were added to separate NMR tubes to 
give samples with the same total volume (0.8 ml) but different mole fractions of 20:TBA-
acetate ranging from 0.9-0.1 20. Results were analysed in Microsoft Excel.  
 
3.6.3.3 Rheometric studies 
Rheology experiments were performed using a TA Instruments Advanced Rheometer 2000. 
A concentric cylinder couette geometry with a gap of 1000 μm and 10 ml of sample was used 
in each case. Samples were prepared by weighing 0.1 g of gelator into a 15 ml glass vial 
along with the appropriate molar equivalents of TBA-acetate and 10 ml of solvent mixture. 
The vials were sealed and carefully heated until the gelator had fully dissolved (care must be 
taken due to pressure build up). The hot gelator solution was transferred into the pre-heated 
concentric cylinders using a preheated glass pipette. Gels of 20 in 1:9 toluene to acetonitrile 
mixtures were cooled from 90-20°C whilst ethyl acetate gels of 20 and chloroform gels of 17 
were cooled from 50-20°C. Oscillatory stress sweep measurements were preformed over a 
range of 0.01-300 Pa with a constant frequency value of 1 Hz.  
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3.6.4 Fluorescence studies 
UV-vis absorption spectra were obtained on a Hewlett-Packard 8453 diode array 
spectrophotometer using standard 1 cm width quartz cells. All emission spectra were 
produced with an excitation wavelength of 345 nm which corresponds to a maximum in the 
UV-vis absorption spectra for both 35 and 36 in dilute toluene solution. Emission spectra 
were obtained using a Jobin-Yvon Horiba Fluorolog 3-22 Tau-3 spectroﬂuorimeter and were 
corrected for the spectral response of the instrument. Solution based spectra were recorded 
with a right angle illumination and collection method using a standard quartz cell with a path 
length of 1 cm. Gel samples were measured in front-facing geometry in 1.75 ml screw top 
vial. Slit widths were varied with samples ranging from 1.5 to 8 nm depending on 
concentration and intensity of sample emission. 
 
Analytical grade solvents were used without drying or degassing procedures. No emission is 
observed for gelators 16 or 17 and negligibly weak fluorescence was observed for 
concentrated gels of phenylalanine derived gelator 20. Dilute toluene solutions were 
produced by heating and sonicating 1 mg of 35 or 36 in 10 ml of solvent and to create a 
saturated solution at room temperature. The samples were then filtered through cotton wool 
to remove excess solid and the concentration was estimated to be in the order of 1 x 10
-7
 mol 
dm
-3
.  
 
3.6.4.1 Co-gelation studies 
1:9 mixed gel samples were prepared by weighing 0.0010 g of 35 or 36 and 0.0090 g of 16, 
17 or 20 into glass screw top vials and adding 1 ml of solvent. Samples were repeatedly 
heated with a heat gun and sonicated to ensure complete dissolution and homogeneous gel 
formation. Slow cooled samples were prepared by placing the vial on a wooden bench top 
and allowing to cool to room temperature. Fast cooled samples were prepared by heating the 
sample with a heat gun until fully dissolved. The sample was then rapidly immersed in a 
water bath (16°C) and at the first sign of phase separation (approximately 10 seconds) briefly 
sonicated (approximately 1 second). If the sample is sonicated well above the Tgel  the sample 
remains in solution whilst prolonged sonication disrupts gels which have already formed. 
Differences in the temperature to which samples are heated and the stochastic nature of gel 
nucleation can mean there is some variation in the time taken for gels to form. 
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3.6.4.2 Anion addition to 35 and 36 in dilute DMF solution 
Concentrated stock solutions were prepared by dissolving 35 or 36 (0.001 g) in DMF (1 ml). 
Samples were made by diluting 0.02 ml of stock solution with 2 ml of DMF in a quartz 
cuvette. Stock solutions of anion were formed by dissolving TBA actetate (0.0390 g) or TBA 
tetrafluoroborate (0.0425 g) in 1 ml of DMF. Anion solutions were added to the cuvette using 
a microsyringe and shaken, but not heated, between measurements. 
 
3.6.4.3 Anion addition to 35 and 36 in toluene mixed gels 
Stock solutions were prepared by heating and sonicating 1 mg of 35 o 36 in 10 ml of toluene 
for 5 minutes then allowing the sample to cool to room temperature. Saturated solutions were 
formed by passing the solution through a pipette containing cotton wool to remove the 
undissolved material. Mixed gel samples were prepared by weighing 10 mg of gelators 16, 17 
and 20 into 1.75 ml vials and adding 1 ml of the toluene stock solution containing 35 or 36. 
The samples were heated until all material was fully dissolved then rapidly cooled in a water 
bath with brief sonication in accordance with the fast cooling method. Stock solutions of 
anion were prepared by dissolving 0.172 g of TBA-acetate or 0.187 g of TBA-
tetrafluoroborate in 0.6 ml of acetonitrile. Gels were reformed following the addition of each 
aliquot of anions and emission spectra recorded after a 5 minute cooling period.  
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Chapter 4: Using Gel Morphology to Control Pore Shape 
4.1 Introduction 
A variety of low molecular weight gelators (LMWGs) have been found to self assemble into 
supramolecular structures capable of immobilising solvent to form a gel.
24, 72, 171
 These gels 
adopt a number of nanoscopic morphologies including fibrous, helical, ribbon-like, tubular, 
lamellar and vesicular structures.
121
 Such frameworks have been used as scaffolds to template 
the formation of rigid nanoscopically structured materials for applications such as filtration, 
catalysis, tissue repair, drug delivery and rewritable materials.
126, 131, 219
 The soft template of 
the gels can be ‘fixed’ in a variety of ways such as by depositing an inorganic material on the 
inner or outer surface of the template or using LMWGs which can themselves be polymerised 
to give a rigid structure.
61, 121, 122
 LMWGs able to gel polymer precursors such as styrene or 
methyl methacrylate which can be subsequently polymerised have been used to give 
composite materials.
125, 126
 The supramolecular nature of the gel matrix means it can be 
removed by washing or chemical treatment of the composites to leave an imprint of the gel 
structure in the polymer. A number of fibrillar,
128-130
 helical,
131, 132
 tubular and macroporous 
structures
133
 have been imprinted in this way.  
 
The present study utilises two hexylene spaced bis-urea gelators functionalised with alanine 
or phenylalanine end groups, namely 17 and 20, respectively. The compounds gel a variety of 
solvents
170
 including a 1:1 mixture of polymer precursor methyl methacrylate (MMA) and 
cross-linker ethylene glycol dimethacrylate (EDGMA). Electron microscopy revealed the 
nanoscopic morphology of the gels was different for the two compounds with xerogels of 20 
showing small cylindrical fibres whilst 17 consists of two-dimensional ribbon-like structures. 
The present study compares the structure and porosity of methylmethacrylate polymers 
templated with the two different gelators.  
 
4.2 Sample preparation 
Gels are formed by heating a set amount of gelator (0, 1, 5, 10 or 20 % w/v) in 1 ml of 1:1 
MMA:EGDMA in a sealed vial to give a clear solution. A high concentration of cross-linker 
was chosen to minimise rearrangement upon washing.
128
 Gelation occurs rapidly upon 
cooling to room temperature. Samples were initially prepared using 1,1′-azobis(cyclohexane 
carbonitrile) as a polymerisation initiator. This initiator is thermally sensitive so has to be 
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diffused into the gel once formed. This is achieved by layering a concentrated solution of the 
initiator on top of a preformed gel and allowing it to diffuse for 18 hours. Later samples used 
a blend of diphenyl(2, 4, 6-trimethylbenzyl)phosphine oxide and 2-hydroxy-2-
methylpropiophenone as the initiator which is thermally stable and can be heated along with 
the gelator ensuring a more even distribution of initiator.  
 
Polymerisation was induced by irradiating the samples with UV light for a further 24 hours. 
The gelator was then removed by washing the samples with hot methanol in a Soxhlet 
apparatus for up to three days. Removal of the gelator was confirmed by both chemical 
analysis which showed no nitrogen in the washed samples, and by NMR spectroscopy of the 
solvent from polymer samples immersed in DMSO-d6 which showed no signals 
corresponding to gelator. Samples were dried under vacuum to remove residual solvent.  
 
The transparency of the gels and corresponding polymers decreases with increasing gelator 
concentration and there is a further increase in the opacity of the polymers following 
washing. The polymers templated by 20 allow more light to pass through than those formed 
with the corresponding concentration of 17. Samples of the polymers were prepared for SEM 
by shattering the brittle polymers and attaching the fragments to carbon tape mounted on 
silicon wafers. The samples were placed under high vacuum and coated with 5 nm of 
platinum prior to imaging. 
 
4.3 SEM Studies 
Electron microscopy images of xerogels of 17 formed from the un-polymerised 1:1 
MMA:EGDMA gel samples revealed ribbon-like structures (Figure 71). The ribbons appear 
to have a consistent thickness of ~25 nm, but exhibit considerable variation in the width 
ranging from hundreds of nanometres to several micrometres. In contrast, SEM images of 20 
prepared in the same way indicate a tangled network of one-dimensional fibrous strands. The 
diameter of individual fibres is relatively uniform (~50 nm) though they are often tangled 
together into larger bunches. A helical twist is evident in some fibres indicating they may be 
composed of smaller fibrils twisted together. Increasing the concentration of gelator has little 
effect on the dimensions of the fibres. The difference in morphology between the two 
gelators is thought to be due to differences in the underlying packing of the molecules in the 
gel, as discussed in Chapter 2.  
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Figure 71 SEM images showing xerogels formed from 1:1 MMA:EDGMA with a) 5 % w/v 17 b) 20 % w/v 17  
c) 2 % w/v 20 d) 5 % w/v 20 
 
Evidence of the gel fibres could be seen in the unwashed gel-polymer composites, 
particularly of 2 where ribbons protruding from, and running along the surface of the polymer 
can be clearly seen. Some contraction of the polymer or gelator appears to have taken place 
with gaps between the gel ribbons and surrounding polymers evident. Less direct evidence of 
the fibres of 5 were observed in the composites, possibly due to their smaller size making 
them difficult to distinguish from the polymer surface. 
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Figure 72 Unwashed polymer composed of 1:1 PMMA:EGDMA formed with (a and b) 10 % w/v 17, (c and d) 
5 % w/v 20 
 
Washing the polymerised gels with methanol to remove the gelator produced polymers with a 
variety of features consistent with the imprinting of gel fibres. Gelator 17 left slits and 
ribbon-like grooves in the polymer surface with dimensions consistent with those seen for the 
xerogels. These features tend to be in isolated patches at lower concentrations whilst at high 
concentrations less well defined, macro-porous materials are formed. Polymers formed by 20 
showed fibre-like imprints and cylindrical pores, again consistent with the gel morphology. 
The shape of individual pores tends to be poorly defined, presumably due to bunching of 
fibres and differences in the angle at which the fibre intersects the surface.  
 
a)                             c) 
 
 
 
 
 
 
 
 
 
 
b)                             d) 
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Figure 73 SEM images of nano-porous polymers formed by a) 1 % w/v 17, b) 1 % w/v 20, c) 5 % w/v 17, d) 5 
% w/v 20, e) 5 % w/v 17, f) 10 % w/v 20, g) 20 % w/v 17, h) 20 % w/v 20. 
a)                                                b) 
 
 
 
 
 
 
 
 
c)                                    d) 
 
 
 
 
 
 
 
 
e)                                    f) 
 
 
 
 
 
 
 
g)                             h) 
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Interestingly, for polymers formed by both 17 and 20 the porous features are not evenly 
distributed throughout the sample (see Figure 73e and f) but tend to be bunched together, 
separated by patches of smooth polymer. In some cases the direction of the fibres appears to 
have been aligned. This presumably reflects bunching and entanglement of the fibres in the 
gel phase. This inhomogeneity and aligning is often seen in SEM images of collapsed 
xerogels and their presence in the polymers indicates that this is a real property of the gels 
rather than a result of the drying process. 
 
  
Figure 74 Optical microscopy images showing different faces of polymer sample a) rough face, b) smooth face 
 
In general the polymers proved relatively inhomogeneous with different fragments displaying 
a variety of different surface textures, some of which contain no evidence of imprinting. It is 
thought that the smooth fragments represent portions of the polymer resting against the glass 
sides of the vial or at the gel surface, as observed by optical microscopy in Figure 74. 1:1 
PMMA:EGDMA reference samples, formed using the same processes but without gelator, 
showed a number of different textured surfaces and occasional holes (Figure 75). However, 
none of the features described for any of the imprinted polymers were observed in the 
reference samples. 
 
 
Figure 75 SEM images of control polymer formed from 1:1 MMA:EGDMA without gelator 
 
a)                           b) 
  128 
4.4 Imprinted Polymer Gas Porosity Measurements 
The porosity of samples of polymers with 1, 5 and 10 % w/v 17 or 20 was measured by gas 
adsorption studies which confirmed the formation of microporous structures by both gelators. 
Results are summarised in Table 9 and the isotherms are shown in Figure 76. Densities were 
measured by gas pycnometry and found to be approximately constant across all samples 
ranging between 1.22-1.28 g/cm
3
. No correlation between density and concentration of 
gelator was observed indicating an open pore structure.  
 
Table 9 Summary of nitrogen gas adsorption data for washed polymers templated with various concentrations 
of compounds 17 and 20.  
 Composition of gelator template 
Gelator 17 20 
Concentration  1 % w/v 5 % w/v 10 % w/v 1 % w/v 5 % w/v 10 % w/v 
Density (g/cm3) 1.2675 ±0.0019 1.2816±0.0067 1.2605±0.0011 1.2695±0.0019 1.2233±0.0020 1.2458±0.0019 
BET Surface Area  
(m²/g) 
0.5425 
 ± 0.0074  
0.2487  
± 0.0099  
4.818  
± 0.027  
1.209  
±0.011  
12.974 
±0.049  
29.70  
±0.14  
BET constant, C: 66.58 31.32 80.87 70.01 87.97 97.94 
Correlation Coefficient: 0.9992 0.9935 0.9998 0.9996 0.9999 0.9999 
BJH average pore  
diameter  (nm) 
17.10 36.03 22.94 8.66 8.71 8.84 
 
BET surface area measurements show the polymers produced by 17 have substantially lower 
surface areas (0.2-4.8 m
2
g
-1
) than those templated by 20 (1.2-30.0 m
2
g
-1
). It is worth noting 
that whilst the absolute surface areas for both polymer types are low compared to materials 
such as charcoal (400 m
2
g
-1
)
220
 or zeolites (50-1250 m
2
g
-1
),
221
 this is unsurprising given the 
low porosity of the materials (<10%). The surface areas are high when compared with 
polyHIPEs (3 m
2
g
-1
, 74% nominal porosity)
222
 which have micron sized pores and porosities 
of >74%. The surface areas increase with the concentration of 20 as expected. The trend is 
less clear for polymers of 17 with the 5 % w/v sample showing an unexpectedly low surface 
area compared to the other samples.  
 
The BET constant, C, is related exponentially to the enthalpy of adsorption in the first 
adsorbed layer and provides an indication of the magnitude of the adsorbant-adsorbate 
interaction.
223
 High C-values (~100) are associated with a sharp knee in the low pressure 
region allowing the precise pressure at which monolayer formation is complete to be 
determined. If the C-value is low (typically less than 20), a specific plateau cannot be 
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determined whilst C-values greater than 200 typically indicate microporosity. The C-values 
obtained for the polymers templated by 20 have values in the range 70-98 which provide a 
good fit to the BET model. The 17 series has comparatively low C-values (31-80), but is still 
large enough to allow a good fit to be made, as reinforced by the strong correlation 
coefficients. As the polymer is the same in each case, and the C-values are obtained in the 
low pressure region of the isotherm so will be unaffected by pore size and shape, it is difficult 
to explain the extent of variation in C-value between samples. The variation may indicate 
incomplete removal of gelator or differences in cross-linker efficiency. However, as the BET 
model does not account for surface energies and the correlation coefficients indicate a good 
fit to the model, this variation is not thought to have broader implications.    
 
Gas adsorption isotherms have been classified based on empirical observations about the 
shape of isotherms and hysteresis loops obtained from different materials.
223
 Both series of 
materials show type IV isotherms with characteristic hysteresis loops associated with 
condensation taking place in mesopores. The series of gels templated with 20 reach a plateau 
at high pressure and show hysteresis over a broad pressure range. The hysteresis loop shape 
matches that of an H2 material which is characteristic of relatively disordered porous 
material. 
223
 The sudden increase in the gradient of the desorption curve at relative pressures 
of 0.4-0.5 is attributed to the phenomena of forced closing and indicates channels of varying 
diameter. Other ‘kinks’ in the curves are thought to represent inhomogeneity either in the 
surface chemistry or pore structure. The sudden increase in adsorption at high pressure in the 
1 % w/v 20 sample was also observed when the measurements were repeated.  
 
In polymers templated by 17 a plateau is rapidly reached at low pressures associated with 
completion of the nitrogen monolayer. This is followed by the unrestricted adsorption of 
nitrogen at higher pressures with no saturation occurring. The hysteresis loop shape matches 
that of a H3 type material which is characteristic of materials with narrow, slit-like pores such 
as those which are observed when plate-like materials agglomerate.
223
 No forced closing is 
seen at 0.4-0.45 relative pressure which indicates a consistent pore diameter. 
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Figure 76 BET isotherms showing adsorption (blue) desorption (red) curves for washed polymer samples 
formed from a) 1 % w/v 17 b) 1 % w/v 20 c) 5 % w/v 17 d) 5 % w/v 20 e) 10 % w/v 17 f) 10 % w/v 20 
 
4.5 Pore size distribution 
The pressure at which an adsorptive will spontaneously condense (and evaporate) in a 
cylindrical pore size can be calculated using the Kelvin equation. However, condensation 
occurs in pores that already have multilayers on the walls. The pore size distribution is 
therefore calculated using the BJH model which modifies the Kelvin equation to take this into 
account.
224
 The average pore diameters for the templated polymers are given in Table 9 and 
the pore size distribution is shown in Figure 77 and Figure 78. The data for the 20 series is 
calculated from the adsorption curves to avoid complications due to forced closing in the 
a)                              b) 
c)                              d) 
e)                              f) 
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desorption isotherms.
224
 Pore diameter is shown plotted against pore volume. Plots of pore 
diameter against pore surface area show the same patterns but with the distributions skewed 
slightly towards lower pore diameters. 
   
 
Figure 77 Pore size distribution calculated from the adsorption isotherm measured for washed polymer samples 
templated with 20: 1 % w/v (blue), 5 % w/v (red), 10 % w/v (green), 
 
The average pore diameter is 8-9 nm in polymers templated with 20 and there is a narrow 
distribution of pore sizes centred around the average. The pore volume increases with the 
concentration of gelator and the range of pore diameters increases from an upper limit of 25 
nm in the 1 % w/v sample to around 80 nm in the 10 % w/v sample. This is consistent with 
the observation by SEM that the size of the fibrils stays approximately constant but with 
increased bunching at higher concentrations of gelator. However, the average pore size is 
smaller than might be expected based upon the SEM images and indicates that in solution 
individual fibrils are less aggregated than they appear in the dried xerogel images.  
 
The average pore size is slightly larger in the 17 templated series, ranging between 19-36 nm, 
and there is a much broader pore size distribution pattern (Figure 78). The shape of the 
distribution for 5 % w/v 17 is poorly defined and with lower pore volume than for the 
samples formed with both higher and lower concentrations of gelator. The 1 % w/v data 
sample ranges in pore size up to 80 nm increasing to 120 nm for the 10 % w/v sample. This 
greater range in pore diameters reflects the broad range of ribbon widths observed by SEM. 
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Further experiments will be undertaken by Dr. David Johnson using mercury porosimetry to 
examine the macroporosity of these materials. 
 
 
Figure 78 Pore size distribution calculated from the desorption isotherm measured for washed polymer samples 
templated with 2: 1 % w/v (blue), 5 % w/v (red), 10 % w/v (green), 
 
4.6 Conclusion 
By making small changes to the molecular structure of a LMWG and hence gel morphology, 
polymeric materials with very different pore shapes, sizes and adsorption characteristics can 
be created. The entangled networks of cylindrical fibres observed in xerogels of 20 produce 
polymers with corresponding circular pores and fibrous imprints. Gas adsorption 
measurements are indicative of a mesoporous material with a random pore structure.  The 
pores formed by 20 have a relatively well defined average pore diameter of 8-9 nm and the 
total volume increases linearly with the concentration of gelator. In contrast the larger ribbon-
like xerogels of 17 give polymers with slit shaped pores and a gas adsorption profile 
indicative of plate-like aggregates. The average pore diameter is larger and there is a broader 
pore size distribution reflecting the variable width of the ribbons of 17. Supramolecular gels 
provide a ready means of creating porous polymers with very different architectures and 
properties which can be tuned by varying the concentration of template. 
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4.7 Experimental Section 
All solvents and reagents were obtained from standard commercial sources and used without 
further purification. Details for the preparation of compounds 17 and 20 are provided in the 
experimental section of Chapter 2. Elemental analysis of the polymers was performed using 
an Exeter Analytical inc. CE-400 Elemental Analyser and NMR experiments using a Varian 
Mercury-400 (400 MHz for 1H). 
 
4.7.1 Preparation of polymers 
Method 1 
0, 5, 25, 50 and 100 mgs of gelators 17 and 20 were weighed into separate 2 ml screw top 
glass vials. 0.5 ml of a 1:1 by weight methylmethacrylate (MMA): ethylene glycol 
dimethacrylate (EDGMA) (Aldrich refs) stock solution was added to each vial. The sealed 
sample was heated until the gelator was fully dissolved and gelation took place rapidly upon 
cooling. 0.05 ml of a 1:1 MMA:EDGMA solution containing 5 mg (1 % w/v) of  1,1’-
azobis(cyclohexane carbonitrile) was layered on top of the sample and allowed to diffuse 
overnight. The samples were irradiated with 254 nm UV radiation using a UVGL-58 
handheld UV lamp for 48 hours at a distance of 5 cm. The samples were washed with hot 
methanol in a soxhlet for 36 hours. The samples were dried overnight under vacuum in a 
desiccator. CHN analysis of the polymers showed no nitrogen was present in the polymers 
indicating removal of the gelator.  
 
Method 2 
0, 10, 20, 100 and 200 mgs of gelators 17 and 20 were weighed into separate 10 screw top 
glass vials. To each vial was added 2 ml of a 1:1 by weight MMA:EDGMA stock solution 
containing 1 % w/v blend of diphenyl(2, 4, 6-trimethylbenzyl)phosphine oxide and 2-
hydroxy-2-methylpropiophenone (Aldrich 405663). The sealed sample was heated until the 
gelator was fully dissolved then rapidly cooled and sonicated to ensure homogeneous gel 
formation. The samples were irradiated with 254 nm UV radiation using a UVGL-58 
handheld UV lamp for 48 hours at a distance of 5 cm. The samples were washed with hot 
methanol in a soxhlet for at least 72 hours. The samples were dried overnight under vacuum 
in a desiccator. CHN analysis of the polymers showed no nitrogen was present in the 
polymers indicating removal of the gelator. Suspension of samples of the polymer in d6-
DMSO showed no indication of gelator by NMR spectroscopy.  
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4.7.2 Scanning electron microscopy 
Samples were applied directly to silicon wafer chips (Agar Scientific) using a cocktail stick 
for gels or a pipette for liquids. Solid samples of polymer were stuck onto the wafers using 
carbon conductive adhesive tape. Samples were stored under vacuum at 1x10
-5 
mbar then 
sputter coated with 5nm platinum in a Cressington 328 coating unit, at 40 mA (density 21.09 
and tooling set at 1) with rotation and a 30
0
 angle of tilt. Samples were imaged using a 
Hitachi S-5200 field emission scanning electron microscope at 1.5 kV. 
 
4.7.3 Gas pycnometry 
The sample density was measured using an AccuPyc II Micromeitics He pycnometer. The 
material was then weighed (0.8-1.5 g) into the sample cup (10 cm
3
) and placed in the 
instrument.  The sample was then allowed to reach thermal equilibrium with the instrument 
for 5 to 10 min.  The material was then purged 20 times (He(g), 19.5000 psig).  The material 
was then placed under pressure (He(g), 19.5000 psig) and the volume measurements taken 
once an equilibrium pressure was reached (0.0050 psi min
-1
).  The final density measurement 
is taken as an average of the 20 repeats and reported with a standard deviation. 
 
4.7.4 Gas adsorption isotherms 
The sample was added to a sample tube (1 inch diameter) and then degassed on the 
instrument (20
o
C) until a constant pressure was reached.  The sample was then weighed (0.8-
1.5 g) into the sample tube which was then fitted with a filler rod and isothermal jacket.  
Nitrogen sorption was then measured under isothermal conditions (77 K) between P/P0  of 
0.0500 to 0.9990 and desorption between 0.999 and 0.140. 
 
BET and Langmuir plots were obtained from measurements at 0.050< P/P0 <0.2500; BJH 
adsorption and desorption plots were obtained at 0.1400< P/P0 <0.990. Pore size distributions 
were obtained using the Faas modified BJH model with a Halsey thickness curve used for the 
20 series and the Harkins Jura thickness curve used for the 17 series. 
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Chapter 5: Supramolecular gels: a new medium for crystallisation 
5.1 Introduction 
Gel media have been utilized for over a century for the growth of inorganic, organic and 
protein crystals.
148-150, 157, 162, 225, 226
 The improved physical characteristics of the resulting 
crystals (better optical quality, larger size and fewer defects) are usually ascribed to the 
suppression of convection currents, sedimentation and nucleation afforded by the viscous gel 
environment.
147, 164 
The majority of crystal growth in gels to date has focused on inorganic 
systems grown from aqueous gels. In many instances the gel is thought to act as an inert 
matrix within which crystal growth occurs, however in some recent cases, the gel structure 
has been shown to influence the polymorphism,
154
 enantiomorphism
164
 and habit of 
crystals.
157
 Occasionally, gel fibres may become incorporated into the crystals, giving rise to 
composite materials.
227
 
 
Conventional gels are formed using polymeric or clay-like materials such as gelatine, 
agarose, polyacrylamide or silica.
150, 228
 More recently, a new class of low molecular weight 
gelators (LMWGs) has emerged which self assemble into supramolecular networks capable 
of forming gels.
24, 25, 60, 62, 229-231
 The supramolecular nature of such systems gives them a 
potential inherent advantage in that their formation is readily reversible. This sol-gel 
transition can be triggered in response to a range of stimuli such as changes in temperature, 
pH, sonication, irradiation with light or, as in the present work, addition of a chemical trigger 
in the form of anions.
62, 72, 85, 87, 100, 186, 214, 232, 233
 Moreover, the chemically diverse nature of 
supramolecular gels means that almost any solvent can be gelled. A broad range of chemical 
species have been shown to form gels including surfactants, sugars, fatty acids, amino acids, 
bis(ureas), and many others, in a variety of solvent systems.
24, 62
 However, the potential of 
LMWGs as a medium for crystal growth remains largely unexplored,
165-167
 with the exception 
of some elegant work on the use of LMWGs for the growth of calcium carbonate
25
 and other 
inorganic minerals
169
, as part of studies on biomineralisation.  
 
The reversible nature of supramolecular gels can be utilized to allow easy recovery of crystals 
whilst the diverse array of chemical functionalities that can be introduced allows for tuning of 
interactions between the gel and growing crystal. LMWGs are generally readily synthesised, 
so depending on the system, are relatively inexpensive, particularly if required on a large 
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scale. This investigation aims to show proof of principle for the growth and recovery of 
organic crystals from anion-triggered supramolecular gels, and to explore the potential of this 
medium for influencing crystal growth, particularly in active pharmaceutical ingredients 
(APIs) for which crystal habit and polymorphism is a key economic and formulation 
problem.
234, 235
  
 
5.2 Development of Methodology 
As well as opportunities, the gel phase poses a number of additional challenges to the growth, 
recovery and characterisation of crystals compared with solution. With little precedent for the 
growth of organic molecules from supramolecular gels, a brief outline explaining the 
reasoning behind the approach taken will be provided in the following section. More specific 
problems and adaptations encountered will be detailed along with specific experiments in 
subsequent sections (5.3 and 5.4) and in Chapters 6 and 7. 
 
5.2.1 Gelators 
Most common polymeric and clay based gelators used for crystallisation are hydrogelators 
and the majority of studies involve the crystallisation of inorganic salts from aqueous gels. 
Many pharmaceutical compounds are relatively hydrophobic in order to permeate cell 
membranes and can be poorly soluble in water. Crystallisation studies of pharmaceutical 
compounds typically involve using a wide range of solvents in order to access as many 
different polymorphs as possible. Pharmaceutical compounds contain a wide variety of 
functional groups which must not disrupt the supramolecular interactions required for gel 
formation. The opacity of gels varies from clear to opaque and identifying whether 
crystallisation has taken place in an opaque gel is more difficult than in a transparent one.  
Sonication, which can encourage homogeneous gelation for this class of gelator, would also 
affect the crystallisation of the compounds so was deemed unsuitable for use in gel phase 
crystallisation. The ideal gelator will therefore reliably form robust, transparent gels without 
sonication in a wide variety of solvents in the presence of a wide range of chemical 
functionalities.  
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[a]
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37  G
[a]
 G
[a]
 G
[a]
 G G G G   G
[b]
    
38           G G G G 
14  G
[c]
          
 
  
Table 10 showing gel formation, G, by compounds 20, 37, 38 and 14 in various solvents. [a]
 
Gels formed upon 
addition of varying amounts of H2O [b] Gel formed in toluene/DMSO mixtures [c] in presence of 0.5 eq. CuBr2 
or CuCl2. 
 
Preliminary experiments were carried out in order to assess the gelators in terms of the 
robustness and reliability of gel formation, which solvents they formed gels in, at what 
concentrations and the opacity of the resultant gels.  Early studies used number of gelators 
previously developed within the group by myself (20) and others (37,
52
 38,
63
 14
71
). Gelators 
20, 37 and 38 were chosen because they reliably form gels in a number of solvents ranging 
from aqueous systems to toluene, whilst 14 is a metallogelator which forms blue coloured 
gels with substoichiometric amounts of CuCl2 in methanol.
19
 Between them the gelators are 
able to gel a range of solvents (Table 10), at different temperatures (Tgel), and with a different 
critical gelator concentration (CGC). This class of compound has the potential to form the 
basis of a library of gelators which will allow the selection of gel properties and specific 
functionalities to match the compound and crystallisation conditions of interest.  
5.2.2 Reversibility 
The viscous nature of the gel state means the use of solution phase techniques, such as 
filtration, to recover crystals are difficult therefore mechanical means are generally used to 
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separate individual crystals from polymeric gels. Whilst this is possible for large single 
crystals, it is inconvenient for microcrystalline samples or large scale experiments. The 
supramolecular nature of LMWGs means that they can readily be dissolved, potentially 
allowing for recovery of crystals by solution phase techniques such as filtration. LMWGs 
have been developed which respond to a wide range of stimuli.
62, 72, 85, 87, 100, 186, 214, 232, 233
 The 
use of anions as a means of bringing about dissolution of supramolecular gels has been 
developed within the Steed group and by others.
19, 178
 The presence of anions has been shown 
to disrupt the urea tape hydrogen bonding motifs which are central to the formation of the one 
dimensional fibres which give rise to the gel state (Figure 79). 
 
 
Figure 79 a) urea tape hydrogen bonding motif which gives rise to long fibres b) hydrogen bonding motif 
adopted by ureas in the presence of anions resulting in breakdown of gel fibres.  
 
Preliminary studies using gelator 20 mirrored findings from more detailed studies
52
 on similar 
compounds which showed tetrabutylammonium (TBA) acetate have the most pronounced 
effect on gel strength. Other anions such as HSO4
-
 and F
- 
have much less effect, even at 
higher concentrations. The choice of solvent is a key limiting factor in the use of anions to 
disrupt gelation. In apolar solvents such as toluene the anions would not dissolve whilst in 
aqueous solutions solvation of the anions prevented disruption of the urea motifs. Mixtures of 
solvents such as 1:9 CH3CN:toluene or 1:9 CHCl3:toluene proved ideal compromises 
providing apolar environments where anion-urea interactions were strong whilst allowing 
sufficient anion to dissolve (Figure 80). 
 
Figure 80 Images showing the effect of the addition of one equivalent of TBA-acetate in 500 μl of acetonitrile 
on a gel of 1 % w/v 20 in 4 ml of toluene over a period of 10minutes.  
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In Chapter 3, rheometric studies examining the breakdown of 1 % w/v gels of 20 in 1:9 
acetonitrile:toluene and ethylacetate found 1.5 and 0.8 equivalents of acetate were required to 
disrupt gel formation. However, in these experiments the gels are formed from hot solutions 
in the presence of increasing concentrations of anion. For the purposes of recovering crystals 
from the gels, the anions must be added to the pre-formed gel structure. This presents a 
kinetic barrier to the anions interacting with the urea groups which may be buried in the 
centre of large fibres with sterically inhibiting or hydrophibic end groups. It is also desirable 
not simply to break down the gel structure, but to fully dissolve the gel matrix which the 
fluorescence studies in Chapter 3 show can take as many as 10 equivalents of anion in 
acetonitrile:toluene mixtures. The anions can be added either as a solid on top of the gel, or as 
a solution dissolved in a suitable solvent such as acetonitrile or chloroform.   
 
5.2.3 Crystal growth 
Crystallisation can be achieved using a variety of approaches including fast and slow cooling, 
evaporation of solvent, addition of anti-solvent, vapour diffusion, sublimation, grinding and 
crystallisation from the melt. Evaporation is unsuitable for gel phase crystal growth as are 
non-solvent based methods. Preliminary investigations using non-drug compounds were 
undertaken into the use of layering or vapour diffusion of an antisolvent to induce 
crystallisation. For example, 0.5 ml of cyclohexane layered on top of a 1 % w/v gel of 20 in 
toluene containing 1 % w/v of 2-hydroxybenzylalcohol (2HBA) induced crystallisation of 
2HBA without disruption of the gel. The same result was also observed in a gel of the same 
composition sealed inside a larger vial containing a small amount of cyclohexane. However, 
the presence of a second solvent was an additional complication and the slower rates of 
crystal growth of little advantage to the already slow rates of crystallisation from the gels. 
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Table 11 Crystallisation of organic molecules from 1 % w/v gels of compound 20 and 38 in various solvents. 
Compound Gelator Solvent Control Gel Cryst 
i) 2-methoxybenzaldehyde 
 
 
 
 
 
 
20 
DMSO:H2O S P - 
EtAc S G        - 
[b]
 
Toluene S G - 
38 
Et2O  PG C
[a]
 
Hexane  G C
[a]
 
Cyclohexane  PG - 
Toluene S G  
ii) Triphenylamine 
 
 
 
 
 
 
 
20 
DMSO:H2O S G        - 
[b]
 
EtAc S G - 
Toluene S G - 
38 
Et2O  G - 
Hexane  G - 
Cyclohexane  PG C
[a]
 
Toluene S G C
[a]
 
iii) Biphenyl-2-methanol 
 
 
 
 
 
 
20 
DMSO:H2O S G - 
EtAc S G - 
Toluene S G - 
38 
Et2O  G C
[a]
 
Hexane  PG - 
Cyclohexane  G C
[a]
 
Toluene S G C
[a]
 
iv) 2-hydroxybenzyl alcohol 
      
            
 
 
 
        
20 
DMSO:H2O S G C
[a]
 
EtAc S G C 
Toluene C G C 
38 
Et2O  G       - 
[b]
 
Hexane  P C 
Cyclohexane  P C 
Toluene C P C 
v) Napthylamine 
 
20 
DMSO:H2O  P - 
EtAc  G - 
Toluene C P - 
38 
Et2O  PG C 
Hexane  G C
[a]
 
Cyclohexane  PG - 
Toluene C G - 
G= gel formation, PG= partial gelation, P= precipitation, S= solution, C= crystal, [a] crystal growth on bottom 
of the vial [b] opaque gel- no crystals observed 
 
Cooling induced supersaturation was identified as the best method for bringing about 
crystallisation. All of the gels used are thermally reversible and form rapidly upon cooling 
from a hot solution. Initially the approach was to weigh both the compound (1-5 % w/v) and 
the gelator (0.1-1 % w/v) into the same vial, add solvent and heat until complete dissolution 
was observed. Upon cooling the gels form rapidly over a period of minutes and the crystals 
OH
OH
OMe
CHO
N
Phe
Phe
Phe
OH
Phe
NH
2
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grow slowly over a period of hours to weeks. This approach has the advantages that 
individual samples are quick to prepare and the technique requires little knowledge of the 
compound’s solubility. However, the problem with this approach is that solubility varies 
considerably between different compounds and solvents. The ‘hit’ rate for achieving good 
crystallisation conditions is therefore very low with too much compound not fully dissolving 
upon heating and too little compound remaining in solution upon cooling. In a preliminary 
study (Table 10) the concentration was set at 10 mg/ml across six different solvents and five 
compounds. Crystallisation was observed in only ten out of the seventy samples with all the 
hits corresponding to just two of the compounds investigated: 2-hydroxbenzyl alcohol and 
napthylamine.  
 
A second approach was developed which was used in the screen of pharmaceutical 
compounds described in section 5.4. An appropriate degree of supersaturation for each 
sample was achieved empirically by gradually adjusting the ratio of compound and solvent 
until the desired rate of crystallisation was achieved. The optimised hot solution was then 
added to the pre-weighed gel in a vial before everything was reheated and cooled to form the 
gel. This process ensured crystallisation was observed in the majority of samples (76/80).  
 
A final approach to generating saturated solutions is to slurry the compound in a particular 
solvent at a set temperature (e.g. 60°C), then to perform a hot filtration to remove any un-
dissolved material. This approach requires less manual adjustment but proved more time 
consuming and inefficient for producing lots of different small-scale samples. The use of 
specialist slurrying and filtration equipment overcame these problems during the studies 
conducted at GSK (Chapter 7).  
 
The rate of cooling is one variable which was not well controlled during these experiments. 
High temperatures (>150°C) are often required to fully dissolve the gelators and large 
variations in dissolution temperatures exist between different compounds, gelators and 
solvent systems. Studies were undertaken at GSK using specialist temperature controlled 
crystallisation equipment. However, the limited heating range (≤140°C) was insufficient to 
fully dissolve the gelator in all solvents and the slow cooling rates (≥5 °C min-1) were 
detrimental to gel formation. This equipment was also unavailable in the Steed lab making it 
impractical for the majority of studies. Heating was therefore carried out to an arbitrary 
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temperature using a heat gun with the mixture being heated and sonicated as required to 
ensure complete dissolution.  The samples were then removed from the heat and allowed to 
cool to room temperature on the bench with gels forming over a period of minutes and 
crystallisation first observed after several hours or days. Although it is not possible to observe 
the time or temperature at which the nm-size critical nuclei form, it is likely given the high 
Tgel of many of the gelators used that nucleation takes place once the gels have formed. As 
the polymorph obtained is locked in at the nucleation stage, controlling nucleation via 
supersaturation of the system, as well gel fibre chemistry, is likely to be key in selectively 
crystallising a particular polymorph. 
 
5.2.4 Crystal characterisation 
After growing crystals in the gels, the crystal habit and form were identified in order to 
understand the effect of the gel media on crystal growth. Where the transparency of the gel 
allowed, a photographic record of shape and position of the crystal was made along with a 
detailed description. Observations about the habit of crystals from opaque gels were made 
once the crystals had been extracted. These observations were later simplified to broad 
categories (block/plate/needle etc.) as records of subtler variations between samples were 
found to add little value due to their complexity.  
 
The presence of gelator in the sample vial can complicate the characterisation of compounds. 
Adding anions to dissolve the gel allows crystals to be filtered and washed, separating the 
gelator (as well as solvent and anions) from the compound. However, recovery by this 
method can only be used in a limited range of solvents and in some cases the addition of 
anions resulted in the dissolution of the crystals. It was therefore necessary to identify crystal 
forms in the presence of the gelator. In cases where the crystals were large or clumped 
together they could be isolated from the gel by hand using a spatula. Where crystals were 
more dispersed, the whole gel-sample was filtered and submitted for analysis.  The typically 
low concentrations of gel compared to product, and low crystallinity of the gel fibres, meant 
that identifying crystal forms by XRPD was generally unproblematic provided there was 
sufficient sample for analysis. IR spectra were more affected by the presence of the gels with 
the additional component making the fingerprint region difficult to interpret. This was not a 
problem for compounds where there are characteristic bands for particular polymorphs which 
do not overlap with those of the gelator. Determination of unit cells from representative 
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single crystals also proved a useful method for identifying crystal form. During studies at 
GSK, in situ characterisation of the crystals inside the gels was possible by Raman 
spectroscopy as discussed in Chapter 7.  
 
Because sedimentation is prevented in gels, crystal growth occurs in the environment in 
which the crystal nucleates. In some cases crystal growth occurred in the centre of gels, but 
often it occurred either at the gel surface or from the walls of the vials. Care was taken to 
preserve as much detail about individual crystallisation events as possible although each 
sample was unique and it was not always possible to establish trends. In a number of cases, 
concomitant crystallisation of more than one form occurred in the same gel. Where possible, 
crystals with clearly different habits were isolated separately and tested for polymorphism 
using the techniques described above. It should be noted that the effects of solvent and gel 
environment on the rate of growth of different faces mean crystals of the same polymorph 
may have very different crystal habits or those of different forms have similar ones. 
Assignment of crystal forms on the basis of morphology alone is therefore unreliable and 
should be used in conjunction with other characterisation techniques such as XRPD, IR or 
XRD. 
5.3 Proof of principle for crystal growth in LMWGs 
5.3.1 The polymorphism of carbamazepine 
Carbamazepine (CBZ), an anticonvulsant, serves as a model compound for many groups 
engaged in the study of crystal polymorphism.
236-241
 There are four known polymorphs of 
CBZ as well as a dihydrate, several solvates and a number of co-crystals. Recently the fourth 
form was grown using a polymer heteronucleus
237, 242
 and a fifth form using seed crystals of 
the closely related 10,11-dihydrocarbamazepine (DHC) form II.
243
 There is some confusion 
across the literature over the nomenclature of these forms as summarised by Grzesiak et al.
236
 
Details of the forms relevant to this report are shown in Table 12. The well-defined crystal 
habits of different common polymorphs of carbamazepine, block shaped form III and needle 
shaped form II, make it an ideal system to study as initial characterisation can be made from 
the morphology.  
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Carbamazepine 
(CBZ) 
 
 
 
Table 12 Solvent-free polymorphs and selected solvated forms of CBZ. 
Form Space group Habit Stability 
order  
Crystallisation method 
I Triclinic,     Needle 2 Melt 
 II Trigonal,     Needle 5 Rapid cooling (5ºC) from EtOH 
III Monoclinic P21/c Block 1 Slow cooling (25ºC) from EtOH 
 
IV Monoclinic C2/c Prism 4 Heteronucleation  
 
V Orthohrombic Pbca Plate 3 Heteronucleation  
 
Dihydrate 
 
Monoclinic P21/c Needle n/a Recrystallisation from wet ethanol  
Acetone/ DMSO 
solvate 
Triclinic,     n/a n/a Evaporation from solvent 
     
 
 
    
5.3.2 The effect of gelator 1 on the crystallisation behaviour of CBZ 
The crystallisation behaviour of carbamazepine was investigated from gels of 20 in various 
solvents and at a range of different concentrations and was compared with crystallisation 
from solution and other gels. Preliminary investigations indicated little disruption of gels of 
20 in the presence of even high concentrations of CBZ and large crystals grew readily in 
some of the samples. A systematic investigation into the polymorphic behaviour of CBZ 
when crystallised from various solutions and gels of 20 at different concentrations is reported 
in Table 13.  
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Table 13 Comparison of gel (1 % w/v 20) and solution phase crystallisation from various solvent systems at 
different concentrations of CBZ 
Solvent system and 
phase 
Concentration of CBZ mg/ml 
5 10 15 20 25 
1:9 
CH3CN:Tol 
G 
G G G G G 
- - - Blocks Blocks 
S - - Blocks Blocks Blocks 
1:9 
CHCl3:Tol 
G 
G G G PG PG 
- Blocks Blocks Blocks Blocks + Needles 
S - Blocks Blocks Needles + Blocks Blocks 
EtOAc 
G 
G G PG 
 
PG 
 
PG 
 - - Needle growth Needle growth Blocks 
S - - Needles + Blocks Needles Needles 
 
 
 
Figure 81 Photographs of 20mg CBZ crystallised from solutions then gels of 20. left to right: form II grown 
from ethylacetate solution then gel, form III grown from acetonitrile:toluene solution then gel,  hydrate grown 
from form DMSO:water solution and clumps of form I grown from DMSO:water gel.  
 
The toluene gels of 20 resulted in a mixture of needles of form II and blocks of form III. By 
adjusting the concentration of CBZ it proved possible to grow either form. Higher 
concentrations of CBZ result in needles of form II whilst lower concentrations produce 
blocks of form III. Varying the ratio of co-solvent to toluene had a similar effect with more 
CHCl3 requiring higher concentrations of CBZ to induce crystal growth and growth of form 
II. Conversion of form II to form III was observed in 1:9 v/v chloroform:toluene solutions 
and also more slowly in the corresponding gels. In 1:9 v/v acetonitrile:toluene mixtures, only 
Solvent system and 
phase 
Concentration of CBZ mg/ml 
10 20 30 40 50 
1:1 
DMSO:H2O 
G 
G G G G G 
- Block Clumps Clumps Opaque gel 
S - - Needles PG of needles G of needles 
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blocks of form III were observed with slightly higher concentrations of CBZ required to 
induce crystal growth in the gel samples of 20 (>20mg/ml) compared with solution 
(>15mg/ml). However, a repeat of this study showed a mixture of needles and blocks formed 
at higher concentrations (>25mg/ml) and no crystallisation was observed from either sample 
at 15 mg/ml of solvent. In ethylacetate gels of 20 form II was also produced with nucleation 
appearing to occur on the glass near the gel surface with crystals growing down into the gel 
(Figure 81). No evidence of conversion to form III was observed in the ethylacetate gel even 
after several months. 
 
TBA acetate can be used to breakdown each of the anhydrous gels of 20 without dissolving 
the carbamazepine crystals.  Figure 82 shows an example of the use of TBA-acetate, added as 
a solid, to recover a single large crystal of CBZ form III grown in a 1:9 CHCl3:toluene gel of 
20. In this example, disruption of the gel occurred over approximately 20 minutes with only 
small amounts of fibrous material remaining. The crystals were extracted by filtration and 
washed with hexane to remove any remaining gelator. No visible degradation to the 
carbamazepine crystal was evident.  
 
 
Figure 82 Recovery of a single crystal of CBZ form III by the addition of a spatula tip of TBA-acetate to a 1 % 
w/v gel of 20 in 1:9 CHCl3:toluene. 
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Figure 83 Comparison of crystals of CBZ obtained from 40 mg CBZ in a 1 % w/v 20 gel of  1:1 DMSO:H2O 
(top-blue) with calculated pattern for CBZ form 1, CSD ref CBMZPN13 (bottom-green).
244
 
 
In DMSO:water solution in the absence of gel, CBZ formed long, needle-like crystals (at 
concentrations of 40 g/ml) which were shown to be a mixture of carbamazepine dihydrate 
and form 3 by XRPD. At low CBZ concentrations no crystal growth was observed in the gels. 
However, at higher concentrations clumps of very fine crystals formed inside the gel of 20 
exhibiting a powder diffraction pattern corresponding to the relatively unusual CBZ form I 
(Figure 83). Form I is the high temperature form of CBZ and is normally produced from the 
melt at 170 ºC. It has also been shown that dehydration of the dihydrate can lead to form I 
under conditions of low humidity.
245
 However, IR spectroscopic experiments carried out on 
the wet samples confirmed that a pure form I rather than the dihydrate is formed in the gel 
phase. The formation of form I in the gel under the same conditions that give the dihydrate 
from solution is a surprising result and suggests that the LMWG can have a significant effect 
on crystal form.  
 
5.3.3 Comparing the effect of different gelators 
Parallel investigations were carried out by other people from the group into the crystallisation 
behaviour of CBZ in gels of compounds 37 and 38 and the results, along with those for 20, 
are summarised in Table 14. A number of interesting observations emerged from the study 
which give insights into crystallisation from supramolecular gels. Whilst needle shaped 
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crystals of form II grown from toluene solutions gradually convert to thermodynamically 
stable blocks of form III, needles produced in toluene gels of 38 remain as needles over many 
months. In contrast to ethylacetate gels of 20 where form II readily forms, ethyl acetate gels 
of 37 always give thermodynamic form III even at high concentrations of CBZ (>50mg/ml). 
Other forms of carbamazepine are also encountered. Acetone gels of 37 containing 50 mg of 
CBZ form the acetone solvate whilst parallel experiments in acetone solution did not produce 
any crystals.
246, 247
 In this case, the gel induces crystallisation at a lower level of super 
saturation than the level required for crystallisation from the pure solvent.  
 
Table 14 Crystallisation of CBZ in gels of 20, 37 and 38. 
Solvent
[a]
 Crystal forms in 
pure solvent
[b]
 
Crystal forms from 
gel 20
[b]
 
Crystal forms from 
gel 37
[b]
 
Crystal forms from 
gel 38
[b]
 
Toluene
[c]
 II and/or III II and/or III II and/or III II transform to III 
CH3CN:Toluene II and/or III II and/or III III n/a
[e] 
CHCl3:Toluene II and/or III II and/or III n/a
[f] 
II transform to III 
Ethyl Acetate II II III n/a
[e]
 
Acetone No crystals
[d]
 n/a
[e]
 Acetone solvate n/a
[e]
 
MeOH:H2O
[c]
 Dihydrate n/a
[e]
 Dihydrate n/a
[e]
 
DMSO:H2O
[c]
 Dihydrate I n/a
[e]
 n/a
[e]
 
[a] Crystallization performed at the same concentration, heating and cooling rates for samples of gel and pure 
solvent. [b] Gels of 20 and 38 are 1 % w/v whilst gels of 37 are 0.1 % w/v[c] Crystals could not be retrieved by 
dissolving the gel with anions [d] Crystallization of the acetone solvate structure occurs upon further super-
saturation by evaporation or addition of more CBZ [e] no gelation in this solvent. [f] CBZ retards gelation. 
 
One further result which provides a good illustration of the potential of this type of system for 
influencing the properties of growing crystals is a study carried out by Dr Marc Piepenbrock 
into the crystallisation of CBZ from hydrogels of metallogelator 14. The crystal form was 
found to be the hydrate in each case however clear differences in morphology were seen 
between crystals grown in the gel and solution phases. Moreover, by varying the 
concentration of copper ions in the gel (0.3-0.7 equivalents) it was possible to ‘tune’ the 
morphology of the crystals as shown in Figure 84.  
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Figure 84 Optical microscopy of CBZ (1 weight%) grown in (a) 1:1 MeOH:water solution, in metallogels of 14 
/ CuCl2 with (b) 0.4, (c) 0.5, (d) 0.7 equivalents of CuCl2. 
 
5.3.4 Monitoring gel drug interactions 
We sought to understand the interactions between gelator and drug molecule in order to 
monitor the influence of the drug on the gel structure and conversely the gel on the drug 
crystallisation. Rheological observations on toluene gels of 38 showed that carbamazepine 
had essentially no effect on the magnitude of the storage and loss moduli of the gel. However, 
in the presence of CBZ (1 % w/v) a marked increase by approximately one order of 
magnitude was observed in the yield stress.
170
 This effect is in direct contrast to anion binding 
by bis(urea) gels, in which the competition between anion binding and gelator self-
association results in marked anion-dependent decreases in gel strength and yield stress.
52
 
The gel-sol transition temperature was also found to be lowered by the presence of CBZ. 
170
  
 
Nuclear magnetic resonance spectroscopy (NMR) was used to probe this relationship further. 
NMR spectroscopic titration experiments showed only very weak apparent binding of CBZ to 
38 with log K11 = 0.84(8) in CDCl3 and a similar (albeit less precise) value in toluene above 
the Tgel at 70°C. Variable-temperature (VT) NMR spectroscopic experiments show that the 
gelator has a marked effect on the chemical shift of CBZ, which is probably linked to the 
disruption of CBZ dimer formation
236
 in solution (Figure 85). Because of its gelation ability, 
the host itself is also likely to undergo signiﬁcant self-association and hence the competition 
between both gelator and CBZ aggregation and gelator–CBZ binding results in a low overall 
apparent binding constant. It was therefore concluded that the increased yield stress may not 
be a result of speciﬁc binding of the CBZ to the gelator, but could arise from the physical 
support of the gel by solid CBZ crystals.  
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Figure 85 Variable temperature 
1
H NMR spectra 20 – 80oC in toluene (a) 0.5 % w/v CBZ, (b) mixture of 20 and 
CBZ and (c) 1 % w/v gelator 20 
 
5.4 Demonstrating the versatility of API crystal growth in LMWGs 
5.4.1 Methodology and objectives 
In addition to the more detailed study carried out into the polymorphism of carbamazepine 
under a wide range of gelators and concentrations, a broader study was undertaken to 
establish the scope of supramolecular gels as a medium for the crystallisation of 
pharmaceutical compounds. During preliminary investigations it was found that a number of 
compounds appeared to completely disrupt gel formation. If this technique is to be widely 
applicable for use in the pharmaceutical industry for the screening of drug compounds it 
needs to be shown to be broadly applicable to a variety of APIs.  
 
Compound 20 was selected for use in these studies as it reliably forms gels in a number of 
different solvent systems. Gel-phase and parallel solution phase crystallisations were carried 
out for the following pharmaceutical or related compounds: Piroxicam (PIX), Sulindac 
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(SUL), Indomethacin (IND), Sparfloxacin (SPF), Theophylline (THE), Caffeine (CAF), 
Acetaminophen (ACP) and Ibuprofen sodium salt (IBU). Experiments were carried out under 
empirically determined conditions designed to bring about crystallisation in the following 
solvents: 1:9 CH3CN:toluene, 1:9 CHCl3:toluene, ethyl acetate, 1:1 DMSO:H2O and 3:2 
MeOH:H2O. All of these solvent mixtures form thermoreversible gels with 20, and the first 
three can be broken down upon the addition of acetate anion. The substrates were chosen as 
commonly available drug substances or model bioactive compounds that represent a wide 
range of structures and functional group types and are either polymorphic, form hydrates or 
otherwise exhibit interesting crystal packing.  
 
 
 
An appropriate degree of supersaturation for each sample was determined empirically by 
gradually adjusting the ratio of compound and solvent until the desired rate of crystallisation 
was achieved. The hot stock solution was then split into two vials, one containing 1 wt% of 
gelator, and both vials were sealed and heated until all solids were fully dissolved. Gels 
formed rapidly over a period of minutes whilst crystallisation took place over a period of 
hours to weeks. Because this approach only tests one set of crystal growth conditions for each 
sample it is not as thorough as carrying out separate crystallisations at different temperatures 
as was done for CBZ. However, it does provide a valuable snapshot into the crystallisation 
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behaviour of each compound and gives a broad overview of the effect of the gel environment 
on the crystallisation behaviour of a wide range of chemically different APIs.  
 
One problem encountered with a number of the APIs (e.g. PIX) was that the addition of 
anions resulted in the dissolution of the crystals. This is assumed to be due to disruptive 
interactions of the anions with bonding motifs in the crystals in a similar way as brings about 
the dissolution of the gels. Anion addition followed by filtration was therefore not used to 
separate the gels from the crystals and characterisation took place in the presence of gelator 
as discussed in section 5.2.4.  It should be noted that characterisation of compounds was 
carried out on samples dried under ambient conditions and the possibility that metastable or 
solvated forms convert to more stable forms once removed from the mother liquor cannot be 
ruled out.  
 
5.4.2 Results 
A summary of the results is given in Table 15 and evidence for the assignments is provided in 
the experimental section 5.6. Compound 20 is used as the gelator at 1 % w/v gelator in each 
case. A reference system to identify different combinations of compound, phase and solvent 
is set out in Table 15 and is used to aid the discussion. Different compounds are labelled with 
a three letter acronym, whilst solvents are labelled A-E with gel and solution phases denoted 
G and S respectively. These are combined to give a unique representation for each 
experiment, for example PIX-A-G refers to the crystallisation of Piroxicam from a 1:9 
acetonitrile:toluene gel.  
 
The anti-inflammatory drug Piroxicam (PIX) has three anhydrous forms and a hydrate which 
are readily distinguished by IR.
248
 Crystallisation of piroxicam from 1:9 acetonitrile:toluene 
gels  produced fast growing, needle-like form II in the gel and large block shaped crystals of 
slow growing form I. In 1:9 chloroform:toluene gels a clump of piroxicam form II was 
obtained from solution and at the gel surface, whilst blocks of form I were obtained from the 
bulk of the gel.  In ethylacetate the gel was partially disrupted by the growth of several 
clumps of form II. In DMSO:water, yellow blocks corresponding to the hydrate were 
identified from solution whilst the kinetic form II was recovered from the gel. In 
methanol:water, small yellow blocks of the piroxicam hydrate were seen dispersed 
throughout the gel systems and on the bottom of the corresponding solution phase vial.  
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Table 15 Table summarising gel formation, crystal habit and crystal form for compounds 1-8 under solvent 
systems A-E in the gel (G) and solution (S) phases.  
  
1:9 CH3CN:Tol 
A 
1:9 CHCl3:Tol 
B 
EtOAc 
C 
1:1 DMSO:H2O 
D 
3:2 MeOH:H2O 
E 
Piroxicam 
PIX 
G 
G 
Needles 
II 
G 
Blocks + needles 
I + II 
PG 
Needles 
II 
G 
Irregular blocks 
II 
G 
Irregular blocks 
Hydrate 
S 
Blocks 
I 
Needles 
II 
Long needles 
II 
Irregular blocks 
Hydrate 
Irregular blocks 
Hydrate 
Sulindac 
SUL 
 
G 
G 
Powder clumps 
Orthorhombic1 
G 
Powder clumps 
Orthorhombic1 
PG 
- 
G 
- 
P 
Needles 
Orthorhombic1 
S 
Powder clumps 
Orthorhombic1 
Powder clumps 
Orthorhombic1 
- - - 
Indometacin 
IND 
G 
PG 
- 
G 
- 
PG 
Plates 
γ 
P 
Needles 
UA 
G 
Needles 
α 
S 
Fibres 
? 
Plate 
γ 
Plates 
γ 
needles 
α 
needles 
α 
Sparfloxacin 
SPF 
G 
PG 
Plates2 
UA 
G 
Small plates 
- 
P 
Needles3 
UA 
G 
Small plates 
? 
G 
Small plates 
- 
S 
Plates 
- 
Plates 
- 
Plates 
UA 
Large plates 
- 
Small plates 
- 
Theophylline 
THE 
G 
PG 
Plates 
Anhydrous 
G 
Blocks 
Anhydrous 
PG 
- 
 
G 
- 
 
G 
- 
 
S 
Plates 
Anhydrous 
Plates 
Anhydrous 
Plates 
Anhydrous 
Large plates 
- 
Needles 
- 
Caffeine 
CAF 
G 
PG 
Spherulites 
β 
PG 
Needles3 
β 
PG 
Needles 
- 
G 
Needles 
β 
G 
Fine needles 
Monohydrate6 
S 
Needles 
β 
Needles 
β 
- 
Gel of fibres4 
β 
Gel of fibres4 
β 
Ibuprofen 
Sodium salt 
IBU 
G 
PG 
Clumps needles 
s-Na- dihydrate 
PG 
Clumps needles 
- 
PG 
Clumps needles 
s-Na- dihydrate 
Viscous liquid 
- 
C 
Block of plates 
s-Na- dehydrate 
S 
Precipitate 
s-Na- dihydrate 
Precipitate 
- 
Needles 
s-Na- dihydrate 
- 
Block of plates5 
s-Na- dehydrate 
Acetaminophen 
ACP 
G 
PG 
Fibres 
- 
G 
Clusters 
I 
PG 
- 
 
P 
Large block 
I 
G 
Large block 
I 
S 
Plates 
I 
Needles 
I 
- 
Large block 
I 
Large block 
I 
For each sample the phase (G= Gel, PG= partial gelation, S= solution, P= precipitate), a description of crystal 
habit and form (colour indicates method of identification IR, XRPD, XRD. UA- in colour indicates assignment 
inconclusive) are given. [1] XRPD and IR patterns match DOHREX in CSD variously assigned as form I or II 
in different papers, [2] reported for repeat at 4ml scale, [3] crystals growth occurred on vial walls above 
solvent/gel, [4] solvent retained upon inversion, [5] took much longer to form than solution sample. [6] Some 
evidence of other forms present. 
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Sulindac (SUL) is a non-steroidal anti-inflammatory drug of which at least three polymorphs 
and three solvates are known.
249, 250
 Crystallisation occurred in both sets of toluene samples 
and in some of the aqueous samples, but in neither of the ethylacetate samples. In all the 
anhydrous gels and solutions dense clumps of needles formed except in SUL-B-G where 
dispersed needles were seen; both were assigned as the orthorhombic form by IR and XRPD. 
In the methanol:water case the gel failed to form and crystals of Sulindac were isolated, 
whilst no crystals were obtained from the corresponding solution. In DMSO water mixtures 
the gel formed, but no crystals were obtained from either the gel or solution. XRPD analysis 
identified the clumps of crystals in SUL-A-G and -S as corresponding to the orthorhombic 
structure DOHREX in the CSD. IR spectra of all crystals correlated strongly and matched 
assignments for form II whose XRPD pattern matches that of DOHREX
249
 although this is 
assigned as form I in other papers.
250
  
 
Indomethacin (IND) is used as an anti-inflammatory agent amongst other applications and the 
γ and metastable α forms have been characterised.251 Crystal growth appeared completely 
inhibited in both of the toluene based gels but was observed in the corresponding solutions. 
Plate-like single crystals isolated from IND-B-S were identified as the γ form from a XRD 
unit cell determination. Long fibres were grown from IND-A-S but the XRPD pattern did not 
match any of the structures in the CSD. Single crystals grew from both the ethyl acetate gel 
and solution and were identified as the γ form by their unit cell. Gel formation was impeded 
in the DMSO:water gel sample but initially formed in the methanol-water sample before 
gradually breaking down over a period of weeks. Large aggregates of fine white needles were 
observed in both aqueous solution samples which were shown by XRPD to be the α-form. 
Spherulitic arrangements of fine needles were found in the gels but could not be identified by 
XRPD due to weak diffraction. IR showed strong correlation in the finger print region of the 
α-form with IND-E-G, but poor correlation with IND-D-G.  
 
Sparfloxacin (SPF) is a third-generation fluoroquinolone antibiotic used to treat a variety of 
diseases and has one anhydrous and a trihydrate form.
252
 Growth in the toluene gels was 
considerably slowed and small yellow blocks dispersed throughout the gel were observed 
whilst larger flat plates were grown from solution. The experiment was repeated on a larger 
scale (4ml) and a root-like network of plates was observed. In ethylacetate gel formation was 
again partially disrupted with needles growing on the walls of the vial above the solution. 
Comparison of XRPD patterns for these two samples (SPF-A-G and SPF-C-G) show overlap 
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of major peaks with neither sample matching the reported anhydrous form (JEKMOB) or 
hydrated forms. Small plates were observed in both the aqueous gels and the corresponding 
solutions although plates tended to be aggregated into clusters in solution and dispersed in the 
gel. The XRPD pattern of SPF-D-S was different again from the other experimental and 
reported patterns. Small amounts of sample make these results inconclusive but potentially of 
future interest. 
  
Theophylline (THE) is used as a muscle relaxant or vasodilator in the treatment of asthma 
and has one stable anhydrous form
253
 and a monohydrate
254
 as well as several solvates 
including DMSO. A metastable anhydrous phase
255
 has also been identified which forms 
upon drying in air of the monohydrate at relatively low temperatures (40-50ºC).
256
 Gels 
formed in all solvents in the presence of theophylline but were disrupted in the case of the 
ethyl acetate system. The three anhydrous gel samples showed a largely amorphous 
background by XRPD and the solution phase samples showed strong preferred orientation 
and a tentative assignment of the expected anhydrous form (CSD ref BAPLOT01)
253
 is made. 
In the aqueous samples, crystallisation occurred from solution but no crystallisation was 
observed in the gel samples.  
 
Caffeine (CAF) has two anhydrous forms; the β-phase is stable at room temperature but 
converts to the α-phase at ~141ºC.257 A 4/5 hydrate is stable at room temperature but only 
under elevated relative humidies and rapidly dehydrates to the β-form under atmospheric 
conditions.
258
 Gel formation was partially disrupted in the acetonitrile-toluene and 
ethylacetate samples but formed in the remaining systems. In samples CAF-B-G and CAF-C-
G growth of needles in feather-like arrangements occurred above the sample and in CAF-A-S 
and CAF-B-S feather-like growth occurred in solution. In CAF-A-G spherulitic growth of 
needles were seen whilst no crystal growth was observed in CAF-C-S. In the aqueous 
solutions CAF-D-S and CAF-E-S, crystallisation resulted in fibre-like networks which 
retained solvent upon inversion, a crude definition of a gel. The growth of these fibres was 
impeded in the gels and more needle-like structures were observed in CAF-D-G and CAF-E-
G. XRPD analysis indicated that all samples measured contained the stable anhydrous β 
form. The exception was CAF-E-G where the strongest match for was with the hydrate 
(CAFINE01) although some additional peaks can be accounted for by partial conversion to 
the β-form.  
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Ibuprofen (IBU) is a widely used non-steroidal anti-inflammatory drug which is normally 
administered as a racemic mixture and can be made more soluble as a sodium salt. Two 
anhydrous forms of racemic ibuprofen and one of the S-enantiomer are known as well as two 
ibuprofen sodium dihydrates, one containing the S-enantiomer and one a racemic mixture.
259
 
260
 The sodium dihydrate is stable under ambient conditions up to 44ºC. Gels formed in the 
three anhydrous systems but did not completely gel the sample. The growth of clumps of 
needles were observed in all three non-aqueous gel systems, fine precipitates were observed 
in the two toluene solutions and larger crystalline structures were observed in the ethlyacetate 
solution. Despite differences in morphology, XRPD for all the samples gave the best match 
for the simulated spectra for KATNOJ, the sodium dihydrate containing only one 
enantiomeric form. A viscous liquid formed in the IBU-D-G and IBU-D-S remained as a 
solution. A large crystal formed after a week in IBU-E-G and over a month in IBU-E-S. 
Despite their size, the crystals formed were composed of fine layers and could not be indexed 
by XRD. XRPD analysis again gave a match for the sodium dihydrate of the single 
enantiomeric form.  
 
Acetaminophen (ACP) has two well characterised forms, the commercially distributed 
monoclinic form I and a less thermodynamically stable orthorhombic form II.
261
 Recently a 
study of the effect of polymer heteronuclei on the polymorphism of acetaminophen found 
that relatively  non-polar side chains tended to lead to the formation of the orthorhombic 
polymorphs whilst more polar side chains led to a mixture of both polymorphs.
262
 A number 
of hydrates have been formed under more unusual conditions: a trihydrate is reported to form 
by crystallisation from aqueous solutions at 0ºC,
263
 a monohydrate at 150K
264
 and a dihydrate 
has been formed at high pressures (1.1 GPa)
265
 as has a methanol:water solvate.
266
 All 
hydrated forms are unstable with respect to the monoclinic form under ambient conditions. 
Gels formed in methanol/water and toluene/chloroform systems, were largely disrupted in 
acetonitrile/toluene and ethylacetate and there was no evidence of gel formation in the 
DMSO:water system. Unit cell determinations of crystals grown from ACP-A-S and ACP-D-
G were found to be the thermodynamically favourable monoclinic form I (HAXCAN01). 
XRPD was used to characterise the remaining crystals which were also found to be form I. 
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5.4.3 Discussion of results 
Gel formation proved to be compatible with a wide range of substituents and of the 40 
combinations tested, gel formation was observed in all but 7 cases. In many cases the 
presence of the API had no impact on gel formation (17 gels). In some cases the gels 
appeared weaker, leaked solvent or appeared disrupted by the gel sample (16 partial gels). 
The ethylacetate gel appeared to be the least robust gel and was either disrupted or failed to 
form in the presence of any of the compounds. The high solubility of many of the compounds 
meant that often the concentration of drug molecules was equivalent to, or considerably 
greater than, that of the gelator. The highest concentrations of compound were 
methanol:water systems with 41 mg/ml of ibuprofen or 40 mg/ml caffeine, four times that of 
the gelator. The smaller molecules (Theophyline, Caffeine, Ibuprofen and Acetaminophen) 
appeared to be more disruptive than the larger more complex ones although it is difficult to 
draw conclusions about the effect of any particular functionalities on gel formation.  
 
After several months, no evidence of crystallisation was seen in four of the systems and 
higher concentrations of API are required. Crystallisation was found to occur in solution but 
not the gel in five instances and in the gel but not solution in one instance (SUL-E-G). This 
indicates that the gel phase tends to suppress nucleation with presumably higher 
concentrations of compound required to induce crystallisation, as observed for CBZ. Other 
phenomena such as the crystallisation of compounds on the sides of the vials and above the 
gel were also observed (e.g. SPF-C-G).  
 
Considerable differences in crystal habit were observed in compounds grown from the gel 
phase compared with solution. A selection of images is given in Figure 86 and a full set can 
viewed in the experimental section 5.7.2. In some instances differences are due to the growth 
of different polymorphs, such as for sparfloxacin in PIX-A-G and PIX-A-S. In cases where 
the underlying polymorphism is the same, differences must therefore be due to effects of the 
gel environment.  In a number of instances where long needles grew in solution, they were 
shorter in the gel phase ACP-B-G/S, CAF-A-G/S. The lack of sedimentation in the gel 
environment also affected the aggregation of crystals accounting for further differences in 
appearance e.g. THE-A-G/S. 
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Figure 86 Pairs of images comparing crystal growth in the gel (top) and solution (bottom) of: a) PIX- A-G/S, b) 
THE-A-G/S. c) THE-B-G/S. d) CAF-A-G/S. e) CAF-D-G/S. f) IBU-A-G/S, g) ACP-A-G/S. h) ACP-B-G/S. 
 
Differences were seen in polymorphism between crystals grown from the solution and gel 
phases. This was most pronounced in Piroxicam where needles of kinetic form II were seen 
in PIX-A-G whilst blocks of form I were seen in the corresponding solution. This is the 
opposite behaviour to that observed for carbamazepine where there was a tendency for the 
thermodynamic form to grow from gels of 20 and the kinetic form to grow from solution. The 
kinetic form was also found in PIX-D-G whereas the hydrate grew from solution. This may 
indicate that the gel is encouraging rapid nucleation giving rise to the kinetic form. However, 
the presence of both forms I and II in PIX-B-G and of the hydrate in PIX-E-G indicate that 
more work needs to be done to establish the crystallisation behaviour of PIX from gels of 20. 
Differences in polymorphism were also seen for the crystallisation of Caffeine from 
methanol:water systems where the monohydrate was seen in the gel and the β-form from 
solution.  
 
Preliminary experiments have also been carried out on various other compounds which were 
not used for a variety of reasons. Cafradroxil and Ampicilin decomposed upon heating which 
a) b)                                c)                                 d) 
 
 
 
 
 
 
 
e) f)                                g)                                  h) 
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is a limitation of the high temperatures required to fully dissolve the gelator using this 
method. Mebendazole was tested but proved insoluble in the solvents tested. Cytosine and 
Diatrizoic Acid were soluble in aqueous systems only whilst 2- and 3-hydroxybenzyl alcohol 
were soluble only in non-aqueous solvents. Preliminary screens were carried out on a ligand 
developed within the group designated NPU and showed a promising range of polymorphic 
behaviour but was put aside as it is not an API.  
 
5.5 Industrial compounds 
In addition to these ‘model’ pharmaceutical systems which were selected for their reliable 
and well characterised crystallisation behaviour, two further pharmaceutical compounds were 
supplied by industrial sponsors GlaxoSmithKline (GSK). For commercial reasons the 
compounds will be reffered to only as GSK-A and GSK-B. Only limited characterisation was 
undertaken of these systems. Preliminary experiments indicate GSK-A and -B can be 
crystallised from gels of 20 using the same procedure and range of solvents as used in section 
5.4. Disruption of the ethylacetate gel occurred in the presence of GSK-A whilst only the 
toluene gels were stable in the presence of GSK-B. No significant differences were observed 
in the polymorphism of the compounds crystallised from the solution and gel states. 
 
 One interesting observation is depicted in Figure 87. GSK B initially crystallised as fine 
needles from both the 1:9 acetonitrile:toluene gel and solution samples. However, in solution 
over a period of months the needles gradually converted into large blocks which were solved 
by single crystal X-ray diffraction and identified as the thermodynamically stable form II. In 
contrast, no change in morphology was observed over the 2 month period in the gel phase 
samples and the needles were isolated and identified as form I by XRPD. The same 
stabilisation of form I was observed in the 3:2 methanol:water gel samples, with conversion 
to form II occurring in solution. However, in this case gelation was disrupted by the presence 
of GSKB and the stabilisation occurred in the presence of a precipitate. This may indicate 
compound 20, rather than the gel phase is stabilising form I of GSK B. 
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Figure 87 Images showing kinetic form I of drug compound GSKB was stable in the gel sample (1 % w/v 1:9 
acetonitrile:toluene) after several months where it had converted to the thermodynamic form in solution.  
  
5.6 Conclusion 
The work outlined in this chapter demonstrates the use of LMWGs as a medium for organic 
crystal growth. The supramolecular nature of these gels allows for the facile recovery of 
crystals upon the addition of acetate anion without damage to the crystals. Although the 
effectiveness of anion-triggered reversal of gel formation is limited by the solvent and the 
ability of the crystalline substrate itself to interact with the anion, gelators can be designed 
that respond to a variety of external stimuli. The ability of LMWGs to gel a wide range of 
solvents allows for detailed screening of compounds. Gel formation was found to be 
compatible with a wide variety of drug compounds although instances where gels failed to 
form in the presence of particular compounds were observed. The vast body of literature on 
supramolecular gels provides a library of gelators that can be chosen to match the 
crystallisation conditions and compound of interest. 
 
LMWGs may act as an inert matrix, slowing down crystallisation and leading to larger, more 
uniform crystals, and inhibiting the conversion of metastable polymorphs. In some cases 
crystallisation was found to occur in the gel but not in solution, whereas in others nucleation 
required higher levels of supersaturation in the gel phase. Clear differences in crystal habit 
have been seen in the gel phase when compared with solution, and in some cases the gel-
phase crystallisation results in the formation of different polymorphs when compared to the 
II I 
I I 
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parallel solution-phase experiments. No gelator-substrate cocrystals were observed, 
suggesting effective phase separation between the rapidly forming gel and the slower 
growing substrate crystals. This important observation indicates the general applicability of 
these systems.  
 
The high-quality single crystals that result from gel-phase crystallisations are of great 
potential use in macromolecular crystallography, where crystal quality, particularly in 
synchrotron work on small samples, is of paramount importance. The diversity of this class of 
gelator potentially allows for tuning of interactions between gel and solute, an idea developed 
in Chapter 6. Supramolecular gels could find an application as an important tool within the 
context of the polymorph screening methodologies that are routinely applied at several stages 
in the drug development pipeline. Interest from the pharmaceutical industry in developing 
this approach led to a collaboration with GlaxoSmithKline (GSK) and details of this work are 
discussed in Chapter 7.  
 
5.7 Experimental section 
5.7.1 General procedures 
Details for the synthesis of gelator 20 can be found in Chapter 2. Compounds 37,
52
 38
63, 170
 
and 14
71
 were prepared by Dr Gareth Lloyd and Dr Mark Piepenbrock. Drug compounds 
were purchased from Sigma Aldrich and were used with no further purification. All solvents 
used were analytical reagent grade.  
 
Variable temperature NMR spectra were performed on a Varian Inova-500 machine (500 
MHz for 
1
H, 126 Hz for 
13
C) and were referenced to residual solvent. Binding constants were 
determined using the non-linear least squares fitting program HypNMR 2006.
218
 Powder 
diffraction was performed on glass or silicon slides using a Siemens D5000 X-Ray 
Diffractometer using CuKα radiation at a wavelength of 1.5406 Å.  Other instrumentation 
and general experimental procedures used are described in Chapter 2. 
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5.7.1.1 Sample preparation 
In Section 5.3 gel phase crystallisations were carried out by weighing the appropriate amount 
of substrate (1-5 % w/v) and gelator (0.1-1 % w/v) in a vial and adding a suitable solvent 
from a stock solution. The sealed vial was then heated until both solids were fully dissolved 
and the mixture was then allowed to cool to room temperature. In each case the gel is formed 
over a period of a few minutes whilst crystallisation takes place over tens of minutes to 
weeks.  
 
In section 5.4 for a typical experiment, a known mass of compound was added to a large vial 
along with a known volume of solvent. This was then heated until everything was dissolved 
and allowed to cool. If the compound did not fully dissolve, or crashed out of solution rapidly 
upon cooling, more solvent was added to the vial and it was reheated. If the compound 
dissolved very easily or did not come out of solution upon refrigeration or after several days, 
more compound was added. A number of iterations of this process were carried out until each 
sample gradually crystallised from solution over a period of hours to days.  The solution was 
heated, then divided between a smaller vial containing a weighed concentration of gelator and 
a reference vial with no gelator. The samples were then heated and allowed to sit at room 
temperature for a period of a week. 
 
5.7.1.2 Sample analysis 
Where possible, recovery of the crystals was achieved by adding a measured amount of 
acetate as the tetrabutylammonium (TBA)
 
salt to break down the gels, followed by filtration 
of the resulting solution and washing with water or diethyl ether. Polymorphs were identified 
by comparing experimental X-ray powder diffraction patterns (D5000) with those calculated 
from the known single crystal coordinates in the CSD, from their solid state IR spectra (PE 
Spectrum 100), or where crystal size permitted, from the unit cell dimensions of a number of 
representative single crystals (Bruker 6000).  
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Figure 88 NMR titration data and fit for binding of CBZ by gelator 20 in toluene at 70 
o
C; above Tgel; log K11 = 
0.87(27) 
 
 
Figure 89 NMR titration data and fit for binding of CBZ by gelator 20 in CDCl3 at 20 
o
C; log K11 = 0.84(8) 
  
CBZ + 1 1wt% Tol  70oC
0.005 0.015 0.025
concentration of Guest
4.54
4.58
4.62
4.66
4.70
c
h
e
m
ic
a
l 
s
h
if
ts
 f
o
r 
n
u
c
le
u
s
 P
ro
to
n
 1
 
0
10
20
30
40
50
60
70
80
90
100
%
 f
o
rm
a
ti
o
n
 r
e
la
ti
v
e
 t
o
 H
o
s
t
unweighted error in chemical shift. (unweighted rms = 5.5205E-3)
-0.01
0.00
0.01
CBZ + 1 1wt% CDCl3
0.00 0.02 0.04 0.06
concentration of Guest
4.88
4.92
4.96
5.00
c
h
e
m
ic
a
l 
s
h
if
ts
 f
o
r 
n
u
c
le
u
s
 P
ro
to
n
1
 
0
10
20
30
40
50
60
70
80
90
100
%
 f
o
rm
a
ti
o
n
 r
e
la
ti
v
e
 t
o
 H
o
s
t
unweighted error in chemical shift. (unweighted rms = 2.2079E-3)
-0.005
0.000
0.005
  164 
5.7.2 Screen of pharmaceutical compounds 
5.7.2.1 Piroxicam (PIX) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 90 a) Structure of Piroxicam b) photographs of PIX crystallised from different solvent combinations 
with and without gelator c) table showing gel and crystal formation in different samples d) selected microscopy 
images of crystal structures from corresponding samples. 
a) 
 
 
 
b) 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
d) 
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Figure 91 Infrared spectrum showing assignments
248
 of crystal forms for Piroxicam (PIX): a) G-A form II 
(blue), b) S-A form I (red), c) G-B needle form II (green), d) G-B block form I (purple), e) S-B form II (mid 
blue), f) G-C form II (orange), g) S-C form II (light blue), h) G-D form II (light red), i) S-D hydrate (light 
green), j) G-E hydrate (light purple), k) S-E hydrate (sky blue). 
 
5.7.2.2 Sulindac (SUL)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
 
b) 
c) 
 
 
 
d) 
 
 
e) 
 
f) 
 
 
g) 
 
 
h) 
i) 
 
 
 
j) 
 
 
 
k) 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
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Figure 92 a) Structure of Sulindac b) photographs of SUL crystallised from different solvent combinations with 
and without gelator c) table showing gel and crystal formation in different samples d) selected microscopy 
images of crystal structures from corresponding samples. 
 
Figure 93 XRPD pattern comparing patterns for a) SUL-A-S (red) and b) SUL-A-G (blue) with c) pattern for 
orthorhombic form II of sulindac (green) generated using CSD reference DOHREX in Mercury. 
a) 
 
 
b) 
 
 
c) 
c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d) 
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Figure 94 IR spectra for samples of Sulindac: SUL-A-G (blue), SUL-A-S (red), SUL-B-G (green), SUL-B-S 
(purple), SUL-E-G (light blue) 
 
5.7.2.3 Indomethacin (IND)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
 
b) 
 
c) 
 
d) 
 
 
e) 
 
f) 
 
 
g) 
 
 
 
a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
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Figure 95 a) Structure of Indomethacin b) photographs of IND crystallised from different solvent combinations 
with and without gelator c) table showing gel and crystal formation in different samples d) selected microscopy 
images of crystal structures from corresponding samples. 
 
Table 16 Comparison of experimental unit cell data and CSD reference INDMET03 
 A B C α β γ V 
3SB 9.22(3) 9.67(3) 10.87(3) 70.3(2) 87.7(3) 70.5(3) 857(5) 
3GC 9.226(1) 9.6064(9) 10.860(1) 69.937(7) 87.24(1) 69.497(8) 844.0(2) 
3SC 9.268(3) 9.699(6) 10.920(2) 69.70(3) 87.29(2) 69.14(4) 857.1(7) 
INDMET03 9.236 9.62 10.887 69.897 87.328 69.501 847.865 
c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d) 
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Figure 96 XRPD pattern comparing experimental data with CSD references for known forms of indomethacin: 
a) IND-A-S (blue), b) IND-D-S (green), c) IND-E-S (purple), d) IND01 (light blue) e) IND02 (orange). 
 
  
 
Figure 97 IR spectrum showing IR patterns for samples of indomethacin, the presence of gelator complicates 
spectra making interpretation difficult: a) IND-A-G, b) IND-A-S, c) IND-B-G, d) IND-B-S, e) IND-C-S, f) 
IND-D-G, g) IND-D-S, h) IND-E-G, i) IND-E-S. 
  
  
a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
 
 
a) 
 
b) 
 
 
 
 
c) 
 
 
 
d) 
 
 
e) 
 
 
 
 
 
f) 
 
 
g) 
 
 
 
 
 
h) 
 
 
 
 
 
i) 
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5.7.2.4 Sparfloxacin (SPF)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 98 a) Structure of Sparfloxacin b) photographs of SPF crystallised from different solvent combinations 
with and without gelator c) table showing gel and crystal formation in different samples d) selected microscopy 
images of crystal structures from corresponding samples. 
a) 
 
 
 
 
 
b) 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d) 
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Figure 99 XRPD pattern comparing experimental data with CSD references for known forms of Sparfloxacin: 
a) SPF-A-G (blue), b) SPF-C-G (red), c) SPF-C-S (purple), d) SPF-D-S (light blue) e) JEKMOB (orange) f) 
COQWOU (grey) g) COQWOU01 (pink) 
 
5.7.2.5 Theophylline (THE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
 
 
 
b) 
 
 
 
 
c) 
 
 
 
d) 
 
 
 
e) 
 
 
 
f) 
 
 
 
g) 
 
 
 
 
a) 
 
 
 
 
 
b) 
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Figure 100 a) Structure of Theophylline b) photographs of THE crystallised from different solvent 
combinations with and without gelator c) table showing gel and crystal formation in different samples d) 
selected microscopy images of crystal structures from corresponding samples. 
 
 
 
 
 
Figure 101 XRPD pattern comparing experimental data with CSD references for known forms of Theophylline: 
a) THE-A-G (blue), b) THE-A-S (red), c) THE-B-G (green), d) THE-B-S (purple), e) THE-C-G (light blue), f) 
THE-C-S (orange) g) BAPLOT01 (green) h) RIGYEM (red) i) THEOPH01 (violet)  
a) 
 
 
 
b) 
 
c) 
 
 
d) 
e) 
 
 
f) 
 
g) 
 
 
h) 
i) 
 
 
 
 
c) 
 
 
 
 
 
d) 
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5.7.2.6 Caffeine (CAF) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 102 a) Structure of Caffeine b) photographs of CAF crystallised from different solvent combinations 
with and without gelator c) table showing gel and crystal formation in different samples d) selected microscopy 
images of crystal structures from corresponding samples. 
a) 
 
 
 
 
b) 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
d) 
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Figure 103 XRPD pattern comparing experimental data (Table 5) with CSD references for known forms of 
Caffeine: a) CAF-A-G (blue) b) CAF-A-S (red), c) CAF-B-G (green) d) CAF-B-S (purple), e) CAF-D-G (blue), 
f) CAF-D-S (orange), g) CAF-E-G (blue), h) CAF-E-S (red), i) NIWFEE03 (light blue),  j) NIWFEE04 
(orange), k) CAFINE (green) 
 
5.7.2.7 Ibuprofen (IBU) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
 
 
 
 
b) 
a) 
 
b) 
c) 
 
d) 
e) 
 
f) 
 
g) 
 
h) 
i) 
 
j)  
 
k) 
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Figure 104 a) Structure of Ibuprofen b) photographs of IBU crystallised from different solvent combinations 
with and without gelator c) table showing gel and crystal formation in different samples d) selected microscopy 
images of crystal structures from corresponding samples. 
 
 
 
 
Figure 105 XRPD pattern comparing experimental data with CSD references for known forms of Ibuprofen: a) 
IBU-A-G (blue), b) IBU-A-S (red), c) IBU-C-G (green), d) IBU-C-S (purple), e) IBU-E-G (blue), f) IBU-E-S, 
g) IBU-E-S (orange), h) KATNOJ2 (mid blue), i) KASVEG (light blue). 
a) 
 
 
 
b) 
 
c) 
 
 
d) 
e) 
 
 
f) 
 
g) 
 
 
h) 
i) 
 
i) 
 
 
 
 
c) 
 
 
 
 
 
d) 
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5.7.2.8 Acetaminophen (ACP) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 106 a) Structure of Acetaminophen b) photographs of ACP crystallised from different solvent 
combinations with and without gelator c) table showing gel and crystal formation in different samples d) 
selected microscopy images of crystal structures from corresponding samples. 
a) 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
 
d) 
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Table 17 Comparison of experimental unit cell data and CSD reference HAXCAN01 
 
 A B C α β γ V 
8SA 7.095(2) 
 
9.322(2) 
 
11.678(3) 
 
89.96(2) 
 
97.54(1) 
 
90.04(2) 
 
785.7(3) 
8GD 7.0972 
 
9.3141 
 
11.6844 
 
90.003 
 
97.588 
 
90.008 
 
765.62 
HAXCAN01 7.1 9.4 11.72158 90 97.1165 7.1 776 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 107 XRPD pattern comparing experimental data with CSD references for known forms of 
Acetaminophen: a) ACP-B-G (blue), b) ACP-B-S (red), c) ACP-D-S (green), d) ACP-E-G (purple), e) ACP-E-S 
(light blue), f) HAXCAN01 (orange), h) HAXCAN (purple). 
 
  
a) 
 
 
 
b) 
 
 
 
c) 
 
 
 
d) 
 
 
 
e) 
 
 
 
f) 
 
 
 
g) 
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Chapter 6: Tailored Gelators for the Crystallisation of 
Pharmaceutical Compounds 
6.1 Designer gelators incorporating specific functionalities 
6.1.1 Background and approach 
The gel matrix is often considered to provide an inert environment with crystal growth taking 
place within the macropores between gel fibres. The nature of the gel structure is such that 
both solvent and growing crystals are ‘trapped’ by the gel matrix, preventing convection and 
sedimentation. The decreased mobility and flux of material delivered during crystal growth in 
gels leads to higher quality crystals of enhanced stability.
267
 The habit of crystals grown from 
gels can be different to those grown from solution as crystal growth is diffusion limited and 
not inhibited by contact with the vessel walls or other crystals.
158
 In an inert gel environment, 
homogeneous nucleation tends to dominate allowing higher levels of supersaturation to be 
achieved than in solution and allowing access to single crystals of metastable phases.
153
   
 
As well as providing a benign environment for crystallisation, interactions between the 
compound being crystallised and the gel fibres may occur. Heteronucleation on gel fibres 
may template the nucleation of particular crystal forms or stabilise metastable forms which 
would otherwise convert or redissolve.
154, 155
 Interactions between fibres and the different 
faces of growing crystals may influence the rate of growth of different faces leading to 
differences in habit for crystals grown from different gels.
157, 158
 Helical gel fibres have also 
been found to produce an enantiomeric excess of one enantiomorph of sodium chlorate where 
a racemic mixture is obtained from solution.
164
 
 
The approach taken in Chapter 5 is to combine an existing gelator with an available 
pharmaceutical compound. This combinatorial approach has revealed a number of differences 
in crystal habit, form and stability between crystals grown from the gel and solution 
phases.
170
 The wide variety of LMWGs reported in the literature means there is enormous 
scope for observing the effect of other gelators on pharmaceutical systems. However, any 
differences observed by this approach are unpredictable and are due to fortuitous matches 
between the gel and crystal structures.  
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One potential advantage of supramolecular gelators is the relative ease with which different 
chemical functionalities can be deliberately incorporated into a gelator’s structure. Rather 
than relying on chance complementarity between gelator and API, this chapter reports 
attempts to design LMWGs incorporating chemical functionalities tailored to mimic those of 
the compound under investigation. The idea is that gels displaying functionalities which 
complement those of the compound under investigation are more likely to interact with 
nucleating or growing crystals and so produce differences in polymorphism or crystal habit.  
 
6.1.2 Synthesis 
Three pharmaceutically relevant compounds were selected for investigation. Carbamazepine 
(CBZ) was selected owing to its use in previous studies. The recent discovery of form V 
carbamazepine growth on the crystal surface of a related compound,
243
 and of form IV on 
polymer heteronucluei,
237
 makes it a promising candidate for investigation. A study using 
polymer heteronuclei found the hydrophobicity of polymer side chains influences the 
polymorphism of acetaminophen (ACP) and it would be interesting to see if the same effect 
was observed in gels.
262
 5-Methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile, known 
as ROY for its red, orange and yellow crystals, has a large number of readily distinguishable 
polymorphs making it an interesting candidate for further study.
268
 
 
Building on previous success with hexamethylene spaced bis-urea gelators (Chapters 2-4), 
compounds 39, 21 and 42 were designed to incorporate functionalities mimicking 
carbamazepine (CBZ), acetaminophen (ACP) and ROY respectively (Scheme 3). Later 
studies identified a second core, 4,4’-methylenebis(2,6-diethyphenylurea) which is utilised in 
the same way for compounds 40, 41, 43. Phenylalanine derived gelators 44, initially 
synthesised as part of parallel studies into the crystallisation of amino acids from gels, 
provides a good reference compound with which to compare the effects of the other gelators. 
 
Initial attempts to prepare 39 by direct reaction of carbamazepine with 1,6-
diisocyanatohexane in chloroform showed no evidence of reaction, presumably due to the 
low nucleophilicity of the urea nitrogen lone pair in carbamazepine. Attempts were made to 
reduce the urea to a primary amine using lithium aluminium hydride, however this resulted in 
the formation of a bright orange compound. The product could not be identified but NMR 
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spectroscopy indicated a mixture of compounds and disruption of the aromatic rings. 
Carbamazepine was unaffected by reaction with less strongly reducing NaBH4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3 Gelators mimicking functionality of: carbamazepine (39 and 40), acetaminophen (21 and 41), ROY 
(42 and 43), and phenylalanine derived gelator 44. 
 
Compound 39 was successfully synthesised by reacting the commercially available acyl-
chloride derivative of carbamazepine, dibenz[b,f]azepine-5-carbonyl chloride, with 
diaminohexane. The initial procedure using only two equivalents of triethylamine led to the 
precipitation of significant quantities of 1,6-diamino hexane hydrochloride salt resulting in a 
low yield (22%) of 39. Higher yields could be achieved using a higher concentration of 
triethylamine to sequester chloride ions as they are produced and prevent precipitation.  
 
Attempts to synthesise 40 by heating under reflux dibenz[b,f]azepine-5-carbonyl chloride 
with 4,4’-methylenebis(2,6-diethylphenylamine) in chloroform with an excess of 
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triethylamine for 18 hours produced only starting material. The reaction was repeated using 
pyridine as a base but no reaction was observed after several days of heating under reflux.  
 
Compound 21 was successfully synthesised, along with its butylene spacer analogue 27. The 
experimental procedures are reported along with the other amino-acid derived gelators in 
Chapter 2. The product is obtained from the chloroform reaction mixture as an immiscible oil 
and a white solid can be obtained either by drying the oil in a drying pistol at 110°C or by 
recrystallisation from water.  
 
Reaction of tyrosine methylester hydrochloride in chloroform and triethylamine with 4,4′-
methylenebis(2,6-diethylphenylisocyanate) produced 41. A number of other amino-acid 
derived gelators based on the 4,4′-methylenebis(2,6-diethylphenylurea) core were also 
synthesised using this same approach. Phenylalanine derived gelator 44
269
 was formed in 
good yield by the reaction of 4,4′-methylenebis(2,6-diethylphenylisocyanate with the 
phenylalanine methylester hydrochloride in the presence of triethylamine.  
 
Attempts to react 2-nitroaniline with hexamethylene isocyanate were unsuccessful. This is 
likely to be due to the nitro-group on the aniline ring reducing the nucleophilicity of the 
amine. Addition of 1,6-diaminohexane to a solution in chloroform of 2-nitrophenylisocyanate 
resulted in the rapid precipitation of a yellow solid which was filtered, washed and identified 
as compound 42. 2-Nitrophenylisocyanate also reacted readily with 4,4′-methylenebis(2,6-
diethylphenylamine) producing a gelatinous precipitate from the chloroform reaction mixture.  
 
6.1.3  Gelation studies 
Compounds 21, 39 and 41-44 were tested in a range of solvents for evidence of gel 
formation. The compound (0.01 g) was heated in 1ml of solvent (1 % w/v) in a sealed vial 
until fully dissolved. The samples were cooled rapidly by placing the vials in a water bath at 
room temperature. They were sonicated briefly at the first sign of precipitation to aid 
homogeneous gel formation. The results upon cooling to room temperature are recorded in 
Table 18. Gel formation was characterised by a simple vial inversion test; if the solvent was 
fully immobilised it was considered to have gelled. The term partial gel was ascribed to 
samples where only partial trapping of the solvent occurred. 
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Table 18: Screening of compounds 21, 39 and 41-44 for gelation behaviour in a range of solvents 
Solvent 
Compound 
21 39 41 42 43 44 
Water P I I I I I 
Acetonitrile O S G G G G 
Methanol O S PG G
[a]
 G G 
Ethanol S S G G
[a]
 G G 
Acetone O S G G G G 
THF O S G PG PG G 
DCM O S I G G G 
Ethylacetate O S G G
[a]
 G G 
Chloroform O S I G G G 
Toluene O S I G G G 
P = precipitate, S = solution, G = Gel, PG = partial gel, O = oil,  I = insoluble with heating,  unstable over time. 
[a] = gel unstable and breaks down over time.  
Carbamazepine derivative 39 is highly soluble and forms clear solutions at room temperature 
in most solvents, even at higher concentrations (tested up to 10 % w/v), and no gels were 
observed. The compound is insoluble in water and addition of water to a concentrated 
methanol solution produces a fine white precipitate. Slow evaporation of a toluene solution 
gave crystals suitable for single crystal X-ray diffraction. This technique revealed the sample 
to be a toluene solvate of 39 by XRD. 
In contrast to other hexamethylene spaced gelators discussed in Chapter 2, the hexylene chain 
has an anticlinal orientation with respect to the carbonyl group with a torsion angle of 
118.62°. This lies between the cis conformation adopted by 23 form B and the all-trans 
conformation observed for the other gelators. The hexamethylene spacer gives the urea 
groups an antiparallel orientation. However, steric hindrance from the bulky aromatic rings of 
the carbamazepine groups prevents hydrogen bonding between the free NH and carbonyl of 
the urea moieties. Instead, the carbonyl groups interact with the aromatic hydrogen atoms on 
an adjacent carbamazepine moiety (O1-C3 3.31 Å) resulting in anti-parallel chains of 
hydrogen bonding interactions. Surprisingly, the hydrogen bonding potential of the NH (N1) 
remains unsatisfied. Disordered toluene is found in the large cavities between the chains of 
molecules. Slightly longer interactions (O1-C7 3.4 Å) between adjacent chains link stacks in 
π-stacking between pairs of carbamazepine groups to give packing in the other dimensions. 
The lack of strong hydrogen bonding interactions is possibly due to the presence of the bulky 
end group and explains the high solubility of 39 and the lack of gel formation observed.  
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Figure 108: X-ray molecular and crystal structure and packing of a toluene solvate of 39, O1-C7 = 3.31 Å. 
 
 
Figure 109 Gels comprising 1 % w/v 41 in (left to right) methanol, ethanol, 1:1 and 9:1 methanol:water, THF, 
acetonitrile, acetone and ethyl acetate. 
a) 
b) 
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As discussed in Chapter 2, no gelation was observed for hexamethylene spaced tyrosine 
derivative 21 which instead forms immiscible oils in a range of solvents. In contrast, diphenyl 
methyl 41 forms robust, translucent gels in a range of solvents such as ethanol, THF, 
acetonitrile, acetone and ethyl acetate (Figure 109). At 1 % w/v only partial gels were 
observed for 41 in methanol but higher concentrations of gelator or the addition of water 
resulted in complete gel formation. The compound is insoluble in less polar solvents such as 
toluene and chloroform as well as water.  
 
Figure 110 SEM images showing xerogels formed from 1 % w/v gels of 41 in a) acetone b) acetonitrile.   
 
Small amounts of gel sample were applied to silicon chips using a cocktail stick and the 
solvent was allowed to evaporate under atmospheric pressure. Acetonitrile and acetone gels 
of 41 prepared in this way showed no evidence of fibre formation within the resolution of the 
instrument. Instead, a number of plate-like structures were observed against a textured but 
continuous background. The gel samples from which the xerogels were prepared were 
unchanged in appearance over the course of the experiment and remained stable over a 
number of weeks. The morphology observed may be due to conversion of the xerogel to a 
different crystal form or precipitation of dissolved material on top of the gel as the solvent is 
removed. Cryo-SEM could be used to ascertain the nanoscopic structure of the gel.  
 
The formation of oils by 21 is thought to be due to competition between different potential 
hydrogen bonding motifs involving the urea and phenol groups. It may be that the less 
flexible aromatic spacer pre-organises the molecule allowing the formation of urea tapes and 
preventing competing interactions. Phenylalanine diphenylmethane spaced gelator 44 also 
showed a greater range of gelation behaviour than its alkylene spacer analogue 20. The full 
range of gelation behaviour by 44 is discussed in Chapter 7. 
a)                                                    b)  
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Figure 111: Gels of 1 % w/v 42 in (left to right) acetonitrile, methanol, ethanol, acetone, THF, DCM, 
ethylacetate, chloroform and toluene. 
 
Unlike the other hexamethylene spaced analogues, ROY mimic 42 forms gels with rapid 
cooling and sonication in the full range of solvents with the exceptions of water and THF. 
However, the gels are opaque and fragile, breaking apart to form a precipitate if gently 
shaken. Gels form without sonication but tend to be less homogeneous with clumps of gel 
and free solvent. The chloroform, toluene, acetonitrile and acetone gels are unstable and form 
a precipitate after a number of days whilst gels from other solvents remain stable. 
 
 
Figure 112 SEM images showing xerogels formed from 1 % w/v gels of 42 in acetonitrile (a and b), toluene (c) 
and acetone (d).  
a)                 b)  
 
 
 
 
 
 
 
c)                                     d) 
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SEM images of xerogels formed from 1 % w/v gels of 42 in acetonitrile showed a mesh of 
poorly defined rectangular fibres with a rectangular cross section. The fibres are hundreds of 
nanometres thick, several microns long and bunch together with fibres merging into each 
other.  A variety of larger plate and block shaped structures were obtained from toluene and 
acetone which may represent the precipitates observed when the gels break down. It would be 
interesting to understand whether a polymorphic transition is responsible for the break-down 
of the gels as observed for compounds 17, 23 and 24 in Chapter 2.  
 
 
Figure 113: 1 % w/v 43 in (left to right) acetonitrile, methanol, ethanol, acetone, THF, DCM, ethylacetate and 
toluene. 
ROY derived compound 43 forms robust, stable, translucent gels in a wide range of solvents 
including acetonitrile, methanol, acetone, THF, ethylactetate and toluene as shown in Figure 
113. Compound 43 is much less soluble than 42 failing to dissolve fully in a number of the 
solvents at 1 % w/v. Undissolved material tends to inhibit gel formation and the use of lower 
concentrations of gelator results in more translucent and homogeneous gels. SEM indicates 
that the gels consist of entangled networks of fine fibres. The small diameter of the fibres 
observed (~20 nm) is consistent with the translucent appearance of the gels which are not 
opaque, unlike the gels of 42.  
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Figure 114 SEM images at two different magnifications showing xerogels formed from 1 % w/v gels of 43 in a-
b) toluene, c-d) acetonitrile e-f) acetone. 
  
a)  b) 
 
 
 
 
 
 
 
c)  d) 
 
 
 
 
 
 
 
 
e)  f) 
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6.2 Crystallisation from tailored gelators 
6.2.1 The polymorphism of ROY 
ROY was first synthesised by medicinal chemists at Eli Lilly as a reagent to prepare 
olanzapine, a schizophrenia drug. There are ten known crystal forms of ROY of which seven 
crystal structures have been obtained. Whilst this does not make ROY the most polymorphic 
compound on record (as water for example has ten known solid state forms) ROY is 
remarkable in that all seven forms can be crystallised and are kinetically stable enough to be 
studied under near-ambient conditions.
270
 Different crystal forms are represented by initials 
reflecting the distinct colour and habits adopted by different polymorphs. The names and 
properties of various ROY polymorphs are given in Table 19. The different colours of ROY 
originate from conformational isomerism. The distinct differences in appearance allow for 
relatively facile in-situ monitoring of crystal growth and the different forms are 
unambiguously distinguishable by infrared spectroscopy.
268
 
Table 19 Selected properties of ROY polymorphs
268
  
Form Y YT04 R OP ON YN ORP 
Description 
Yellow 
prism 
Yellow 
prism 
Red Prism 
Orange 
Plate 
Orange 
needle 
Yellow 
needle 
Orange-red 
plate 
θ(deg) 104.7 112.8 21.7 46.1 52.6 104.1 39.4 
     2231 2224 2212 2226 2224 2222 2217 
H-HY, KJ/mol 0 0.9 1.4 1.9 2.6 3.0 4.1 
The Y form is most stable under ambient conditions with enthalpies increasing in the order Y 
< YTO4 < R < OP < ON < YN < ORP. However, all of these forms are kinetically stable 
over months or years and often grow concomitantly from both solution and the melt.
268
 Some 
of the polymorphs are known to nucleate on and outgrow those of other crystal forms.
271, 272
 
The polymorphism of ROY is altered by crystallisation from liquids in contact with polymer 
surfaces,
262
 gold islands,
273
 in capillary tubes,
274
 porous solids
275
 and from micro-
emulsions
276
 and micro-gels.
155
  
 
Compounds 42 and 43 were designed to mimic the functionality of ROY by incorporating a 
nitrophenyl substituent as part of the chemical structure of a bis-urea derivative, a known gel 
forming motif.
51, 52, 170
 The nitrophenyl groups are expected to comprise the exterior of the gel 
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fibres upon assembly of the gel by the classic urea -tape motif, presenting ROY molecules 
with an ordered fibre surface on which to nucleate. This may favour the nucleation of 
different polymorphs to those found in solution or which homo-nucleate within a more 
conventional gel that does not interact with the substrate. In order to establish whether any 
differences observed are due to specific interactions with the gelator, rather than generic 
effects of a gel environment, crystallisations of ROY were undertaken from a range of 
different gels as well as solution.  
6.2.2 Crystallisation of ROY from different gelators 
A solution containing 100 mg/ml of ROY was allowed to crystallise from toluene gels of the 
designer gelator 43, as well as four different generic gelators used in previous studies 
(compounds 17, 20, 32 and 38). Toluene was selected as the solvent because a wide variety 
of the gelators reliably form gels in the solvent without sonication. The opacity and instability 
of hexamethylene spaced ROY mimic 42 in toluene made it unsuitable for use in this study.  
 
 
Figure 115 (a) Crystals of ROY grown from five different gels (left to right: 17, 20, 32, 38) and a solution phase 
control experiment (b) red crystals growing in a gel of 43 which is designed to mimic ROY, (right) and yellow 
crystals in a  non-specific gel (38)(left), (c) isolated crystals of Y and R forms. 
 
a) 
b) 
 
 
 
 
 
 
c) 
c) 
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After one month the generic gelators and solution produced large yellow blocks identified by 
single crystal X-ray unit cell determination as the thermodynamically most stable Y form. 
Under the same conditions, 1 % w/v gels of 43 produced red crystals corresponding to the R 
form. Figure 115 shows images of the crystals obtained from different gels. These 
preliminary results appear to indicate that the designer gelator, 43, induces the crystallisation 
of a different polymorph of ROY to that obtained from solution or a range of generic gels. 
 
In order to test this observation, five repeats using the same concentration of ROY in toluene 
(100 and 200 mg/ml) were undertaken along with a samples at lower (50 mg/ml) and higher 
(150 mg/ml) concentrations. Crystallisations from gels of ROY mimic 43 were compared 
with solution samples and three different generic gelators: hexamethylene spaced 20 and 17 
and diphenylmethane spaced gelator 44. Gels were formed with 1 % w/v of gelator in each 
case except for compound 44 which, for solubility reasons, was used at 0.5 % w/v. An 
additional sample containing a non-gelling solution saturated with 43 at room temperature 
was also investigated. The purpose of this reference was to test whether any differences 
observed were due to the gel state or compound 43 acting as a solution-based additive.  
 
Samples were prepared from stock solutions in crimp top vials, sealed, and heated until all 
solids had completely dissolved. Samples were allowed to cool on the bench to room 
temperature without sonication. Crystallisation generally took place over several hours to 
weeks and results are recorded at various time intervals in Table 20. Clear differences in 
crystal colour and shape allow the different polymorphs to be distinguished and intermediate 
assignment of crystal form is purely on the basis of visual observation. Assignments of the 
final crystal forms were confirmed by IR spectrometry. XRPD patterns for each of the 
different crystal forms were compared with generated patterns taken from the CSD to 
confirm the assignments.   
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Table 20 Crystallisation and polymorphism of ROY crystallised from different gelators and solution over time 
Gelator 
 
ROY mg/ml 
toluene 
Crystal form observed at time interval 
24 hours 72 hours 96 hours 2 weeks >1 month 
20 
 
 
 
100 Y Y Y Y Y 
100 Y Y Y Y Y 
100 - - - - R 
100 - Y Y Y Y 
100 - - - - R 
50 - - - - - 
150 Y Y Y Y Y 
200 - Y Y Y Y 
 
37 
 
 
 
100 R+Y Y Y Y Y 
100 R R R R R 
100 R+Y R+Y R+Y Y Y 
100 - - R R R 
100 - - R R+Y Y 
50 - - - - Y 
150 - Y Y Y Y 
200 R R R R R 
 
 
44 
 
 
100 - - - Y Y 
100 - - Y Y Y 
100 - R R R R 
100 - - - R R 
100 - R R R Y 
50 - - - - Y 
150 - - - Y Y 
200 - - Y Y Y 
 
43 
 
100 R R R R+Y Y 
100 - - - R R 
100 - - - R R 
100 - - - R R 
100 - ON ON ON ON 
50 - - - - Y 
150 R R R R R 
200 - R R R R 
Solution 
(no 
gelator) 
100 Y Y Y Y Y 
100 - R R R R 
100 R R R R R 
100 - Y Y Y Y 
100 - - - Y Y 
50 - - - Y Y 
150 Y Y Y Y Y 
200 Y Y Y Y Y 
Solution 
saturated 
with 43 at 
20°C 
 
100 Y Y Y Y Y 
100 - - - Y Y 
100 R R R R R 
100 - Y Y Y Y 
100 - R R R R 
50 - - - - Y 
150 Y Y Y Y Y 
200 - Y Y Y Y 
Y, R, ON refer to the crystal form of ROY obtained. R+Y indicates concomitant polymorphism. All gelators 
used at 1% w/v in toluene except 38 which was used at 0.5 % w/v.  
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Figure 116 Typical IR spectra for ON (blue), R (red) and Y (green) polymorphs of ROY grown from gels. 
 
Figure 117 Assignment of crystal forms of ROY based on comparison of experimental (unbroken lines) and 
calculated (dotted lines) XRPD patterns: ON form, QAXMEH (blue),
268
  R form, QAXMEH02 (red),
268
 Y form, 
QAXMEH01 (purple).
268
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There is considerable variation in the time taken before crystals are first observed, ranging 
from hours to weeks for a single set of conditions. Three different polymorphs, the Y, R and 
ON crystal forms, were identified. No trend in the time at which particular polymorphs are 
observed could be deduced with both the R and Y forms first appearing in samples after less 
than 24 hours and more than one month. A number of cases of concomitant crystal growth 
between the R and Y forms were observed. Over time crystals of the Y form began to appear 
in a number of the samples where only crystals of the R form were observed previously. 
Where both the Y and R form are present, the R form gradually converts into the more stable 
Y form. However, in the absence of the Y form, crystals of R remain stable after several 
months in both the gel and solution phases. 
 
In solution samples without any gelator at 100 mg/ml of ROY, the R form is observed in two 
cases whilst Y was observed in three. Higher concentrations of ROY gave the Y form which 
was also observed in the 50mg/ml sample after two weeks. The same pattern was observed 
for the non-gelling 43 solution reference indicating 43 has no significant effect on crystal 
growth as a solution based additive. In most cases, many more individual crystals formed 
from solution than in the gel phase samples, although there was considerable variation 
between repeats.  
 
In the gels of 44 and 17 the R form was observed slightly more often than from solution. This 
is particularly true in the case of 17 where the R form was also observed at higher 
concentrations. In gels of 20 only the Y form was produced across all samples, although the 
R form was later observed after several months in two of the samples which had failed to 
crystallise. The Y form was observed for all samples in the 50 mg/ml samples.  
 
In gels of the designer gelator 43, large single blocks of R were seen in five of the eight 
samples. One of the 100 mg/ml repeats produced jagged yellow/orange needles growing from 
the surface which were identified as ON by IR spectrometry and XRPD. The 150 mg/ml 
sample produced many separate smaller crystals which were also identified as the R form by 
IR and XRPD.  After >6 months the Y form was eventually observed in the 50mg/ml sample. 
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Figure 118 Photographs showing crystallisation of a) ON form, b) and c) different morphologies of the R form 
and d) concomitant crystal growth of the R and Y forms. 
 
One possible explanation for the differences in polymorphic behaviour observed is that the 
gels were heated to different extents in order to dissolve the different gelators, resulting in 
slightly different cooling profiles. Thermostatically controlled conditions would remove this 
variable but were not possible due to the high temperatures required to dissolve the gels in 
some instances. However, the toluene solutions are saturated with ROY at 60°C which is well 
below the dissolution temperature of all of the gelators. Furthermore, crystal growth is 
typically observed after several days and no correlation between crystal form and the time at 
which the crystals are first observed could be determined. An additional factor to consider is 
that in some samples the crystals grow against the sides of the vials and on the surface of the 
gels. In these cases heteronucleation on the glass vial or from dust at the gel surface may 
determine the crystal form rather than the gel matrix. However, both the Y and R forms were 
observed growing against the glass vials and on the gel surface indicating that  this is unlikely 
to account for the variation in polymorphism observed.   
 
With more repeats, the effect of different gelators on the crystallisation of ROY is less clear 
cut than indicated by the preliminary experiments. In the absence of gelator both the R and Y 
forms are observed. A mixture of the R and Y forms is also observed in all of the gel 
samples. Gels of 20 show more instances of the Y form than observed from solution whilst 
gels of 17 and 44 showed slightly higher instances of the R form. The largest difference in 
polymorphic outcome compared with solution was observed in gels containing the ROY 
mimic 43. The ON form is produced which is not observed in any of the other samples. 
Otherwise, the R form is almost exclusively observed with the Y form only produced in the 
50 mg/ml ROY sample after several months. Evidence that these differences are due to 43 in 
a)                                 b)                                  c)                              d)   
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the gel state rather than solution come from the reference samples containing a non-gelling 
solution of 43 where no difference in polymorphism was observed compared to solution.  
 
Because multiple forms of ROY crystallise under the same conditions, and even 
concomitantly from the same sample, many more repeats are required to establish whether 
the differences in polymorphism observed are statistically significant. The stochastic nature 
of the crystallisation of ROY from solution is well documented.
155, 268
 In one study a solution 
of ROY evaporated from 10,000 500 μm gold islands on a single plate produced six out of 
the seven stable forms of ROY.
273
  
 
6.3 Conclusion 
Incorporating specific functionalities into low molecular weight gelators offers an interesting 
new approach to influencing crystallisation. A variety of functional groups, mimicking those 
of pharmaceutical compounds, were successfully incorporated into bis-urea molecules. The 
presence of sterically bulky groups or competing hydrogen bonding functionalities prevented 
gel formation in some cases. However, a number of the compounds were found to form gels 
in a variety of solvents showing that such groups can be incorporated in principle. The 
aromatic spaced gelators showed particularly strong gelation behaviour with a number of 
different end groups. Investigations were undertaken into the influence of different gelators 
on the polymorphism of ROY but proved inconclusive due to the large number of stable 
polymorphs at room temperature. More detailed studies into the effect of crystallising 
pharmaceutical compounds from different LMWGs and into interactions between crystals 
and gel fibres are required to establish the utility of this approach. 
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6.4 Experimental section 
6.4.1 Source of compounds 
Compound MOP 133 was synthesised by Dr Marc Piepenbrock. Compound 38 was 
synthesised by Masters student Gary Cameron under the supervision of Jonathan Foster.
269
 
Compound 5 was originally synthesised by Jonathan as part of work submitted for 
assessment as part of his Masters thesis.
179
  
6.4.2 Synthesis 
Instrumentation and general procedures for the analysis of compounds and gels are as 
described in the experimental section of Chapter 2. ROY was kindly provided by Dr Sharon 
Cooper. Other drug compounds and all solvents and reagents were obtained from standard 
commercial sources.   
 
N-[6-(benzo[b][1]benzazepine-11-carbonylamino)hexyl]benzo[b][1]benzazepine-11-
carboxamide (39) 
Dibenz[b,f]azepine-5-carbonyl chloride (95%) (1.00 g, 3.9 mmol, fibrous green solid) was 
dissolved in chloroform (30 ml) in an ice bath to produce a light green solution. Addition of 
1,6- diamino hexane (0.22 g, 1.9 mmol) and triethylamine (0.40 g, 3.9 mmol) dropwise over 
30 mins produced an orange solution. The reaction was allowed to proceed at room 
temperature for two hours and a white crystalline precipitate formed. The solution was 
filtered and the precipitate identified as 1,6-diamino hexane hydrochloride salt by NMR 
spectroscopy. The organic layer was washed twice with water, dried with MgSO4, filtered 
and reduced under vacuum to produce a pink gum. After 1 hour under vacuum in a drying 
pistol (110°C) a green solid was produced. The solid was washed then recrystallized from 
toluene to produce a white powder which was dried in a heating pistol for 30 minutes (0.233 
g, 0.42 mmol, 22%). 
1
H NMR (500MHz, DMSO-d6, J/Hz): 7.45 – 7.40 (4 H, m, Ar-H), 7.39 
– 7.36 (2 H, m, ArH), 7.35 – 7.30 (2 H, m, ArH), 6.96 (2 H, s, CH), 5.35 (1 H, t, J 5.8, 
NHCH2), 2.86 (2 H, q, J 6.5, NHCH2), 1.22 (2 H, t, J 7.1, NHCH2CH2), 1.10 – 0.97 (2 H, d, J 
3.8, CH2CH2CH2). 
13
C{
1
H} NMR (126MHz, DMSO-d6),156.17 (s, CO), 141.06 (s, ArC), 
135.67 (s, ArC), 130.94 (s, CH), 129.97 (s, ArCH), 129.96 (s, ArCH) 129.86 (s, ArCH), 
40.87-39.60 (s, under DMSO multiplet, NHCH2), 30.24 (s, NHCH2CH2), 26.54 (s, 
CH2CH2CH2).  m/z (ES
+
-MS):  577.294 ([M+Na], 100%), 555.342 ([M+H], 51.69%) CHN 
expected C36H34N4O2: C, 77.95; H, 6.18; N, 10.10. Found: C, 77.26; H, 6.02; N, 9.70.  
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Crystal data for 39: C43H42N4O2, M =646.81, clear colourless plate, 0.3 x 0.2 x 0.01 mm
3
, 
triclinic space group     (No. 2), V = 853.55(10) Å3, Z = 1, Dc = 1.258 g/cm
3
, F000 = 344, 
Bruker SMART CCD 6000 area detector, MoK radiation, = 0.71073 Å,  T = 120K, 2max 
= 55.0º, 10606 reflections collected, 3917 unique (Rint = 0.0727).  Final GooF = 0.985, R1 = 
0.0539, wR2 = 0.147, R indices based on 1928 reflections with I >2(I) (refinement on F
2
), 
255 parameters, 0 restraints. Lp and absorption corrections applied,  = 0.078 mm-1.  
 
Methyl (2S)-2-[[4-[[3,5-diethyl-4-[[(1S)-1-[(4-hydroxyphenyl)methyl]-2-methoxy-2-oxo-
ethyl]carbamoylamino]phenyl]methyl]-2,6-diethyl-phenyl]carbamoylamino]-3-(4-
hydroxyphenyl)propanoate (41) 
Tyrosine methylester hydrochloride (6.39 g, 27.5 mmol) and triethylamine (3 g) were 
dissolved by heating under reflux in chloroform (500 ml). 4,4′ methylenebis(2,6-
diphenylisocyanate) (5g, 13.7 mmol), dissolved in chloroform (20 ml) was added and the 
mixture heated under reflux for 24 hours. Upon cooling the precipitate was filtered, washed 
with chloroform and dried. NMR indicated the product contained triethylamine so the solid 
was ground and washed with water (50 ml) by sonication for 1 hour at 60 °C. The product 
was filtered and dried in a heating pistol to give a white solid (8.7053 g, 11.56 mmol, 84%) 
1
H NMR (600MHz, DMSO-d6, J/Hz): 9.21 (1 H, s, ArOH), 7.5 (1 H, s, ArNH), 6.94 (2 H, s, 
ArH), 6.88 (2 H, s, ArH), 6.70 – 6.60 (1 H, m), 6.36 (1 H, s, ArNH), 4.37(2 H, d, J 6.4, C*H), 
3.77 (1H, s, ArCH2Ar), 3.58 (3 H, s, OCH3), 2.85 (1 H, d, J 24.8, C*CH2), 2.41 (4 H, d, J 6.5, 
CH2CH3), 1.02 (6 H, t, J 7.5, CH2CH3). 
13
C{
1
H} NMR (151 MHz, DMSO-d6) 173.28 (s, 
COOH), 156.47 (NHCO), 142.22 (s, ArC), 139.63 (s, ArC), 132.62 (s, ArC), 130.52 (s, ArC), 
127.34 (s, ArC), 126.59 (s, ArC), 115.47 (s, ArC),54.63 (s, C*), 52.09 (s, OCH3), 41.15 
(ArCH2Ar), 37.25 (s, C*CH2), 24.82 (s, CH2CH3), 15.10 (s, CH2CH3).  m/z (ASAP
+
-MS): 
499.9 (100%)  CHN expected C43H52N4O8: C, 68.60; H, 6.96; N, 7.44. Found: C, 65.61; H, 
6.97, N; 7.04. 
 
1-(2-nitrophenyl)-3-[6-[(2-nitrophenyl)carbamoylamino]hexyl]urea (42) 
1,6 diamino hexane (0.35 , 3.046 mmol) dissolved in chloroform (20 ml) was added dropwise 
to a solution of 2-nitrophenyl isocyanate (1 g, 6.093 mmol) in chloroform (20 ml). A bright 
yellow precipitate rapidly formed from the solution which was stirred for a further hour at 
room temperature. The precipitate was filtered, washed with DCM and dried in a heating 
pistol for 10 minute to give the product as a bright yellow solid (1.3 g, 2.99 mmol, 84%). 
1
H 
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NMR (600MHz, DMSO-d6, J/Hz):  9.30 (1 H, s, ArNH), 8.30 (1 H, dd, J 8.6, 1.3, ArH), 8.02 
(1 H, dd, J 8.6, 1.3, ArH), 7.60 (1 H, ddd, J 8.7, 7.2, 1.6, ArH), 7.48 (1 H, t, J 5.0, NH), 7.08 
(1 H, ddd, J 8.4, 7.2, 1.3, ArH), 3.08 (2 H, td, J 6.9, 5.4, NHCH2), 1.44 (2 H, p, J 6.7, 
NHCH2CH2), 1.36 – 1.27 (2 H, m, CH2CH2CH2). 
13
C{
1
H} NMR (151 MHz, DMSO-d6): 
154.63 (s, CO), 137.09 (s, ArH), 136.47 (s, ArH), 135.39 (s, ArH), 125.72 (s, ArH), 122.30 
(s, ArH), 121.64 (s, ArH), 40.87-39.60 (s, under DMSO multiplet, NHCH2), 29.79 (s, 
NHCH2CH2), 26.56 (s, CH2CH2CH2). CHN expected C20H42N4O6: C, 54.05; H, 5.44; N, 
18.9. Found: C, 52.59; H 5.24; N: 13.19. 
 
1-[4-[[3,5-diethyl-4-[(2-nitrophenyl)carbamoylamino]phenyl]methyl]-2,6-diethyl-phenyl]-3-
(2-nitrophenyl)urea (43) 
2-Nitrophenylisocyanate (5g, 30.47 mmol) and 4,4 methylenebis(2,6 diethylanilene) (4.729 g, 
15.23 mmol were dissolved in chloroform (100 ml) and stirred at room temperature. A 
gelatinous precipitate rapidly formed but the mixture was heated under reflux for 18 hours. 
The reaction mixture was cooled, filtered, washed with chloroform (2 x 25 ml) and 
diethylether then dried in a heating pistol for 10 minutes. The solid was ground to give 36 as 
a fine yellow powder (8.3 g, 12.99 mmol, 85.3 %). δ H (600 MHz, CDCl3) 9.56 (1 H, s, 
NO2ArNH), 8.70 (1 H, d, J 8.2, ArH), 8.02 (1 H, d, J 7.9, ArH), 7.52 (2 H, t,  J 7.8, ArH), 
7.03 (4 H, s, ArH), 6.96 (2 H, t, J 7.8, ArH), 5.99 (1 H, s, ArNH), 3.99 (2 H, s, ArCH2Ar), 
2.60 (8 H, dd, J 29.2, 6.5, CH2CH3), 1.10 (12 H, t, J 7.5, CH2CH3). δ C (151 MHz, CDCl3) 
143.35(s, COO), 135.76 (s, ArCH), 135.55 (s, NCO), 128.3 (s, ArCH), 121.62 (s, ArCH), 
121.12 (s, ArCH), 41.64 (s, ArCH2Ar), 24.82 (s, CH2CH3), 14.80 (s, CH2CH3) m/z (ASAP
+
-
ms, 350°C): 474.2 (M-CONHPhNO2, 100 %), 336.3 (75 %), 307.2 (50 %), 620.2 (15%) CHN 
expected C35H38N6O6: C, 65.82; H, 6.00; N, 13.16. Found: C, 65.47; H, 5.97; N,13.19,  
 
Methyl (2S)-2-[[4-[[4-[[(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoylamino]-3,5-diethyl-
phenyl]methyl]-2,6-diethyl-phenyl]carbamoylamino]-3-phenyl-propanoate (44) 
Phenylalanine methyl ester hydrochloride (0.50 g, 2.32 mmol) was dissolved in 20 ml of 
chloroform and an excess of triethylamine added. 4,4′-methylenebiz(2,6-
diethylphenylisocyanate) (0.42 g, 1.16 mmol) in 20 ml chloroform solution was added 
dropwise and the reaction was then left stirring at 70°C for 18 hours. The solution was 
washed with water and the product isolated by removing the solvent on a rotary evaporator. 
38 was isolated as a white powder (0.42 g, 0.58 mmol, 50 %): 
1
H NMR (500 MHz, DMSO-
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d6, J/Hz): 7.54 (2H, s, ArNH), 7.33-7.24 (10 H, m, ArH), 6.90 (4H, s, ArH), 6.49 (2H, s, 
CHNH), 4.49-4.44 (2H, m CH), 3.79 (2H, s, ArCH2Ar), 3.61 (6H, s, OCH3), 2.99 (4H, d, J 
9.8, CHCH2Ar), 2.44-2.39 (8H, m, ArCH2), 1.03 (12H, t, J 7.4, CH2CH3). 
13
C NMR{
1
H} 
(126 MHz, DMSO-d6, J/Hz): 173.5 (s, COO), 156.7 (s, NHCO), 142.5 (s, ArC), 139.9 (s, 
ArC), 145.0 (s, ArC), 137.8 (s, ArC), 128.9 (s, ArC), 127.2 (s, ArC), 126.9 (s, ArC), 54.7 (s, 
CH), 52.4 (s, OCH3), 41.4 (s, ArCH2Ar), 25.1 (s, ArCH2CH3), 15.4 (s, ArCH2CH3). m/z 
(ES
+
-MS): 102.2 (Et3N+H]
+
, 100%, 822.6 ([M+Et3N]
+
, 42 %), 823.6 ([M+Et3N]
+
, 30%). 
Anal. calc’d for C43H52N4O6: C, 71.64; H, 7.27; N, 7.77 %. Found: C, 71.29; H, 7.30; N, 7.70 
%.  
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Chapter 7: Can supramolecular gels be used as part of an industrial 
polymorph screening procedure?  
7.1 The importance of crystal form in the pharmaceutical industry 
Most pharmaceutical products are formulated as solids with the active pharmaceutical 
ingredient (API) in a crystalline state.
277
 The success of a drug therefore depends not only on 
the structure of the drug molecule itself, but also how it packs together in the solid state. 
Polymorphism describes two or more crystalline phases with the same molecular composition 
but different crystal packing arrangements.
234
 Different polymorphs can have very different 
physical properties such as habit, solubility, stability, colour and melting point. This 
dependence of properties on solid form is particularly important in the pharmaceutical 
industry where the solubility of different crystal forms impacts upon the bioavailability of a 
drug compound meaning conversion of one form to another can render a drug ineffective or 
dangerous.
278
 Other properties such as crystal habit, density, hardness and compressibility can 
determine how easy to process and tablet a compound is and are important considerations in 
selecting a crystal form. Incorporation of solvent molecules into the crystal lattice gives rise 
to solvates (or hydrates in the case of water) and can also lead to differences in physical 
properties. Screening of drug compounds as salts
279
 with different counter ions, or as co-
crystals
280
 by the incorporation of other neutral molecules has been used as an effective 
strategy for optimising the properties of API crystals. Amorphous solids, which lack long 
range order, are another possibility offering the advantage of high solubility, however there is 
a danger of physical instability and rearrangement to more stable crystalline forms.
281
  
 
A classic case study into the costly effects of a previously unidentified polymorph emerging 
once a product has gone to market is that of the antiretroviral Ritonovir.
235
 Originally 
marketed as gel-filled capsules containing a solution of Ritonovir, the emergence of a more 
stable, and less soluble, crystal form rendered the formulation unsafe and 
unmanufacturable.
282
 As well as their physical implications, new crystal forms with ‘novel’ 
and ‘non-obvious’ properties can be patented.283 This legal dimension means there are huge 
financial implications associated with the discovery, or failure to discover, new crystal forms. 
Different polymorphs or co-crystals can also provide patenting opportunities, and a possible 
means of designing around the existing rights of other companies.
278
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For these reasons, considerable investment has been made by pharmaceutical companies into 
ensuring that all crystal forms have been identified and that the solid state behaviour of an 
API is well understood. A collaboration with GlaxoSmithKline was developed which led to a 
month long industrial placement in their Particle Science group in Stevenage. The placement 
initially lasted three weeks and was followed a month later by a shorter stay of three days. 
The objective of the visit was to identify the feasibility and utility of incorporating 
crystallisation from LMWGs into the early polymorph screening procedures undertaken at 
GSK. 
 
7.2 Methodological Development 
A wide range of crystallisation procedures are undertaken at GSK Stevenage by the particle 
science group in order to characterise the polymorphic behaviour of candidate drug 
compounds. Pertinent to this investigation are cooling crystallisations undertaken as part of 
polymorph screens. Software is used to assist in the generation of 96 different combinations 
of solvents based on solubility data from a preliminary screen of the drug compound. The 
drug and solvent combinations are then automatically dispensed into ninety six well arrays 
and the compound slurried at a set temperature to create saturated solutions. After filtration to 
remove undissolved solid, the solutions cooled either to room temperature, or to 4
o
C in a 
fridge.  Once crystallisation has taken place, the crystals are filtered and characterised either 
by Raman spectrosocpy or XRPD in order to identify the crystal form.  The whole process is 
highly optimised with automation used where possible and with each stage anticipating the 
requirements of the next. The approach is high-throughput and, combined with other routes, 
probes a wide range of crystallisation conditions in a systematic and reproducible way.  
 
The aim of this project is to adapt the process in order to develop a screening procedure for 
crystallisation from supramolecular gels. The specialist equipment available also provides an 
excellent opportunity to test the influence of the gel phase on crystallisation from a wide 
range of conditions. Preliminary studies set out to establish what equipment, gelators and 
APIs would be best to use for further studies.  
7.2.1 Compound selection 
A number of candidate drug compounds were made available by GSK for use in the study. 
Due to commercial sensitivities these compounds will be refered to as GSKA-E. Preliminary 
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experiments involving GSK-A and GSK-B are described in section 5.5. GSK-C has been 
used by a number of other groups so the compound used in this study is designated GSK-D 
for consistency. GSK-D crystallises readily and has three non-solvated crystal forms and two 
solvates making it an interesting system for further investigation. GSK-E is formulated as a 
salt and the tosylate, mesylate, citrate and hydrochloride API salts were available for testing. 
7.2.2 Gelator selection 
The high throughput screening procedure outlined in Section 7.2 endeavours to create 
suitable and diverse crystallisation conditions for the candidate drug compound using 
mixtures of solvents. Ideally only one or a small number of gelators should be required to 
form gels in the full range of solvents. The amount of gelator required to gel a given solvent 
combination would also ideally be standardised to simplify screening procedures. The gels 
should also be able to form in the presence of all (or at least most) drug compounds which 
can vary enormously in their functionality and reactivity.  However, most LMWGs require 
very specific conditions (solvent, gelator concentration, heating profile) and the gelator may 
be disrupted by the presence of some drug compounds.  
 
Gel formation is usually achieved by heating the solid gelator in a solvent using a heat gun 
until it is fully dissolved with the gel forming upon cooling of the solution to room 
temperature. In order to scale up the crystallisation process, rather than heating each vial 
individually, blocks of vials are heated collectively. However, many of the gelators 
developed within the Steed group require high temperatures to fully dissolve, in some 
instances above that of the boiling point of the solvent. Great care is therefore required when 
collectively heating samples. Solvents with boiling points of less than 50°C were treated 
separately and only exposed to high temperatures for short periods of time. Samples were 
heated in HPLC vials sealed with silicone caps. It is important to ensure the caps form a good 
seal to the vials otherwise the solvent evaporates upon heating.  It is not possible to insert 
needles into the vials as the build-up of pressure is necessary to prevent evaporation of the 
solvent at the high temperatures required to dissolve the gelator. Great care must therefore be 
taken whilst heating the samples. 
 
The equipment used to heat the blocks of vials in the slurrying experiments has a maximum 
heating temperature of 60°C, well below that required to dissolve most of the gelators. 
Temperature controlled reactor blocks with 48 wells were available which could reach 
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temperatures of approximately 120°C or 150°C. This is well below the approximately 400°C 
heating range of a heat gun. The cooling rate of the equipment was also limited to 5°C/min 
which proved detrimental to gel formation in some instances.  
 
Preliminary studies were undertaken into gel formation in eight different solvents by five 
different gelators. Initially a standard gelator concentration was used for all samples of 0.5 % 
w/v with 1 ml of solvent used. The samples were heated and the solubility at 5°C intervals 
was noted. Once the maximum temperature of 120°C had been reached, the samples were 
cooled in the block at ~5°C/min. The temperature at which the gelator dissolved and the 
phase of the mixtures upon cooling are recorded in Table 21.  
 
Phenylalanine derived hexylene spaced gelator 20 proved the most soluble, but only forms 
gels in one of the solvents under the conditions tested. Alanine derived hexylene spaced 
gelator 17 is less soluble but forms partial gels in four of the solvents tested. Phenylalanine 
derived diphenylmethane spaced compound 44 is poorly soluble in most of the solvents but 
nevertheless forms strong clear gels in all solvents apart from toluene where a partial gel is 
formed. ROY mimic compound 43 forms strong gels in some mixtures but is poorly soluble 
in toluene and chlorobenzene and highly soluble in THF. Compound 41 is poorly soluble in 
most of solvents except THF with insoluble material forming a crust on the surface of the 
solvent.   
 
The concentrations of the gelators in the different solvents were adjusted on the basis of this 
data and the experiment was rerun (Table 22). Whilst the higher concentrations of compound 
helped ensure gel formation in some cases, e.g. 20 in ethylacetate or 17 in acetonitrile, this 
was not always sufficient to ensure gel formation. In some cases homogeneous gels failed to 
form in compositions where they have previously been shown to form with the aid of fast 
cooling and sonication. Compound 41 produced gels in five of the solvents, but with 
undissolved material remaining at 120°C in three of them. Compound 44 was observed to 
consistently form strong clear gels at 0.2 % w/v across all of the solvents tested and was 
therefore selected for further studies. 
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Table 21 Temperature at which 0.5 wt% of gelator dissolved (Ts) in various solvents and phase upon cooling to 20°C.  
            Gelator 
Solvent 
20 17 44 41 43 
Ts(°C) Phase (20°C) Ts(°C) Phase (20°C) Ts(°C) Phase (20°C) Ts(°C) Phase (20°C) Ts(°C) Phase (20°C) 
Acetone 70 S 90 PG >120 G
c
 105 G 95 PG 
Acetonitrile 90 S 90 PG 120
a
 G 105
a
 G >120
 b
 G
b
 
THF 80 S 90 PG 90 G 85 S 85 S 
EtOAc 90 P 120
a
 P >120 G
c
 >120 G
c
 >120
 b
 PG 
Toluene 115 G >120 PG >120 PG
c
 >120 P 120
a
 PG 
Ethanol 85 S 60 S >120 G 95 PG >120
b
 P 
Propan-2-ol 85 S 85 S >120 G 105 PG >120
 b
 PG
b
 
Chlorobenzene 105 P 120
a
 P >120 G >120 I 120 PG 
S = solution, P= precipitate, G= Gel, PG= Partial gel, (a) all dissolved except small amounts of undissolved material remained,  (b) Crust of undissolved material developed 
on surface of solvent (c) contains precipitate belonging to undissolved material. 
 
  
Table 22 Phase of gelator at 120°C and at 20°C in various solvents at different concentrations of gelator 
           Gelator 
 
Solvent 
20 17 44 41 43 
Gelator  
 wt% 
Phase at Gelator  
. wt% 
Phase at Gelator  
. wt% 
Phase at Gelator  
. wt% 
Phase at Gelator  
. wt% 
Phase at 
120°C 20°C 120°C 20°C 120°C 20°C 120°C 20°C 120°C 20°C 
Acetone 1 S S 1 S PG 0.2 S G 0.5 S G - - - 
Acetonitrile 1 S P 1 S G 0.2 S
a
 G 0.5 S G 0.2 S PG 
THF 1 S S 1 S PG 0.2 S PG 1 S
a
 S
a
 - - - 
EtOAc 1 S G 1 S
a
 PG 0.2 S
a
 G 1 I G 1 I G 
Toluene 0.5 S G 1 I G 0.2 S G - - - - - - 
Ethanol - - - - - - 0.2 S G 1 S
a
 G - - - 
Propan-2-ol - - - - - - 0.2 S G 1 S
a
 G - - - 
Chlorobenzene - - - - - - 0.2 S G - - - 1 I G
a
 
G= Gel, PG= Partial gel, (a) small amounts of undissolved material remained 
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7.2.3 Gelation Screen of compound 44 
 
 
 
 
 
Compound 44 was originally synthesised by Masters student Gary Cameron as part of his 
Masters studies under the supervision of Jonathan Foster. The compound was identified as 
forming robust, clear gels in an unusually wide range of solvents. In order to establish just 
how versatile a gelator 44 is, it was screened for gelation behaviour in as wide a range of 
solvents as possible. Compound 44 (5 mg) was dispensed into crimp-top vials and 0.5 ml of 
solvent (1 % w/v gel) was dispensed by hand into the vials using a pipette. The samples were 
heated to an arbitrary temperature using a heat gun until all solids had dissolved where 
possible. In some instances sonication was used to aid dissolution. The samples were then 
cooled on the bench at room temperature. Table 23 records the results of these experiments.  
 
 
Figure 119 Photographs of gels of 44 in various solvents; numbers refer to solvents described in Table 23 
 
Table 23 Test for solubility and gelation behaviour of 44 in different solvents 
 Solvent Type % w/v Hot 20°C 
1 Water Water 1 I I 
2 Methanol Alcohol 1 S G 
3 2-Methoxyethanol Alcohol 1 S G 
4 1-Propanol Alcohol 1 S G 
5 Nitromethane Nitro 1 S G 
6 Acetonitrile Nitrile 1 S G 
7 Dimethyl sulfoxide Sulfoxide 5 S G 
8 Acetone Ketone 0.1 S G 
9 2-Butanone Ketone 0.2 S G 
10 Dichloromethane CHC 1 S G 
11 Methyl actetate Ester 1 PS G 
12 Methylisobutyl ketone Alcohol 1 S G 
N
H
N
H
N
H
O
N
H
O
O O
O O
44 
  206 
 Solvent Type % w/v Hot 20°C 
13 Chloroform CHC 1 S G 
14 Ethyl acetate Ester 0.1 S G 
15 Chlorobenzene Aryl Halide 1 S G 
16 Tetrahydrofuran Ether 0.1 S G 
17 1,4-Dioxane Ether 1 S G 
18 Diethyl ether Ether 1 I I 
19 Toluene Aromatic 0.1 S G 
20 Cyclohexane HC 1 I I 
21 Heptane HC 1 I I 
22 1-butanol Alcohol 1 S G 
23 2-Propanol Alcohol 0.2 S G 
24 Trifluoroethanol Alcohol 1 S S 
25 Dimethyl carbonate Carbonate ester 1 S G 
26 Formamide Amide 1 S P 
27 Carbon disulphide Sulfide 1 PS G 
28 Ethanol Alcohol 0.1 S G 
29 Acetic acid Acid 5 S G 
30 3-Methyl-1-butanol Alcohol 1 S G 
31 N,N-dimethylacetamide  Alkyl amide 1 S(cold) S 
32 1-Methyl-2-pyrrolidininone Lactam 10 S G 
33 Pyridine Amine 1 S S 
34 Anisole Amine 1 S G 
35 Tetrachloroethylene PCC 1 S G 
36 Hexane HC 1 I I 
37 1-Pentanol Alcohol 1 S G 
38 Pentane HC 1 I I 
39 p-Xylene Aromatic 1 S G 
40 2-methyl-1-propanol Alcohol 1 S G 
41 2-butanol Alcohol 1 S G 
42 Isopropyl acetate Ester 1 S G 
43 Isopropyl ether Ether 1 I I 
44 N,N-dimethyl formamide Amide 5 S G 
45 1,2-Dimethoxyethane Ether 1 S G 
46 Ethylene glycol Alcohol 1 S G 
47 Isobutyl acetate Ester 1 S G 
48 Methylcyclohexane HC 1 I I 
49 Benzonitrile Nitrile 1 S G 
50 Nitrobenzene Nitro 1 S G 
51 Benzyl-alcohol Alcohol 1 S G 
52 2-Pentanol Alcohol 1 S G 
53 Cyclopentyl methyl ether Ether 1 PS G 
54 2-Methyl-2-butanol Alcohol 1 S G 
55 2-Pentanone Ketone 0.2 S PG 
56 Butyronitrile Nitrile 0.2 S G 
57 diisobutyl ketone Ketone 0.2 I I 
58 1-Hexanol Alcohol 1 S G 
59 1-Heptanol Alcohol 1 S G 
60 1-Octanol Alcohol 1 S PG 
61 3-Methyl-2-butanol Alcohol 1 S G 
62 2-Ethyl-1-hexanol Alcohol 1 S G 
63 Diethylene glycol dimethyl ether Ether 1 S G 
64 Cyclohexanone Ketone 0.5 S G 
65 Cyclopentanone Ketone 0.5 S G 
66 Benzene Aromatic 0.2 S G 
67 Ethyl formate Ester 0.2 S G 
68 Diisopropyl ether Ether 1 I I 
69 Trifluoroacetic acid Acid 1 S S 
HC = hydrocarbon, CHC = chlorohydrocarbon, S = soluble/solution, PS= partially soluble, I = Insoluble G= 
Gel, PG= Partial Gel, P = precipitate.  
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The gels formed were typically highly transparent and example images are shown in Figure 
119. Of the sixty nine solvents investigated, strong gels form in fifty two of the systems with 
partial or weak gels forming in a further two. The compound remained as a solution upon 
cooling at the concentrations tested in seven cases and was insoluble in nine solvents. In one 
case (formamide) a non-gelling precipitate formed from solution. Formamide is known to 
decompose upon heating and it is not known if this was responsible for the precipitate.  
 
In order to form a gel, the compound must dissolve in the solvent at high temperature, but 
come out of solution as a gel at low temperature. Compound 44 is poorly soluble in highly 
apolar solvents such as ethers and hydrocarbons. The low boiling point of these solvents 
further limits their potential to dissolve the gelator. Compound 44 is highly insoluble in water 
but tends to be highly soluble in polar aprotic solvents such as DMSO, DMF, NMP and 
DMAc with 1 % w/v of gelator dissolving at room temperature without heating. Gels were 
formed using higher concentrations of 44 in DMSO (5 % w/v), DMF (5 % w/v) and NMP (10 
% w/v).  The solvents are strong hydrogen bond acceptors so are likely to compete strongly 
with the carbonyl of the urea inhibiting urea tape formation.
38
 Adding small amounts of anti-
solvents such as water or alkanes reduces the solubility of the gelator and induces gel 
formation at lower concentrations. Acetic acid and pyridine were also found to fully dissolve 
44 at room temperature, as was trifluoroethanol. This was found to be due to high solubility 
rather than pH with gels forming in acetic acid at 5 % w/v. Gels also form in acetone with 
trifluoroacetic acid or triethylamine added to give solutions ranging from pH 1-9 and weaker 
gels form between pH 9-11.  
 
Compound 44 is able to reliably form gels in the presence of a diverse array of functionalities 
including: alcohols, esters, aromatics, chlorohydrocarbons, ketones, nitrile and nitro 
compounds. Gels may still be formed in the presence of non-gel forming solvents and 
solubility appears to be key the key factor in determining gel formation.  
 
7.2.4 Binary Solvent Mixtures 
At GSK, binary mixtures of solvents are used as part of solution based studies in order to 
create varied conditions which match the solubility of the API. Based on experimental 
solubility data of GSK-D in a number of solvents, solubility prediction software
284
 was used 
to create ninety six binary mixtures of solvents in which a reasonable amount of GSK-D was 
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soluble at high temperature and insoluble at the lower temperature. The results of the 
crystallisation experiment are discussed in detail in sections 7.3 and 7.4. 
 
Compound 44 was tested for gelation behaviour in the ninety six different solvent 
combinations used in the study in the absence of drug compound. A low concentration of 
gelator, 0.2 % w/v, was selected in order to ensure dissolution of the gelator below 120°C in 
as many solvents as possible. Compound 44 (2 mg) was automatically dispensed into ninety 
six vials and 1 ml of solvent mixture added. The vials were transferred to a thermostatically 
controlled heating block and heated to 120°C. In some cases sonication was used to help 
dissolve the gelator. Once the gelator was fully dissolved, the vials were cooled to room 
temperature then in a fridge to test for gelation behaviour. A summary of the results are 
provided in Table 23 and full details are given in Table 30 which can be found in the 
experimental section. 
 
Of the ninety six solvent combinations studied during cooling from 120°C to room 
temperature, seventeen form gels at 0.2 % w/v from a clear solution, a further seventeen form 
partial gels, thirty seven remain as solutions and two form precipitates. In sixteen cases the 
compound did not fully dissolve at high temperatures but of these mixtures six still formed 
gels and ten more formed partial gels. In six solvent mixtures the sample was unchanged 
upon heating or after cooling with the gelator remaining insoluble throughout. Refrigerating 
the samples strengthened two of the weak gels so that they were fully self-supporting and 
induced gelation from solution in one case and partial gelation in five other samples.  
 
The binary study again demonstrates the importance of solubility, rather than the presence of 
particular functional groups or solvent properties, in enabling gel formation. Gels formed in 
the presence of high concentrations of anti-solvents such as water, diethyl ether and 
cyclohexane. Indeed, the presence of anti-solvents enabled gel formation from solvents where 
the compound was highly soluble. Increasing the concentration of gelator to 0.5 or 1 % w/v 
may aid gel formation in cases where solutions or only partial gels formed. This has been 
seen experimentally for example in chloroform where 44 remains soluble at 0.2 % w/v but 
forms gels at 1 % w/v. Decreasing the concentration may help in cases where the compound 
didn’t dissolve at 120°C but formed gels or partial gels. Being able to heat to higher 
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temperatures would also increase the solubility of the gelator in all samples enabling gelation 
in a greater range of solvent mixtures at a higher standard concentration. 
 
Figure 120 Photograph showing 0.2 % w/v 44 in different binary solvent mixtures.  
 
 
Table 24 Summary of phase transitions in the various solvent systems with 0.2 % w/v gelator 44 going from 
120-5°C 
Transition S-G S-PG S-S S-P PS-G PS-PG I-I 
120-20°C 17 17 37 2 6 10 6 
120-5°C 19 21 31 2 6 10 6 
S= clear solution, PS= Small amounts of insoluble material remained, I= larger amounts of insoluble material 
remained, S(cold)= soluble without heating at 20°C, P= precipitate, G=Gel, PG=Partial gel 
 
7.2.5 Conclusion  
The low solubility of 44 is essential to its success in forming gels in a wide range of solvents 
at a low concentration. However, the same low solubility also means it is difficult to ensure 
complete dissolution of even low concentrations of the gelator at 120°C. Being able to heat to 
higher temperatures and pressures would allow uniformly higher concentrations of gel to be 
used, but presents safety and equipment issues. Another issue is the thermal stability of the 
drug compounds being tested which are likely to react or degrade at high temperatures. One 
solution would be to modify the solubility prediction software to select only solvent/gel 
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combinations which were compatible with gel formation at moderate temperatures whilst still 
maintaining a diverse range of environments. Ultimately, issues with solubility are likely to 
be a limiting factor in the utility of using thermally formed LWMGs and a different approach 
may be required (see section 7.5).  
 
7.3 GSK-D study low temperature (20°C-5°C) 
Following preliminary investigations GSK-D was selected for use in crystallisation studies. 
Characterisation of this compound from the solution phase had already been undertaken by 
GSK and the aim of this investigation was to mimic that study and compare the results.  In 
order to establish the influence of the gelator on crystallisation, it is desirable to follow the 
procedures used in the solution phase study as closely as possible. The procedure being 
replicated was the crystallisation of the API from saturated solutions of ninety six different 
solvent combinations at room temperature by cooling in a fridge. The experiment was scaled 
down and only forty eight of the solvent combinations were investigated. Thirty one solvent 
combinations were selected because crystallisation had been observed from these mixtures in 
the solution based screen in order to allow comparison of the resulting crystal forms. Solvents 
with boiling points of less than 50°C were excluded from the screen. The remaining binary-
solvents were selected because it was thought they were likely to form gels and because they 
represented a diverse range of conditions.  
 
Saturated solutions were prepared using the same procedures as the solution based screen. An 
excess of API was dispensed into vials and a total of 1 ml for each of the ninety six solvents 
was dispensed into the vials. The samples were sealed and slurried for 24 hours at room 
temperature. After 24 hours the slurries were filtered into glass tubes. 
 
In the solution based screen, the glass tubes were then refrigerated inducing crystallisation 
over a period of days to weeks. In the gel phase study, an automated solvent dispenser was 
used to transfer the saturated solutions into new vials containing a weighed amount of gelator 
(2 mg). The new vials were sealed, heated to 120°C until the gelator was fully dissolved and 
cooled to room temperature allowing the gels to form. Technical problems meant that the 
transfer of solution was not 100% efficient with most samples receiving approximately 0.7 ml 
of solvent but some as low as 0.1 ml of solvent and in one case none at all. The volume of 
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solution for crystallisation varied considerably and the concentration of gelator deviated 
significantly from 0.2 % w/v. 
 
Table 25 Comparison of phase transition undergone by 44 in the absence and presence of GSK-D 
Phase transition upon 
cooling (120-5°C) S-G S-PG PS-G PS-PG S-S I-I 
  
      X 
0.2 % w/v 44 12 12 3 6 13 2 - 
+ GSK-D 15 1 10 1 15 3 3 
S= clear solution, PS= Small amounts of insoluble material remained, I= larger amounts of insoluble material 
remained, S(cold)= soluble without heating at 20°C, P= precipitate, G=Gel, PG=Partial gel, X= sample failed. 
 
Table 25 summarises the phase transitions which took place in both this study and in the 
absence of gelator. Twelve samples were found to completely gel where only partial gels had 
been obtained in the absence of GSK-D with 0.2 % w/v of gelator. It is possible that this 
strengthening of the gel is due to some supramolecular interaction of GSK-D molecules with 
the gel fibres or mechanical strengthening of the gel by the crystals. However, a more likely 
explanation is that incomplete transfer of the solvent resulted in increased gelator 
concentrations and so stronger gelation. Low volumes of solvent are also the most likely 
explanation for the eight additional cases where the compound did not dissolve. In two cases 
solutions were observed where partial gels had formed in the absence of the API. This may 
indicate a weak disruptive effect of GSK-D on the gelator in some solvent mixtures.  
 
Once gelled, the samples were refrigerated and left to crystallise. After 24 hours crystals were 
observed in seventeen samples and after ~1 month crystals were observed in a further sixteen. 
The total of thirty four crystals obtained from gels is comparable with thirty five crystals 
obtained from solution. In ten cases, crystals were observed in the gel sample but not from 
solution and in eight from solution but not the gel. Of the samples in which crystals were 
observed, eleven corresponded to cases where strong gels had formed from clear solutions. 
One crystal was formed from a partial gel and seven were formed from a strong gel but where 
the gelator had not completely dissolved at 120°C. In ten cases crystals had grown from 
solution in samples where the gelator had dissolved but had not formed a gel and in one case 
where the gelator was insoluble.  
 
Samples obtained previously during the solution phase screen were characterised by Raman 
spectroscopy using an automated procedure to isolate, characterise and cluster the results. 
The same procedure was followed for the gel samples with gel samples transferred for 
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filtration by hand using a glass pipette or spatula. Given the diversity of solvent mixtures 
being used, dissolution using anions was not attempted. Small amounts of gelator were 
therefore present in the samples being analysed, however this did not appear to cause any 
problems. During the first visit, technical difficulties during filtration meant insufficient 
sample was available for characterisation in a number of cases.  
 
A second approach developed was to analyse the crystals in situ, in the gel, without filtering. 
The vial was inserted into the spectrometer on a stage which could be adjusted so that the 
Raman laser was aligned with an individual crystal suspended in the gel sample. Where 
crystals grew in the centre or on the surface of the sample they had to be isolated using a 
spatula and analysed on a glass slide. This approach allowed much smaller crystals to be 
analysed and crystals with different habits or grown in different environments (e.g. surface, 
above the gel, in the gel) to be analysed separately.  In-situ analysis potentially allows 
polymorphic transitions to be monitored over time. However, this approach was less effective 
where the crystals were dispersed throughout the sample and the process would be less easy 
to automate as software is likely to struggle to distinguish between crystal and gel.  
 
GSK-D is known to form three different polymorphs as well as solvates with DMSO, NMP 
and benzonitrile. Form 2 is the most stable at room temperature and form 1 the least stable. 
Heating of form 2 or form 3 to higher temperatures produces form 1. Slurrying of form 1 at 
room temperature produces form 2 or form 3 which eventually converts to form 2. The 
DMSO, benzonitrile and NMP solvates can be formed by addition of solvent to form 1. The 
non-solvated forms 1-3 and solvates can be readily distinguished by Raman spectroscopy 
with key peaks in the 3000-3400 cm
-1
 region. There are no significant peaks in this region in 
the Raman spectra for compound 44.  Mixtures containing DMSO were further checked for 
solvate formation by comparing the fingerprint region of spectra. In most cases overlap from 
solvent peaks did not prove problematic in identifying spectra, however in a number of cases 
there was insufficient material for the spectra to be assigned. 
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Table 26 Summary of samples where crystallisation took place in the gel 
No. Solvent (3:7) 
Phase Description Crystal Form 
120°C 0°C Colour Crystal Habit Gel Sol. 
8 acetone:acetone S G O Fine needles, Plates above 2 and 3 UA 
10 2-butanone:2-butanone S G Y Plate above 3 2 
15 methyl acetate:2-methoxyethanol S G O Small needles X 2 
16 methyl acetate:1,2-dimethoxyethane S G Y Plate above 3 2 
22 ethyl acetate:acetonitrile S G O Yellow needles 2? - 
27 tetrahydrofuran:nitromethane S G Y Cylinders 1 - 
28 tetrahydrofuran:acetone S G YO Needles on surface 2 2 
51 tetrachloroethylene:ethanol S G OY Needles from surface 1 2 
61 2-butanol:toluene S G YO Needles above and below 1 2 
87 cyclohexanol:isopropyl acetate S G Y Fine needle above 1 2 
88 t-butanol:butyronitrile S G O Fine needle above 1 2 
9 acetone:tetrachloroethylene PS G Y Plate above 3 2 
11 2-butanone:methyl acetate PS G Y Long needles/plates 1/3 and 3 - 
23 ethyl acetate PS G Y Blocks above 3 - 
30 toluene:ethyl acetate PS G Y Mesh of needles 1 - 
62 isopropyl acetate:methylisobutyl ketone PS G Y Yellow needles 1 - 
71 methylcyclohexane:nitrobenzene PS G Y Clump of plates/needles 1 3 
79 2-pentanone PS G Y Needles above 1 - 
91 
3-methyl-2-butanol:cyclopentyl methyl 
ether 
PS G OR Needles above UA 2 
5 2-methoxyethanol S PG O Needles X 2 
7 acetonitrile:chloroform S S Y Needles and plates 2 3 
21 chloroform:chloroform S S Y Block above 2 3 
25 chlorobenzene:dimethyl sulfoxide S S Y Mesh of needles UA DMSO 
37 2-propanol:chloroform S S Y Cylinders 2 3 
40 N,N-dimethylacetamide:anisole S S O Cylinders 2 
 
45 1-methyl-2-pyrrolidinone:acetic acid S S O Clump of needles above 1 UA 
52 tetrachloroethylene:acetic acid S S R Long fine needles 1 UA 
56 p-xylene:methanol S S O Needles above UA 2 
57 p-xylene:dimethyl sulfoxide S S OY Needles UA DMSO 
89 2-ethyl-1-hexanol:chloroform S S Y Needles/plates 2 2 
95 methanol:THF S S O Thick needles above 1 - 
96 methanol:1-methyl-2-pyrrolidine S S O Blocks 2 - 
78 2-pentanone:p-xylene I I Y Yellow needles 1 2 
S= Solution, PS=Partially solution, I= Insoluble, G=Gel, PG= Partial Gel, O=orange, Y=yellow, R= Red, 
YO/OY/OR- colours inbetween, UA = unassigned.  
 
GSK-D produced solutions of a variety of colours ranging from yellow and orange to red. 
The colours of different solutions are noted in Table 26 and Table 30. No correlation between 
solution colour and crystal form could be identified with crystals of all polymorphs being 
yellow in colour. There was some variation in the habit of crystals between the different 
forms. Form 3 tended to be plate like, form 2 thicker needles or blocks and form 1 finer 
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needles. Representative images of crystal habits are shown in Figure 121 although 
considerable variation was observed.  
 
 
Figure 121 Images of GSK-D showing a) needles of form 1, b) blocks of form 2 c) plates of form 3. 
 
Considerable differences in polymorphic behaviour of GSK-D were observed in the gel 
phase compared with solution. The correlation between crystal forms obtained from a 
particular solvent combination in the different screens is low with only one successfully 
assigned match. In the solution phase screen, form 2 was obtained from all systems apart 
from four cases where form 3 was obtained and two where the DMSO solvate was obtained. 
In the gel phase study by contrast, form 1 was obtained in fourteen cases with form 2 
obtained nine times and form 3 six times.  
 
The increase in the less thermodynamically stable form 1 in the gel screen could indicate 
some form of templation by the gel fibres or slowing of the rate of conversion to more stable 
forms. However, form 1 is also the most stable form at high temperatures and the gel phase 
samples had an additional step where they were heated to 120°C, possibly inducing 
nucleation of form 1. Within the gel phase study where all the samples were heated, form 2 
was observed more often in samples that remained as solutions upon cooling than in those 
that formed gels. However, this could be due to differences in solvent mixtures and a repeat 
of the full solution phase study in which the samples are heated to 120°C would provide a fair 
test and allow direct comparison between samples.  
 
A further complication in the analysis is that in some of the samples the crystals were 
observed growing either on the surface of the gel or on the glass of the vial above the gel. All 
of the reported plates of form 3 were found growing above the gel as were a number of 
crystals of form 1 and 2. This could be due to heteronucleation on impurities on the gel 
surface and walls occurring more readily than homonucleation in the gel phase. This would 
a)                                               b)                                              c) 
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indicate the gel is behaving as an inert environment. Because the crystals are not immersed in 
the solvent the rate of transformation to the more stable form 2 would be slowed compared 
with the solution phase study. This might further help explain the increased prevalence of the 
less stable forms.  
 
7.4 GSK-D high temperature study (60°C- 20°C) 
As part of routine polymorph screening procedures undertaken at GSK, a second solution 
based crystallisation study had been undertaken by cooling solutions saturated with GSK-D 
at 60°C to room temperature. The larger temperature gradient creates different growth 
conditions and can lead to different polymorphs. Unfortunately it was not possible to 
replicate this study using the procedure used for the lower temperature gel phase 
crystallisation study described in section 7.4. This is because the transfer and filtration of 
saturated solutions into vials containing pre-weighed gelator could only be undertaken at 
room temperature using the equipment available.  
 
A second approach was therefore developed to allow a study using crystallisation from higher 
temperatures to room temperature. All 96 solvent combinations used in the low temperature 
solution based screen were used in this study. Both API and gelator were weighed directly 
into the same vial before solvent was added. The vial was then heated to 120°C until all 
material had been dissolved (where possible) then allowed to cool on the bench to room 
temperature.  
 
The mass of API was selected to be either 10mg or 20mg depending on whether 40 or 60 
milligrams respectively of compound had been used to create saturated solutions in the 
solution based screen.  This approach had the advantage that it involved far fewer steps and 
so was much quicker than the previous method. It also enabled higher levels of 
supersaturation and faster rates of crystal growth to be achieved. Potential disadvantages of 
this approach are that the API may not fully dissolve at high temperatures or could crash out 
of solution upon cooling before the gel has fully formed. However, solvents are selected by 
solubility software
284
 to ensure reasonable solubility of the API at room temperature and are 
then heated to 120°C meaning that low solubility is unlikely to be problematic. Preliminary 
studies showed that many of the gels form and are stable above 80°C, in some cases 120°C, 
and gels form very rapidly so premature crystallisation is also unlikely to be problematic.  
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The high temperature study of GSK-D was also designed with adjusted concentrations of 
gelator. For solvent combinations in which gels had formed successfully in the 44 gel screen, 
0.2 % w/v of gelator was used again. Where the gelator was soluble at 120°C the amount of 
gelator was increased to 0.5 % w/v where partial gels formed upon cooling and to 1 % w/v 
where no gels formed. Where gels were formed but the compound did not fully dissolve a 
lower concentration of 0.1 % w/v was used. Other cases were judged individually. 
 
These adjustments were found to have a positive impact upon the number of samples where 
the gelator fully dissolved at 120°C and in terms of gel formation. Of the ninety six gel 
solvent combinations, sixty formed gels with the adjusted concentrations compared to twenty 
five at 0.2 % w/v in the absence of drug compounds.  No record was kept as to whether 
complete dissolution had taken place at 120°C for the first forty eight solvent combinations. 
Of the last forty eight samples where dissolution was recorded, only six failed to fully 
dissolve at 120°C compared to fifteen in the same solvents when a constant concentration of 
0.2 % w/v was used. Adjustments to the concentration of gelator meant that gels formed in 
sixty of the ninety six samples with partial or weak gels in a further eight. Varying the 
concentration of gelator for different solvent mixtures achieves much better results for 
ensuring both the dissolution of the gelator at high temperatures and gel formation at low 
temperatures. However, in a small minority of solvent combinations gelator remained 
undissolved at high temperatures and no gelation was observed. In such cases simply 
adjusting the concentration of gelator would never achieve gel formation from a clear 
solution.  
 
Crystallisation was observed in sixty nine out of the ninety six solvent combinations in this 
experiment. Comparing the forty eight crystallisations used in the low temperature study, 
crystals were only observed in twenty seven of the samples compared to thirty four in the low 
temperature studies. The choice of 10 or 20 mg of GSK-D in each vial was too low to induce 
crystallisation in many of the samples. This highlights a limitation of this approach as the 
solubility of compounds is difficult to predict. With hindsight, undissolved material was 
unlikely to have been a significant problem had higher concentrations of GSK-D been used 
as the samples were heated well above 60°C in order to dissolve the gelator. 
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Form 2 was the most prevalent crystal form and was identified in twenty seven of the 
samples. Form 1 was observed in sixteen cases and form 3 in just one. The prevalence of 
form 2 may reflect the lower levels of supersaturation resulting in formation of the 
thermodynamically more stable form. Needles and plates were observed growing on the wall 
of the vials above the gel and such samples are noted in Table 30 with an asterisk. Time 
pressure meant priority was given to assigning crystals observed growing in the gels so the 
form of these crystals was not identified. In the low temperature study, all of the crystals 
identified by Raman as form 3 grew above the surface of the gel. It is likely therefore that 
many of the crystals whose form was not identified are form 3, which may account for the 
low number of form 3 crystals observed in this study compared to the low temperature gel 
study.  
 
Comparing crystal forms obtained in this study with those observed in the low temperature 
gel and solution phase studies is complicated by differences in temperature, method, 
concentration of GSK-D, gelator, whether crystallisation had taken place and if the crystal 
forms could be assigned. Comparison of the two gel phase studies showed poor correlation 
between the crystal forms observed (different in nine cases, the same in six). This lack of 
correlation indicates that there is not a strong templating effect by the gelator and that other 
effects such as concentration and temperature are more important in determining crystal 
form. However, the stochastic nature of crystallisation and complexity of comparing data 
means it is difficult to draw many conclusions from this study.  
 
One interesting phenomenon demonstrated by the gel phase is shown in Figure 122. The 
image shows an orange block assigned by Raman spectroscopy as form 2 growing out of 
yellow needles assigned as form 1. Because material remains suspended in the gel phase, a 
depletion zone can be seen around the growing block of form 2 as it cannibalises the 
surrounding needles. This provides a good visual demonstration of the stability relationship 
observed between forms 1 and 2.  
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Figure 122 Photograph showing depletion of fine needles of GSK-D form 1 by a growing crystal of form 2 
suspending in a 0.2 % w/v gel of 44.  
 
7.5 Compatibility of LMWGs with API salts 
As well as forming gels in a wide variety of solvents, to be industrially relevant LMWGs 
must tolerate a variety of industrially relevant drug compounds. Proof of principle for the 
compatibility of drug compounds from supramolecular gels was established in Chapters 5 and 
6.  Compound 44 is able to form stable gels in the presence of a wide range of different 
neutral drug compounds as well as ibuprofen sodium salt. 
 
 
Figure 123 Left to right: Piroxicam, Indomethacin, Sparfloxacin, Theophyline, Caffeine, Ibuprofen sodium salt, 
Acetaminophen, Carbamazepine, GSK-A, and GSK-B crystallised from toluene gels of 44.  
 
The formulation of APIs as salts has proved a useful technique for increasing the solubility of 
compounds and adjusting other properties through the careful choice of counterion.
279
 Given 
the tendency of supramolecular gels to dissolve in the presence of anions such as acetate it 
was interesting to understand whether API salts can be crystallised from supramolecular gels. 
GSK-E is one such API which is marketed as a salt and a variety of GSK-E salts were 
available for testing. Conditions were selected to match screens previously carried out on a 
variety of free base APIs (and Na-Ibuprofen) using 1 % w/v 44 in five different solvent 
systems. The same conditions were also replicated using 44 and solution phase 
crystallisations undertaken for comparison. Salts of GSK-E with four different anions: 
chloride, tosylate, mesylate and citrate were investigated. 
 
Form 1 
 
 
 
Form 2 
 
 
Depletion Zone 
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Figure 124 Gels of left hand side- 1 % w/v 20, right hand side- 1 % w/v 44, made with saturated solutions (at 
60°C) of GSK-E a) hydrochloride, b) tosylate, c) mesylate, d) citrate salts in  (left to right) 9:1 toluene:CHCl3, 
9:1 toluene:CH3CN, Ethylacetate, 1:1 DMSO:H2O, 3:2 Methanol:water.  
 
Saturated solutions were formed by slurrying the GSK-E salts in selected solvents at 60°C 
overnight. The resulting solutions were hot filtered into vials containing 1 % w/v gelator 
using syringes capped with filtration devices. In three instances (noted by superscript ‘a’ in 
Table 27 and Table 28) fully saturated solutions were not formed at 60°C due to the very high 
solubility of the salt in the solvent mixture. The sample was heated using a heat gun until 
fully dissolved and then allowed to cool to room temperature. 
 
Table 27 Gel formation by 1 % w/v 20 gelator from various solutions of GSK-E salts 
            Solvent  
GSK-E  
1:9 
CH3CN:Tol 
1:9 
CHCl3:Tol EtOAc 
1:1 
DMSO:H2O 
3:2 
MeOH:H2O 
HCl G G G PG Sa 
Tosylate G G G G S 
Mesylate G G P G P 
Citrate G G G Sa Sa 
G= Gel, PG= Partial Gel, P= precipitate, S= solution, * solution not fully saturated with API salt. 
 
a) 
 
 
 
b) 
 
 
 
c) 
 
 
 
d) 
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Compound 20 formed gels in all of the non-aqueous solvent systems in the presence of all 
four salts of GSK-E, except for the mesylate salt which disrupted gel formation in the 
ethylacetate sample. Gelation was generally weaker in the aqueous systems with some gels 
and partial gels forming in DMSO: H2O mixtures but none forming in MeOH:H2O mixtures. 
This is likely to be due in part to the greater solubility of the GSK-E salts in the aqueous 
solutions. Precipitates were observed for the mesylate salt in the methanol:water and 
ethylacetate solutions with gels forming in other cases. 
 
Previous studies investigating the use of anions to break down gels have found them to be 
ineffective in aqueous systems, thought to be due to hydration of the anions. Urea hydrogen 
bonding is also thought to be more important to gel formation in less polar environments 
whilst hydrophobic effects are more important in aqueous systems. The ability of the gels to 
form in the presence of significant quantities of anions in non-aqueous systems, and to 
dissolve gels in aqueous systems is therefore an interesting observation which requires 
broader investigation. 
 
Table 28 Gel formation by 1 % w/v 44 gelator from various solutions of GSK-E salts 
            Solvent  
GSK-E 
1:9 
CH3CN:Tol 
1:9 
CHCl3:Tol EtOAc 
1:1 
DMSO:H2O 
3:2 
MeOH:H2O 
HCl G G G G G 
Tosylate G G G G G 
Mesylate G G G G G 
Citrate G G G G G 
 
Compound 44 formed gels with all four salts in all of the solvent systems investigated. This is 
remarkable given the high concentrations of anions used, particularly in the aqueous systems. 
It would be interesting to see if more variation is seen at lower concentrations of gelator as 1 
% w/v is relatively concentrated for this system. The ability of 44 to reliably form gels in a 
wide range of solvent systems in the presence of high concentrations of anions provides proof 
of principle for the use of LMWGs as a medium for the crystallisation of API salts. 
7.6 Freeze-drying study 
Many of the problems encountered during this study have been due to the need for high 
temperatures to form the gels. One possible solution investigated is to pre-form a gel in a 
suitable solvent, freeze-dry it to remove the solvent, then resolvate the gel with a solution 
containing the drug molecule to be crystallised. This would overcome many of the 
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complications associated with forming the gels in situ, greatly simplify the crystallisation 
process and allowing the crystallisation of thermally sensitive drug molecules from the gels. 
It would also potentially allow crystallisation from solvent systems where gels do not 
normally form due to issues with solubility.  
 
To test this, 1 % w/v gels of 44 were formed in a variety of suitable solvents (0.5ml) and 
freeze-dried. Of the eight gels attempted, four successfully formed stable aerogels and one an 
aerogel which collapsed slightly. The aerogels appeared as a homogeneous, opaque white 
solid which occupied approximately the same space as that of the gel. The collapsed aerogel 
contained a similar looking white solid but had not retained its shape and consisted of many 
fragments at the bottom of the vial. The other samples contained white solid coating the sides 
of the flask or free-flowing precipitates at the bottom of the flask.  
 
Table 29 The effect of freeze-drying gels formed from various solvents and of the addition of a second solvent 
to the aerogels 
No. Starting Solvent Phase Effect of freeze-drying Addition of solvent 
17 1,4-dioxane G Aerogel 1,4-dioxane- Partial Gel 
59 2-methyl-2-butanol G Aerogel Water-imiscible layers 
25 Dimethyl-carbonate G Aerogel Hexane-fine precipitate 
5 Nitromethane G Thick coating on vial walls  
6 Acetonitrile G Xerogel  
49 1,2-dimethoxyethane G Fine coating on vial walls  
43 2-butanol G Fine coating on walls + solid  
57 2-pentanol G Fine coating on walls + solid  
 
In order to test whether or not the aerogels could be resolvated, three scenarios were tested. 
Firstly, 1,4-dioxane was added to an aerogel formed from the same solvent. This resulted in 
the collapse of the aerogel to give a precipitate which trapped some of the solvent. Upon 
standing, a stable, translucent gel formed which retained approximately half of the solvent 
upon inversion. A much clearer and more complete gel was achieved by sonication of the 
sample in a water bath for approximately 30minutes during which time the water had heated 
to 40°C.   
 
The xero-gel fibres appear capable of re-gelling the solvent, however destruction of the aero-
gel upon addition of the solvent means that the macroscopic structure is broken preventing a 
sample-spanning gel reforming. Sonication appears to aid the formation of a sample-spanning 
structure. Further investigations have shown that gels can be formed by 44 in solvents such as 
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NMP, cyclohexanone, chlorobenzene and chloroform by sonicating a sample of the solid 
gelator in the solvent. After ten minutes of sonication a fine suspension is formed which 
gradually gels over a period of minutes to hours. This potentially provides an alternative 
route to gel formation which does not require heating. 
 
Figure 125  Effect of careful addition of (left to right) 1,4-dioxane, water and hexane to aerogels formed by 
1wt% 44 from 1,4-dioxane, 2-methyl-2-butanol, dimethyl-carbonate 
In a second experiment, water was added to an aerogel formed from 2-methyl-2-butanol. 
Compound 44 is insoluble in water so it is not possible to form a hydrogel. The water initially 
formed a layer resting on top of the aerogel which did not collapse. After several minutes the 
layers inverted with the denser water layer going to the bottom and the aerogel floating intact 
on top. After several months the aerogel remained floating on the water in three large blocks. 
The hydrophobic nature of the aerogel and high-surface tension and viscosity of water are 
likely to account for the lack of wetting of the aerogel.  
 
In a third experiment, hexane was added to an aerogel formed from dimethylcarbonate. 
Compound 44 is insoluble in hexane and other apolar solvents and therefore  does not  form 
gels. Addition of the hexane resulted in the immediate collapse of the aerogel leaving a fine 
precipitate. No evidence of gelation behaviour was observed over several weeks. 
7.7 Conclusions 
Industrial polymorph screening procedures have been successfully adapted for crystallisation 
of an API that is currently being commercially developed. Most stages could make use of 
existing processes and equipment with only one additional heating step required. However, 
the high temperatures required to ensure dissolution of the gelator coupled with variations in 
the boiling points of different solvent combinations meant that this additional step was 
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problematic. Attempts to circumnavigate this problem using pre-formed aerogels provideed 
an attractive solution which requires further investigation.  
 
The gelator, 44, was remarkably robust at forming gels from a wide variety of solvent 
conditions, particularly when the concentration of the gelator was adjusted according to the 
solvent used. Gelation was unaffected by the presence of a wide range of different drug 
compounds including a number of API salts.  
 
Raman spectroscopy was successfully used to identify crystal forms in the presence of gelator 
either by filtration or in situ. Large differences in the solid form and prevalence of each 
polymorph were observed between the solution and gel phase studies. However, the 
additional heating step used in the gel but not the solution study and the tendency for crystals 
to form outside of the gel complicates the analysis. No new crystal polymorphs or solvates of 
GSK-D were discovered. 
 
Overall this high throughput study demonstrates that with some achievable modifications to 
procedure and gel structure, LMWGs could be adapted for use in industrial polymorph 
screening procedures. However, further work is required to demonstrate that the differences 
in polymorphism observed are due to the gel phase and that this route potentially provides 
access to polymorphs not identified by conventional techniques if it is to be adopted.  
 
7.8 Experimental Section 
Drug compounds GSKA-E were supplied by GSK and further details regarding compound 
structure and polymorphism can not be provided due to commercial sensitivity. Compound 
44 was synthesised by Masters student Gary Cameron under the supervision of Jonathan 
Foster. Further details regarding the synthesis of compounds 17 and 20 are provided in 
Chapter 2 and 41, 43  and 44 in Chapter 6. The low temperature solution phase study was 
undertaken by Reshma Chudasama. Raman spectroscopic measurements were preformed on 
a Thermo Scientific, Nicolet, NXR9650 Raman spectrometer.  
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Table 30 Summary of phases found at various temperature for 0.2wt% 44, assignments of crystal forms from previously undertaken solution study, gelation and crystal data 
for 20-4°C gel phase study of GSK-D of studies in various binary solvent mixtures. 
  
Solvent System (3:7) 
44 Gel study[a] Sol.[b]  Low Temperature GSK-D study[c] mg/ml High temperature GSK-D study[d) 
1
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1 water:formamide I I I   
 
  
   
1 20   S Y Precipitate 2 
2 water:ethylene glycol I I I   
 
  
   
1 20   S Y Precipitate 2 
3 methanol:water I I I   
 
  
   
1 20   S Y Precipitate 2 
4 methanol:methanol S PG PG - S G O - - 5 10   G Y Yellow Precipitate + Blocks 2+2 
5 2-methoxyethanol:2-methoxyethanol S S PG 2 S PG O Needles X 5 10   G O Red crystal + yellow needles above 2+1 
6 2-methoxyethanol:dichloromethane S S S   
 
  
   
10 10   P 
 
White fibres/yellow precip 1 
7 acetonitrile:chloroform S S PG 3 S S Y Needles and plates 2 5 10   PG Y Long blocks 2 
8 acetone:acetone S G G UA S G O Fine needles + Plates above 2 +3 2 20   G Y Block 2 
9 acetone:tetrachloroethylene S G G 2 PS G Y Plate above 3 2 10   S S Block 2 
10 2-butanone:2-butanone S G G 2 S G Y Plate above 3 2 20   S 
 
O block on surface, Y block above 2+1 
11 2-butanone:methyl acetate S G G - PS G Y Long needles/plates 1/3  2 20   G Y Block 2 
12 2-butanone:ethylene glycol S S S   
 
  
   
10 20   G O Block 2 
13 dichloromethane:methanol S S S   
 
  
   
10 20   G 
 
Blocks  2 
14 dichloromethane:ethylene glycol S P P   
 
  
   
10 10   Oil O Oil - 
15 methyl acetate:2-methoxyethanol S S PG 2 S G O Small needles X 5 10   G O Plates above - 
16 methyl acetate:1,2-dimethoxyethane S G G 2 S G Y Plate above 3 2 10   G Y -   
17 methylisobutyl ketone:1-propanol S G G   
 
  
   
2 10   G Y -   
18 methylisobutyl ketone PS PG PG - PS PG Y - - 1 20   G Y Long blocks 2 
19 methylisobutyl ketone:nitrobenzene S G G   
 
  
   
2 20   G Y White precipitate 3 
20 chloroform:nitromethane S PG PG   
 
  
   
5 20   G Y Fibres on bottom + blocks above 1+2 
21 chloroform:chloroform S S S 3 S S Y Block above 2 10 10   G Y White fibrous material   
22 ethyl acetate:acetonitrile S G G - S G O Yellow needles 2? 2 20   G Y Block 2 
23 ethyl acetate:ethyl acetate PS G G - PS G Y Blocks above 3 1 10   G Y Needles above * 
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Solvent System (3:7) 
44 Gel study[a] Sol.[b]  Low Temperature GSK-D study[c] mg/ml High temperature GSK-D study[d) 
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24 ethyl acetate:1-methyl-2-pyrrolidinone S S S  - 
 
  
   
10 10   S O -   
25 chlorobenzene:dimethyl sulfoxide S S S DMSO S S Y Mesh of needles UA 10 10   S Y -   
26 chlorobenzene:N,N-dimethylformamide S S S  - 
 
  
   
10 10   PG R -   
27 tetrahydrofuran:nitromethane S PG PG - S G Y Cylinders  1 5 10   G Y Blocks 2 
28 tetrahydrofuran:acetone S PG PG 2 S G YO Needles on surface 2 5 20   G Y Blocks + needles above * 
29 diethyl ether:chloroform S P P   
 
  
   
5 10   G Y Blocks + needles above * 
30 toluene:ethyl acetate PS G G - PS G Y Mesh of needles 1 1 10   G Y Blocks + needles above * 
31 toluene:tetrahydrofuran S G G - S G YO 
  
2 10   
W
G Y -   
32 cyclohexane:1-methyl-2-pyrrolidinone S S S  - 
 
  
   
10 10   S Y -   
33 cyclohexane:N,N-dimethylformamide S S S  - 
 
  
   
10 10   S O -   
34 heptane:ethyl acetate PS WG PG  - 
 
  
   
1 10   PG Y -   
35 heptane:tetrahydrofuran S G G  - 
 
  
   
2 10   G Y Cloudy   
36 1-butanol:tetrachloroethylene S G WG 2 S G YO - 
 
5 20   G Y Block needles 1 
37 2-propanol:chloroform S S S 3 S S Y Cylinders 2 10 20   S Y P + fine needles above * 
38 3-methyl-1-butanol:3-methyl-1-butanol S WG G - S G O - 
 
5 10   G Y Fine needles 1 
39 DMAc:carbon disulfide S S S  - 
 
  
   
10 10   S Y -   
40 N,N-dimethylacetamide:anisole S S S - S S O Cylinders  2 10 20   G Y Precipitate 2 
41 1-methyl-2-pyrrolidinone:water I I I  - 
 
  
   
1 10   S Y Precipitate   
42 1-methyl-2-pyrrolidinone:2-butanone S S S 2 S S YO - 
 
10 10   PG Y -   
43 1-methyl-2-pyrrolidinone:toluene S S S  - 
 
  
   
10 20   G Y -   
44 
1-methyl-2-pyrrolidinone:carbon 
disulfide S S S  - 
 
  
   
10 10   S Y -   
45 1-methyl-2-pyrrolidinone:acetic acid S S S UA S S O Clump of needles above  1 10 10   S Y Blocks 2 
46 1-methyl-2-pyrrolidinone:DMAc S S S  - 
 
  
   
10 10   S Y -   
47 pyridine:2-methoxyethanol S S S  - 
 
  
   
10 20   G R Needles above * 
48 pyridine:1,4-dioxane S S S  - 
 
  
   
10 20   G Y Needles above * 
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Solvent System (3:7) 
44 Gel study[a] Sol.[b]  Low Temperature GSK-D study[c] mg/ml High temperature GSK-D study[d) 
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49 anisole:N,N-dimethylformamide S S S  - 
 
  
   
10 20 S G O -   
50 tetrachloroethylene:acetonitrile S PG PG  - 
 
  
   
5 20 S G Y Needles above and in gel 1 
51 tetrachloroethylene:ethanol S PG PG 2 S G OY Needles from surface 1 5 20 S G Y Fine needles 1 
52 tetrachloroethylene:acetic acid S S S UA S S R Long fine needles-solution 1 10 20 S S Y Needles 1 
53 hexane:carbon disulfide S PG PG  - 
 
  
   
5 20 I I Y Blocks 2 
54 1-pentanol:pentane x X X  - 
 
  
   
2 10 PS G Y Blocks 2 
55 pentane:methylisobutyl ketone I I I  - 
 
  
   
1 10 S WG Y Needles 1 
56 p-xylene:methanol S S S 2 S S O Needles above UA 10 10 S G YO Needles 2 
57 p-xylene:dimethyl sulfoxide S S S DMSO S S OY Needles UA 10 10 S S YO -   
58 p-xylene:chlorobenzene S WG WG 2 PS G Y - 
 
5 10 PS G Y Gelator   
59 2-methyl-1-propanol:diethyl ether PS PG PG  - 
 
  
   
1 10 PS G Y Blocks 2 
60 2-methyl-1-propanol:diisobutyl ketone PS G G  - 
 
  
   
1 20 PS G Y Long needles 1 
61 2-butanol:toluene S PG PG 2 S G YO Needles above and below 1 5 10 S G Y Needles above * 
62 isopropyl acetate:methylisobutyl ketone PS PG PG - PS G Y Yellow needles 1 1 20 S G Y Blocks 2 
63 isopropyl acetate:heptane PS PG PG  - 
 
  
   
1 20 I I Y Blocks + gelator 2 
64 isopropyl ether:isobutyl acetate PS G G  - 
 
  
   
1 20 PS G Y Fine needles 1 
65 DMF:tetrahydrofuran S S S  - 
 
  
   
10 20 S G Y -   
66 N,N-dimethylformamide:2-propanol S S PG  - 
 
  
   
5 20 S G O Needles UA 
67 1,2-dimethoxyethane:benzonitrile S WG WG  - 
 
  
   
5 20 S G Y Needles UA 
68 ethylene glycol:acetonitrile S S PG  - 
 
  
   
5 20 S S O Fibres + orange block 1  
69 isobutyl acetate:1,2-dimethoxyethane S WG WG  - 
 
  
   
5 20 S G Y -   
70 isobutyl acetate:isobutyl acetate I I I 2 X X X - 
 
1 10 S ? 
  
2 
71 methylcyclohexane:nitrobenzene S G G 3 PS G Y Clump of plates/needles 1 2 10 S G Y Cloudy   
72 benzonitrile:cyclohexane PS G G  - 
 
  
   
1 10 S G Y Needles 1 
73 benzonitrile:1-methyl-2-pyrrolidinone S S S  - 
 
  
   
10 10 S S Y -   
74 benzyl alcohol:benzyl alcohol S S S 2 S S O - 
 
10 10 S G Y -   
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Solvent System (3:7) 
44 Gel study[a] Sol.[b]  Low Temperature GSK-D study[c] mg/ml High temperature GSK-D study[d) 
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75 2-pentanol:2-pentanone S G G  - 
 
  
   
2 10 S G Y Needles above * 
76 2-methyl-2-butanol:acetic acid S S S  - 
 
  
   
10 10 S G Y Branched needles 1 
77 2-pentanone:methyl-t-butyl ether PS PG PG 2 I I Y - 
 
1 10 S G Y Needles above * 
78 2-pentanone:p-xylene PS G G 2 I I Y Yellow needles 1 1 10 S G Y -   
79 2-pentanone:2-pentanone PS PG PG  - PS G Y Needles above 1 1 10 S WG Y Orange block 2 
80 butyronitrile:1-butanol S WG G  - 
 
  
   
5 10 S G Y Orange blocks + fine needles 2+1 
81 butyronitrile:butyronitrile S G G  - X X X - 
 
2 10 S S Y Needles 1 
82 diisobutyl ketone:1,4-dioxane S G G  - 
 
  
   
2 10 S G Y -   
83 diisobutyl ketone:DMAc S S G  - 
 
  
   
5 10 S S Y -   
84 diisobutyl ketone:diisobutyl ketone I I I  - I I Y - 
 
1 10 PS S Y Needles 2 
85 1-octanol:pyridine S S S  - 
 
  
   
10 10 S G O Plates above * 
86 1-octanol:1-octanol PS WG WG  - I X X - 
 
1 20 S G Y Fine needles 1 
87 cyclohexanol:isopropyl acetate S G G 2 S G Y Fine needle above 1 2 20 S G Y Branched needles 1 
88 t-butanol:butyronitrile S G G 2 S G O Fine needle above 1 2 20 S G O Orange blocks 2 
89 2-ethyl-1-hexanol:chloroform S S S 2 S S Y Needles/plates  2 10 10 S P 
 
White precip 2 
90 1-heptanol:cyclopentyl methyl ether PS PG PG 2 PS G - - 
 
1 10 S G Y -   
91 
3-methyl-2-butanol:cyclopentyl methyl 
ether S WG PG 2 PS G OR Needles above  UA 5 10 S G R Needle blocks above * 
92 1-hexanol:dimethyl carbonate S WG WG  - 
 
  
   
5 10 S G Y -   
93 Methanol:acetic acid (80%) S PG PG  - 
 
  
   
5 10 S G Y Fine precip 2 
94 1-methyl-2-pyrrolidinone S PG PG 2 S S O - 
 
5 10 S G Y Needles 1 
95 methanol:THF S S S  - S S O Thick needles above 1 10 10 S PG Y -   
96 Methanol:1-methyl-2-pyrrolidine S S S  - S S O Blocks 2 10 10 S G RO -   
S = Solution/soluble, PS = partially soluble, I = Insoluble, G= Gel, PG= Partial Gel, WG = Weak gel, A,B,C refer to non-solvated forms A-C, DMSO refes to DMSO solvate, colour refers to solution with Y = yellow,  
O=orange, R=Red, YO, OY, OR colours in between  Blank space= experiment not undertaken, - no result reported, * insufficient time to complete experiment. [a] Mixed solvents were dispensed into vials containing 
0.2 % w/v 44 and heated to 120°C then cooled to 20°C and 4°C.  [b] Results of solution phase experiment previously undertaken [c] Filtered solutions saturated at room temperature with GSK-D were added to vials 
containing 0.2 % w/v 44 and heated to 120°C then cooled to 4°C. [d] Given masses of 44 and GSK-D were dispensed into vials along with 1 ml of mixed solvent. The vial was sealed and heated until all solid was 
dissolved and allowed to cool to room temperature.
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Chapter 8: Conclusion 
This thesis has contributed a number of new urea based gelators to the growing body of 
LMWGs in the literature. The bis-urea motif employed proved highly successful at bringing 
about gelation in molecules functionalised with a range of different spacer and peripheral 
groups. The series based on oligomethylene spacers functionalised with different amino acids 
identified a number of ‘optimal’ compounds (notably 17 and 20) which produced robust gels 
in a variety of solvents.  Small differences in spacer length and R-group were found to have a 
dramatic impact upon gelation behaviour and conformational flexibility resulted in extensive 
polymorphism. The series was successfully extended to include 1- and 2- pyrenylalanine 
gelators (35 and 36) which proved effective gelators as well as ROY and CBZ mimics (39 
and 42). In general the more rigid diphenyl methyl spacer proved more tolerant of competing 
hydrogen bonding functionalities and in reliably forming gels in a wider range of solvents. 
Compound 44 was particularly remarkable in reliably forming gels in over 52 different 
solvents at very low gelator concentrations (typically 0.2 % w/v).  
 
The complex, hierarchical nature of gels with their solid-like structure but predominantly 
liquid-like composition presents a number of challenges to their study. Solid state analytical 
techniques such as crystallography, XRPD and IR revealed the importance but inadequacy of 
molecular packing in explaining gelation behaviour. SEM provided valuable insight into the 
higher order structure of the gels revealing a number of distinct fibre morphologies associated 
with different gelators, polymorphs and mixed gel systems. Analysis of polymers templated 
by gelators 17 and 20 corroborated the differences in fibre shape and size distribution 
observed in the xerogels. Rheometry allowed characterisation of the gels in their native state 
and confirmed gelation in the systems tested. The use of fluorescent gelators provided 
another handle with which to investigate gelator behaviour both in solution and in the gel 
state. However, as with a number of the other mixed gel systems, the pyrenylalanine gelators 
were found to induce changes in gel fibre morphology and molecular packing.  
 
As observed in related urea systems, anions were found to disrupt urea hydrogen bonding 
interactions leading to dissolution of the gels. Disruption of the macroscopic structure of the 
gels as measured by rheology was found to occur at considerably lower concentrations of 
anions than required to prevent aggregation of the gelator molecules as measured by 
fluorescence. This mechanism was effectively utilised to aid recovery of crystals grown in 
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LMWGs. However, limitations due to the solubility and effectiveness of anions in different 
solvents, and their tendency to dissolve crystals, mean gels which respond to alternative 
stimuli (e.g. electrochemical, light etc.) may be more suitable for this application.   
 
The gels were developed towards a number of applications. The different architectures of 
gelators 17 and 20 enabled the templation of porous polymers with different pore shapes 
which may find applications in filtration. The fluorescent response exhibited by gelators 35 
and 36 upon binding to acteate, but not tetrafluoroborate, makes them suitable for use as an 
anion sensor. The ability to turn gelation on and off or tune the rheology of the gel system 
using anions allows the gels to be used as ‘smart’ materials for applications such as drug 
delivery and crystal recovery.  
 
Proof of principle was demonstrated for the crystallisation of a wide range of 
pharmaceutically relevant compounds from LMWGs. A number of differences were observed 
in crystal habit and polymorphism in crystals grown from gels compared with those grown 
from solution. It proved possible to design LMWGs which incorporate specific functionalities 
into their structure which mimic those of the drug compound being crystallised. Gelator 43, 
which incorporated a nitroaniline group to mimic that of ROY, showed some promise in 
bringing about a higher proportion of the R-form than observed from solution or generic gels 
and should be investigated further. The potential of supramoelcular gels for use in early stage 
screening of pharmaceutical compounds in an industrial setting was shown to be feasible during a 
placement with the particle science group at GSK in Stevenage. The high temperatures required 
to form the gels and need to control sample cooling are two factors which require further 
development. The inherent reversibility of the gels, their ability to gel a wide range of solvents 
and opportunity to design gelators incorporating specific functionalities mean LMWGs hold great 
promise as a medium for crystal growth. 
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